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Abstract 
Modelling and Investigation of NMDAR-Mediated Calcium 
Signalling at Hippocampal Dendritic Spine in Alzheimer’s Disease 
by 
Jingyi Liang 
 
Alzheimer’s disease (AD) is a devastating, incurable neurodegenerative disease affecting 
millions of people worldwide. Dysregulation of intracellular Ca2+ signalling has been 
observed as an early event prior to the presence of clinical symptoms of AD and is believed to 
be a crucial factor contributing to its pathogenesis.  
Mathematical modelling and computational analysis offer great opportunities to overcome the 
experimental limitation and investigate alterations in AD to advance our understanding of the 
Ca2+ dysregulations of AD and their contributions to disease pathology. In this study, we 
develop a mathematical model of a CA1 pyramidal dendritic spine, integrating essential 
components and reactions related to NMDAR-mediated Ca2+ response in the dendritic spine. 
We conduct computational experiments using this model to mimic alterations under AD 
conditions to investigate how they are involved in the Ca2+ dysregulation in the dendritic 
spine. The alterations in glutamate availability, as well as NMDAR availability and activity, 
are studied individually and globally. The simulation results suggest that alterations in 
glutamate availability mostly affect synaptic response and have limited effects on 
extrasynaptic receptors. Overactivation of extrasynaptic NMDARs in AD is unlikely induced 
by presynaptic stimulation, but by upregulation of resting level of glutamate, possibly resulted 
from these alterations. Furthermore, internalisation of synaptic NR2A-NMDAR shows great 
damage to postsynaptic Ca2+ response in comparison with the internalisation of NR2B-
NMDARs, thus, the suggested neuroprotective role of the latter one is very limited during 
synaptic transmission in AD. 
We also simulate alterations of the internal Ca2+ store, ER, under AD conditions by including 
ER-related components to the model and investigate how these alterations affect the roles of 
ER in NMDAR-mediated Ca2+ response in the spine head. Simulation results suggest that the 
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proposed neuroprotective function of up-regulation in RyR expression may make the cell 
more vulnerable by amplifying the cytosolic Ca2+ level. The simulation results also suggest 
alterations in ER may have more impacts in basal synaptic transmission than high frequency-
induced transmissions in AD. In addition, the simulation results predict that inhibition of 
SERCA pumps may be beneficial to rescue the spine head from Ca2+ dysregulation by ER 
Ca2+ overload in AD. 
To further study the effects of alterations of NMDARs in their roles in downstream events, we 
add a CaMKII state transition model to the downstream of our Ca2+ model to study how 
alterations of NMDAR affect CaMKII state transition, an important event in the early phase 
of  LTP. Simulation results suggest a cooperation between NR2A- and NR2B-NMDAR is 
required for LTP induction. Under AD conditions, internalisation of membrane NMDARs 
may be the cause of loss of synapse number by disrupting CaMKII-NMDAR formation. 
 
Keywords: Alzhemer’s disease, Amyloid-β, Ca2+ dysregulation, glutamate transimission, 
AMPAR, NMDAR, ER, CaMKII-NMDAR formation, mathmatical modelling, parameter 
esitimation, ordinary differential equations 
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In pyramidal neurons of the hippocampus, N-methyl-D-aspartate receptor (NMDAR) and α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) at membrane play 
crucial roles in mediating the Ca2+ response of postsynaptic neuron and synaptic plasticity 
formation (Regehr and Tank 1990). Dysregulations of these membrane receptors have been 
exclusively studied and are believed to contribute to pathological changes in AD (Danysz and 
Parsons 2012). Inside the neuron, Endoplasmic reticulums (ERs) as the largest intracellular 
Ca2+ stores are widely distributed within neurons and participate in Ca2+ signalling. ER Ca2+ 
dysregulation in neurons has been shown to further affect downstream events, such as 
triggering membrane hyperpolarization, reducing electrical excitability and mitochondrial 
dysfunction (Stutzmann, Caccamo et al. 2004, Schon and Area-Gomez 2013). It is believed 
that alteration of ER Ca2+ signalling is a key upstream event in AD pathophysiology that 
initiates and accelerates other severe events such as amyloid plaque deposition and neuronal 
apoptosis (Cheung, Shineman et al. 2008). Ca2+ dysregulation in ER contributes to the 
persistent rise in cytosolic basal Ca2+ level, which in turns affects sleep/wake cycle (Berridge 
2014). In AD, increase in wakefulness significantly disrupts the processes of memory 
consolidation and erasure during sleep, and contributes to the loss of memory. Upregulation 
in basal Ca2+ level observed in AD transgenic mice is suggested to interrupt mechanisms 
related to learning and memory (Kuchibhotla, Goldman et al. 2008). Increase in intracellular 
Ca2+ level shows to enhance long-term depression (LTD), a form of synaptic plasticity which 
weakens synapses, and may result in memory deficits (Li, Hong et al. 2009). Other key 
features of AD, such as inflammation and oxidative stress, are also related to intracellular 
Ca2+ dysregulation. Chronic neuroinflammation is one of early features of AD, which is 
critically linked to the disease pathogenesis (Ferreira, Clarke et al. 2014). Inflammation can 
be induced by amyloid-β (Aβ) directly or by increasing oxidative stress during aging in the 
brain (Floyd and Hensley 2002, Berridge 2014). Inflammatory responses of astrocytes and 
microglia lead to local aberrant Ca2+ signalling as well as promote Ca2+ signalling in neurons, 
contributing to memory loss and apoptosis in AD (Berridge 2014). Beside inflammation, 
increased generation of reactive oxygen species (ROS) during aging or stimulated by Aβ can 
affect Ca2+ signalling pathway directly (Christen 2000). This leads to elevated intracellular 
Ca2+ level and causes excitotoxic effects and neuronal death (Ermak and Davies 2002, Uttara, 
Singh et al. 2009). Meanwhile, the increased intracellular Ca2+ level stimulates mitochondria 
and induce excessive mitochondria ROS formation, leading to aggravated neuronal oxidative 
stress (Müller, Cheung et al. 2011).  
In addition to important roles in enormous intracellular responses, intracellular Ca2+ dynamics 
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regulates intercellular communication between neurons and between neurons and other cells 
(Pasti, Volterra et al. 1997, Augustine 2001). Abnormal intracellular Ca2+ in presynaptic 
terminal impairs the release of neurotransmitters (Palop and Mucke 2010). This will disturb 
synaptic transmission and ultimately result in aberrant network activity. Moreover, 
appropriate spino-dendritic compartmentalization provides a foundation for proper neuronal 
signalling and intercellular communication. In AD transgenic mice, intracellular Ca2+ 
dysregulation is related to the loss of Ca2+ compartmentalization and alteration of neuronal 
morphology, which affect dendritic signal integration and interneuronal communication 
(Kuchibhotla, Goldman et al. 2008). Besides, exosome is one of important factors for 
interneuronal communication, by which lipids, proteins and RNAs can be transferred to target 
neurons. Its secretion is strongly promoted by increased intracellular Ca2+ (Chivet, Hemming 
et al. 2012). In AD, release of pathogenic proteins, such as Aβ, amyloid precursor protein 
(APP), Tau and cystatin C in AD, is also associated with exosome secretion. This might 
explain the spreading of the pathology of AD in the nervous system in the brain (Rajendran, 
Honsho et al. 2006, Ghidoni, Paterlini et al. 2011, Chivet, Hemming et al. 2012). 
Furthermore, reduced local connectivity and disturbed global functional organization have 
been observed in brains of AD patients (Supekar, Menon et al. 2008). It is suggested that 
these dysregulation on local interneuronal communication may underlie the mechanisms of 
disturbances on brain synchrony and functional connectivity among distinct brain regions 
(Arendt 2009, Sanz-Arigita, Schoonheim et al. 2010).  
 
 
 
 
 
 
 
 
4 
 
1.2 Motivation and main research questions 
Ca2+ dysregulation in the dendritic spine has been reported in response to different alterations 
in AD conditions (see Chapter 2). Under experimental conditions, the resulting effects of 
these alterations are being studied in transgenic animal models or by injecting certain factors, 
such as Aβ, into healthy animals or cells. It is expensive and challenging to study these 
complex behaviours because of the limitations of the current available technology. 
Controversial results from different research groups may be due to different experiment 
materials or methods they used. Systems biology provides great opportunities to study this 
kind of problem, using mathematical modelling and computational methods. Therefore, 
insights can be obtained by properly interpreting the simulation results from thoughtfully-
designed computational experiments. In this thesis, we aim to answer the following questions 
on the Ca2+ dysregulation in AD using mathematical modelling: 
(1) How would alterations in glutamate transmission and NMDARs reported in AD affect the 
Ca2+ response in the dendritic spine? Which type of alteration is the most vulnerable one?  
To answer this question, we need to select key alterations that have previously been suggested 
to link to Ca2+ dysregulation of the spine head in AD. A mathematical Ca2+ model then needs 
to be developed to represent a CA1 pyramidal dendritic spine, according to published 
experimental observations or data. The model should also able to test the selected alterations 
after including the relevant mechanisms. The simulation results should be able to bring new 
insights about dysregulation in NMDAR-mediated postsynaptic Ca2+ responses by different 
alterations in AD. 
 (2) As the major internal Ca2+ source, how would ER affect the Ca2+ response in the 
postsynaptic spine head under AD conditions? How may these effects contribute to synapse 
dysfunction?  
To answer these questions, we need to take the ER Ca2+ signalling into consideration. The 
Ca2+ model should be modified by putting ER components into suitable locations in the spine 
head model, and certain parameters should be calibrated or estimated in the presence of ER. 
Then, this model is used to test key alterations in ER in AD. The simulation results should 
provide predictions on the impacts in the postsynaptic Ca2+ response by different alterations in 
ER. 
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(3) How would alterations in synaptic NMDARs affect their roles in Ca2+ signalling and in the 
downstream form of the CaMKII-NMDAR complex, a critical factor in long-term potentiation 
(LTP) induction? Which alteration would predominantly suppress NMDAR-mediated LTP 
induction? What pathological consequences in AD may these effects link to?  
To answer these questions we add components related to the CaMKII-NMDAR complex 
formation into the Ca2+ model. Then, with this model, we investigate the effects of different 
alterations of NMDARs on Ca2+ signalling as well as downstream key events leading to 
CaMKII-NMDAR complex formation. The simulation results should provide new insights into 
contributions by subunit-specific alterations of synaptic NMDARs in postsynaptic responses. 
1.3 Objectives for this study  
This study invesitgat key alterations related to Ca2+ signalling in spine head in AD using 
mathmatical models of  CA1 pyramidal dendritic spine. There are three major objectives in 
this study.  
(1) To investigate the effects of Aβ-dependent disturbances in NMDAR-mediated Ca2+ 
dynamics in the dendritic spine 
We develop a mathematical model based on the characteristics of the CA1 pyramidal 
dendritic spine. This model integrates the major events of the NMDAR-mediated Ca2+ 
response to presynaptic stimulation the dendritic spine. We use this model to mimic Aβ-
dependent alterations in the availability of glutamate and NMDAR, as reported under the AD 
condition. By manipulating the key parameters related to these alterations, we explore their 
effects on the postsynaptic Ca2+ responses, both individually and globally. 
(2) To investigate the effects of disturbances of ER in the NMDAR-mediated Ca2+ 
dynamics in the dendritic spine 
We extend the model developed for Objective (1) by including the ER components in the 
model. We focus on major alterations relating to Ca2+ handling by ER under the AD 
condition, and analyse the effects of them on the Ca2+ response in the spine head. 
(3) To study the effects of Ca2+ dysregulation in a chosen downstream event, CaMKII-
NMDAR complex formation  
We add a model of the state transitions of CaMKII downstream to our Ca2+ model to 
understand the contributions of NMDAR to the NMDAR-dependent LTP. We use this model 
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to investigate the roles of NMDARs with different subunit compositions - as a Ca2+ channel 
and as a binding partner of CaMKII in the PSD. We also investigate the effects of disturbances 
on the availability of different NMDARs under AD conditions on the Ca2+ signalling and 
downstream CaMKII activation.  
1.4 Thesis structure 
This thesis consists of six chapters. Figure 1.1 illustrates the organization of chapters and the 
main research questions to be answered in Chapters 3 to 5, respectively, are also included. 
In the current chapter, Chapter 1, we introduce AD and Ca2+ dysregulations in AD and discuss 
the motivations and objectives of the thesis. Chapter 2 reviews the experimental findings of 
Ca2+ dysregulation in AD, including the latest publications. We also discuss existing 
computational modelling approaches in Ca2+ signalling studies and their potential to 
understand the underlying causes of AD. In Chapter 3, we develop a mathematical model of a 
CA1 pyramidal dendritic spine. We use this model to explore proposed disturbances of Aβ 
under the AD condition and their contribution to glutamatergic signalling and NMDAR-
mediated Ca2+ signalling in the dendritic spine. Chapter 4 extends the Ca2+ model in Chapter 
3 with intracellular ER components to investigate the major alterations of ER reported in AD, 
and their roles in Ca2+ signalling in the dendritic spine on AD pathology. Chapter 5 links our Ca2+ 
model to a CaMKII state transition model. We use the integrated model to extend our 
understanding of the effects of disturbances on NMDAR availability under AD conditions on 
downstream CaMKII activation in the early phase LTP. In the final chapter, Chapter 6, we 
summarise the work and the contribution of this thesis and suggest future directions that could 
be taken to broaden our understanding about Ca2+ dysregulation in AD. 
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Figure 1.1. Chapter organization of the thesis. 
 
  
Chapter 3. Ca2+ Model 
How do Aβ disturbances under AD conditions affect 
glutamatergic signalling and NMDAR-mediated Ca2+ signalling 
in the postsynaptic spine? 
Chapter 4. Extended Ca2+ Model 
How do disturbances in the ER under AD conditions affect the 
postsynaptic Ca2+ response? 
ER components 
Chapter 1. 
Introduction 
Chapter 2. 
Literature Review 
Chapter 5. NMDAR-dependent CaMKII State Transition model 
How do synaptic NMDAR alterations reported in AD disrupt the 
downstream CaMKII state transition in E-LTP? 
 
 
CaMKII state transition model 
Chapter 6. 
Conclusion and Future Directions 
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2.1.2 Glutamate receptors 
Once released, glutamate can activate both metabotropic glutamate receptors (mGluRs) and 
ionotropic glutamate receptors (iGluRs) (Michaelis 1998, Dingledine, Borges et al. 1999). 
The mGluRs themselves do not function as ion channels, instead, they trigger other signalling 
pathways, indirectly leading to cellular events, such as the opening of ion channels. The 
opening of intracellular Ca2+ channels initiated by the activation of mGluRs is discussed in 
Section 2.1.3. The iGluRs are located at chemical synapses, both pre- and postsynaptically, 
and mediate vesicle fusion and postsynaptic response, respectively (Engelman and 
MacDermott 2004). iGluRs have also been found in the extrasynaptic space, where they can 
be activated by glutamate spillover from the synaptic cleft or by the ectopic release of 
glutamate, such as  release from the adjacent glia (Fellin, Pascual et al. 2004, Petralia, Wang 
et al. 2010). In the  mammalian central nervous system, there are three major types of iGluRs: 
AMPAR, NMDAR and the kainate receptor. The kainate receptor is less well studied than the 
other two and is not the focus of this research. AMPAR and NMDAR are mobile and their 
trafficking from their synthesis sites and between the synaptic and extrasynaptic zones is 
crucial to their synaptic transmission and the formation of different forms of synaptic 
plasticity (Collingridge, Isaac et al. 2004). 
2.1.2.1 NMDAR 
NMDAR is the major type of Ca2+ channel contributing to the postsynaptic Ca2+ response in 
pyramidal neurons of the hippocampus (Bloodgood and Sabatini 2007). Morover, it has also 
been found at extrasynaptic locations, such as the dendritic spine neck, the dendritic shaft, and 
in  neuron bodies.  It is a heterotetramer, mostly comprising two NR1 and two NR2 subunits 
(Furukawa, Singh et al. 2005). There are eight and four splice variants of NR1 and NR2 
subunits, respectively. Those subunits share similar membrane topologies in that they contain 
an extracellular N-terminal domain with three transmembrane regions (M1, M3 and M4), a 
pore lining region (M2), an extracellular N-terminus and an intracellular C-terminus (Cull-
Candy 2001). The agonists bind to the their extracellular binding domains; in NR1 subunits it 
is the glycine-binding site, whereas in NR2, it is the glutamate-binding sites. To activate 
NMDAR, all binding sites at the four subunits need to be occupied. Therefore, it requires the 
binding of two molecules of glutamate to the NR2 subunits and two molecules of agonist to 
the NR1 subunits. Recent research has found that NMDARs at different locations are gated by 
different co-agonists: D-serine for the synaptic NMDARs and glycine for the extrasynaptic 
NMDARs (Papouin, Ladépêche et al. 2012). The affinity for glutamate by NMDAR depends 
on their NR2 subunit composition. The NMDAR subunit compositions at different locations 
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change during postnatal development (Petralia 2012). The ratio of NR2A to NR2B increases 
at the synaptic site and decreases at the extrasynaptic site during postnatal development. In 
mature synapses, NR2A-NMDARs are predominant at the synaptic sites, which take about 
60% of the total synaptic NMDARs (Cheng, Hoogenraad et al. 2006). In contrast, NMDARs 
located outside the synaptic region are mainly NR1/NR2B-NMDARs. They are proposed to 
play opposite physiological roles in mediating intracellular signalling and death pathways: 
activation of synaptic NMDARs shows neuroprotective effects, whereas stimulation of 
extrasynaptic NMDARs contributes to cell death (Hardingham and Bading 2010).  
In addition to the binding of glutamates and their co-agonists, Ca2+ entry through NMDAR 
requires the relief of Mg2+ blocks (Mayer, Westbrook et al. 1984). The Ca2+ permeation of 
NMDAR is mainly mediated by the M2 and M4 regions. The receptor is voltage-dependent 
and blocked by physiological concentrations of Mg2+ at resting membrane potential. During 
stimulation, the Mg2+ block is relieved by membrane depolarization, which can be produced 
by the opening of AMPARs. NMDARs are often found to be co-localized with AMPARs at 
the central synapses (Dingledine, Borges et al. 1999).       
2.1.2.2 AMPAR 
AMPAR is not permeable or less permeable to Ca2+ in comparison to NMDAR (Michaelis 
1998). The activation of AMPAR by glutamate is fast and leads to a brief depolarization that 
only lasts for a few milliseconds. When the so-called excitatory postsynaptic potentials 
(EPSPs) generated by AMPAR are large enough, they will generate an action potential at the 
postsynaptic neuron. Therefore, the number of AMPAR in PSD is crucial for synaptic 
transmission and different types of synaptic plasticity formation. Their numbers in PSD are 
not fixed but are precisely mediated by the trafficking mechanisms (Collingridge, Isaac et al. 
2004).     
2.1.3 ER  
Intraneuronally, NMDAR-dependent Ca2+ influx is augmented via Ca2+-induced Ca2+ release 
(CICR) from intracellular Ca2+ stores. In the ER, Ca2+ homeostasis and signalling are 
precisely mediated by release and sequestration mechanisms, via Ca2+ channels and pumps, to 
accomplish the regulation of numerous downstream activities (Berridge, Bootman et al. 2003, 
Verkhratsky 2005). The mechanisms of intracellular Ca2+ signalling is briefly illustrated in 
Figure 2.2. ER Ca2+ handling involves Ca2+ release from the ER through two types of Ca2+ 
channels, inositol 1,4,5-trisphosphate receptors (IP3Rs) and ryanodine receptors (RyRs), and 
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Ca2+ uptake via the Ca2+ pumps, the sarcoendoplasmic reticulum Ca2+ transport ATPase 
(SERCA) pumps. Two separate mechanisms involved in the process of Ca2+ release from the 
ER via IP3Rs and RyRs are inositol 1,4,5-trisphosphate (IP3)-induced Ca2+ release and Ca2+-
induced Ca2+ release (CICR), respectively. 
 
Figure 2.2. Neuronal ER Ca2+ signalling. Intracellular Ca2+ concentration is regulated 
by ion channels (e.g., voltage-gated Ca2+ channels (VGCCs) and ionotropic glutamate 
receptors (iGluRs)) and transporters in the plasma membrane. Intracellularly, the 
regulation of Ca2+ homeostasis involves Ca2+ ions bind to Ca2+ buffer proteins and 
release from organelles, especially ER. Ca2+ ions release from ER via IP3Rs and RyRs 
and uptake by ER via SERCA. Activation of IP3Rs requires IP3, which is generated by 
stimulation of metabotropic glutamate receptors (mGluRs) in the plasma membrane. 
Depletion in ER Ca2+ level promotes Ca2+ influx via membrane store-operated Ca2+ 
channels, such as ORAI, by translocation of the stromal interaction molecules (STIMs) 
into the ER–plasma membrane junctions. Besides, Ca2+ ions in ER can be transported 
into mitochondria via mitochondria-associated ER membrane (MAM) to stimulate 
mitochondrial metabolism. This figure is produced using Servier Medical Art 
(http://www.servier.com/Powerpoint-image-bank). 
 
IP3R is a ligand-gated Ca2+ channel embedded in the ER membrane and is activated by the 
intracellular second messenger, IP3 (Bezprozvanny 2005). IP3-mediated Ca2+ release is 
initiated by the agonist stimulation of G protein-coupled plasma membrane receptors, such as 
mGluRs. Subsequently, mGluRs catalyze the activation of G-proteins, which, in turn, activate 
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phospholipase C (PLC). PLC catalyzes a membrane phospholipid, phosphatidyl inositol-
bisphosphate (PIP2), to release IP3 and diacyl glycerol (DAG) (Mattson, LaFerla et al. 2000). 
In addition, IP3Rs are also regulated by cytosolic Ca2+ after activation, in a rapidly stimulated 
and slowly inhibited, fashion (Foskett, White et al. 2007, Taufiq Ur, Skupin et al. 2009). They 
can interact locally with nearby channels to coordinate Ca2+release in clusters through the 
CICR process (Berridge 1997). This will generate the hierarchical recruitment of elementary 
Ca2+ release events and lead to the propagation of regenerative Ca2+ waves through cells in 
response to strong extracellular stimulation (Foskett, White et al. 2007, Rahman and Taylor 
2009). 
The other Ca2+ channel, RyR, is the largest ion channel protein to date and exists in three 
isoforms, RyR1, RyR2 and RyR3, all of which can be found in the brain (Galeotti, Vivoli et 
al. 2008). These RyR subtypes seem to have different involvement in memory processing, 
synaptic plasticity and other events in the brain (Galeotti, Vivoli et al. 2008, Adasme, Haeger 
et al. 2011). Ca2+ release through RyRs is stimulated by cytosolic Ca2+ ions via the process of 
CICR. Although IP3Rs can also be activated by Ca2+ ions, as mentioned above, CICR is more 
usually related to RyR-mediated Ca2+ release. As an inherent, positive feedback mechanism, 
CICR can greatly amplify the initial Ca2+ signals and contribute to subsequent neuronal 
events, such as neurotransmitter release and Ca2+-dependent gene expression (Hidalgo, Bull et 
al. 2004). 
The SERCA pump of the ER has the highest affinity for Ca2+ and plays an opposite role to the 
Ca2+ channels: it refills the ER by pumping Ca2+ ions back from the cytosol (Green, Demuro 
et al. 2008). SERCAs, together with Ca2+-buffering proteins, Ca2+ pumps and transporters on 
other organelles or plasma membrane, form a Ca2+ buffering system which contributes to 
buffer cytosolic Ca2+ transients and restores the cytosolic Ca2+ concentration back to resting 
levels (Wuytack, Raeymaekers et al. 2002). SERCA pumps are suggested to play an 
interdependent role to refilling ER Ca2+ stores and maintaining the CICR process (Buchholz, 
Pottorf et al. 2012). Furthermore, SERCA pumps are one of the key factors in store-operated 
Ca2+ entry (SOCE), a process involving extracellular Ca2+ influx via the plasma membrane 
Ca2+ channels in response to the depletion of intracellular Ca2+ stores (Stutzmann and Mattson 
2011). The tight coupling between the ER refilling and SOCE is managed by SERCA pumps 
(Manjarres, Rodriguez-Garcia et al. 2010). 
The ER is physically in contact with other cytoplasmic organelles and the plasma membrane. 
Through these contact sites, ER Ca2+ release is closely coupled with other cellular events via 
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communication with other cytoplasmic organelles, especially mitochondria, and with Ca2+ 
channels in the plasma membrane (Elbaz and Schuldiner 2011). Depletion in the ER Ca2+ 
level will cause SOCE and Ca2+ refilling via store-operated Ca2+ channels (SOCs) located in 
the plasma membrane. In the ER, a family of Ca2+ sensor proteins, the stromal interaction 
molecules (STIMs), will be activated by the decreased ER Ca2+ level and translocate into the 
ER–plasma membrane junctions. STIMs can then activate SOCs, such as the ORAI channels, 
and induce the Ca2+ influx via them (reviewed in (Soboloff, Rothberg et al. 2012)). The ER is 
physically connected to the mitochondria by a lipid, raft-like structure, called mitochondria-
associated ER membrane (MAM) (Rowland and Voeltz 2012). The MAM plays important 
roles in multiple cellular functions, including maintaining intracellular Ca2+ homeostasis. It 
allows selective transmission of Ca2+ ions from the ER to the mitochondria and, thereby, 
regulates the functions of the mitochondria and cell survival. This process is regulated by a set 
of proteins localized in the MAMs (reviewed in (Hayashi, Rizzuto et al. 2009)). 
     
2.2 Overview on AD and Ca2+ dysregulation 
AD was first described by Alois Alzheimer in 1906 (Goedert and Spillantini 2006). It is the 
most common form of all neurodegenerative diseases, and it is the leading cause of dementia, 
resulting in progressive loss of memory, cognitive function and, ultimately,  death.  Aging is 
the most important risk factor for developing AD. Based on the age of onset, AD is often 
divided into two categories: early-onset and late-onset. Less than 5 percent of all AD cases are 
early-onset AD, which affects people younger than 65. About 13% of early-onset AD cases is 
familial AD (FAD), because of inherited genetic mutations. In contrast, the rest AD cases, 
including the late-onset ones which have an age of onset of over 65, are called  sporadic AD 
(SAD) and they are not inherited and caused by unestablished factors (Thies and Bleiler 
2013). Noticeably, although FAD and SAD have different onset times and development 
speeds, they present similar neurodegenerative processes, such as a loss of memory and 
neuronal cell death (Stutzmann and Mattson 2011). 
AD is characterised by the the abnormal accumulation of harmful proteins, Aβ protein plaques 
and neurofibrillary tangles in the nervous system (Mattson 2004). It is widely believed that 
these hallmarks are in connection with a massive loss of neurons and synapses in the patients’ 
brains. AD has been identified for more than 100 years, however, to date, the cause of AD is 
still not fully understood. Scientists believe that AD is a result of multiple factors and to explain 
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the underlying mechanisms of AD pathophysiology, various hypotheses have been proposed, 
such as amyloid hypothesis, tau hyperphosphorylation hypothesis, oxidative stress hypothesis 
cholesterol hypothesis and vascular hypothesis (Selkoe 1991, Hardy and Higgins 1992, Francis, 
Palmer et al. 1999, Spires-Jones, Stoothoff et al. 2009). Amyloid hypothesis is the dominant 
hypothesis and many other hypotheses are variants of it (Hardy and Selkoe 2002, Selkoe and 
Hardy 2016). 
2.2.1 Amyloid hypothesis 
The amyloid hypothesis was first proposed in the early 1990s (Selkoe 1991, Hardy and Higgins 
1992). It suggests that AD is initiated by Aβ oligomers and Aβ plaques in brain tissue. Aβ 
deposition may directly injure brain neurons and contribute to neuronal toxicity, neuronal death 
and the subsequent degeneration and cognitive deficiencies in AD patients. During the past 20 
years, Aβ deposition has been widely accepted to be the leading cause of AD by the majority 
of researchers and a large number of experimental research projects are being carried out based 
on the amyloid hypothesis.   
Aβ is produced from a sequence beginning with the cleavage of its precursor, called the 
amyloid precursor protein (APP), by certain secretase enzymes (Patterson, Feightner et al. 
2008, Duyckaerts, Delatour et al. 2009). The process of APP cleavage is illustrated in Figure 
2.3. APP is a transmembrane protein with a long extracellular N-terminal domain, a 
transmembrane domain, and a short intracellular C-terminal domain (Turner, O'Connor et al. 
2003). APP can be cleaved by two different kinds of enzymes, α-secretase and β-secretase, at 
different sites to produce two different peptides. The α-secretase cleaves APP within the 
critical Aβ region that lies in part of the extracellular N-terminal and transmembrane domains. 
The cleavage releases a large soluble amino-terminal fragment, sAPPα, and a smaller C-
terminal fragment, which will be further cleaved by γ-secretase. Cleavage by α-secretase 
prevents the generation and release of the Aβ peptide and, thereby, it is called the non-
amyloidogenic pathway in APP processing. In the alternative amyloidogenic pathway, APP is 
cleaved by β-secretase outside the critical Aβ region, releasing sAPPβ and a smaller C-
terminal fragment. The γ-secretase further cleaves the C-terminal fragment releasing the Aβ. 
The majority of Aβ peptides are 40 residues in length (Aβ40), while a small proportion (≈10%) 
are 42 residues in length (Aβ42) (LaFerla, Green et al. 2007). Compared with Aβ40, Aβ42 is 
more hydrophobic and readily forms amyloid plaques, which are considered to play a causal 
role in the progression of AD (Patterson, Feightner et al. 2008). Therefore, Aβ42 is believed to 
be the most neurotoxic form of the Aβ peptides. 
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Figure 2.3. The process of APP cleavage. The transmembrane protein APP can undergo 
a series of proteolytic cleavage by different secretase enzymes. When it is cleaved by α-
secretase in the middle of the Aβ domain, it is not amyloidogenic. However, when APP is 
cleaved by β- and γ-secretase enzymes, neurotoxic Aβ peptides are released, which can 
accumulate into oligomer aggregates. Mutations in the APP gene tend to inhibit cleavage 
by α-secretase and, consequently, enable preferential cleavage by β-secretase. Mutations 
in the presenilin-1 and presenilin-2 genes, which are components of the γ-secretase 
complex, increase cleavage by γ-secretase at this site. In both situations, the result is 
excess Aβ peptide production.  
 
Under normal physiological conditions, Aβ peptides can be removed from brains quickly by its 
clearance mechanisms. For example, Aβ peptides can be degraded proteolytically by multiple 
enzymes, especially neprilysin (NEP) and insulin degrading enzyme (IDE) (Jiang, Lee et al. 
2008). The balance between production and clearance of Aβ determines steady levels of Aβ. 
An imbalance will result in the deposition of Aβ and formation of amyloid plaques. In FAD, 
mutations of APP, presenilins 1 and 2 genes will lead into increasing production of Aβ and the 
ratio of Aβ42/Aβ40 increases the cleavage activity of β-secretase and γ-secretase (LaFerla, Green 
et al. 2007, Duyckaerts, Delatour et al. 2009). In SAD, rather than an overproduction of Aβ, the 
formation of amyloid plaques is more likely attributed to the failure of Aβ clearance. The initial 
cause of this failure is still unclear.  
Aβ has the ability to self-associate and exists in many different assembly forms, ranging from 
oligomers to fibrils and amyloid plaques. Initially, fibrillar Aβ that constitutes amyloid plaque 
was assumed to be toxic. However, recent research suggests that Aβ oligomers are the most 
toxic form, and may result in nerve damage (Shankar and Walsh 2009, Crews and Masliah 
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2010). Aβ oligomers at pathophysiological levels are considered to contribute to the 
activation of inflammatory neuronal cascades, oxidative stress, mitochondrial disturbances, 
Ca2+ metabolism deregulation, tau protein phosphorylation and neuronal apoptosis (Golde 
2003, Sanz-Blasco, Valero et al. 2008, Berridge 2010, Jin, Shepardson et al. 2011, Mucke and 
Selkoe 2012). Moreover, Aβ oligomers can inhibit hippocampal long-term potentiation (LTP) 
and facilitate hippocampal long-term depression (LTD) and, thus, cause impairments in 
synaptic plasticity, learning, and memory (Malchiodi-Albedi, Paradisi et al. 2011).   
2.2.2 Ca2+ hypothesis  
Aβ is proposed to cause neuronal toxicity via a variety of pathways, and several hypotheses 
extending from the amyloid hypothesis attempt to further elucidate the alterations resulting 
from amyloid pathology. The most important, and feasible, pathway is through the Ca2+ 
signalling systems by triggering deregulation of Ca2+ homeostasis. The Ca2+ hypothesis that 
links altered Ca2+ signalling to Aβ-induced neuronal dysfunction is becoming more popular, 
and is supported by accumulating experimental evidence (Van Dam and De Deyn 2006). The 
deregulation of Ca2+ homeostasis is suggested to account for the decline in cognitive function 
in the early stages of AD, and neuronal loss in the late stage of AD. Therefore, the focus of 
this research is mainly on the amyloid and Ca2+ hypotheses. 
Aβ oligomers may interact with neuronal membranes and result in a significant elevation of 
intracellular Ca2+ levels in AD. High levels of Ca2+ are toxic and will induce neural apoptosis, 
the most common form of programmed cell death, leading to neuronal dysfunction and 
neurodegeneration in both SAD and FAD (Berridge 2010). Meanwhile, alteration of Ca2+ 
signalling may accelerate Aβ formation, thus, a degenerative feed-forward cycle of Aβ 
formation and  dysregulation of Ca2+ signalling is formed.  
Since 1987, when Khachaturian (1987) first proposed the Ca2+ hypothesis, a growing body of 
evidence reveals that dysregulation of Ca2+ signalling plays a crucial role in the initiation and 
development of AD (LaFerla 2002, Berridge 2010, Berridge 2013). A rise in the resting level 
of cytosolic Ca2+ in neurons has been reported in both transgenic AD animal models and 
autopsies of brains from patients who have died from AD, which suggests it is a causal factor 
in neuronal excitotoxicity, synaptic loss and cell death during the development of AD (Lopez, 
Lyckman et al. 2008).  
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2.2.3 Dysregulation of glutamatergic transmission by Aβ in AD  
The extracellular Aβ oligomers have been shown to impair intracellular Ca2+ homeostasis by 
promoting an influx of extracellular Ca2+ through the plasma membrane (Demuro, Mina et al. 
2005, Kawahara, Ohtsuka et al. 2011). This can disrupt the plasma membrane Ca2+ 
permeability, particularly by forming Ca2+-permeable pores that affect certain Ca2+-permeable 
channels and/or interact with membrane lipids and affect their integrity. In this section, we 
review dysregulation related to the NMDAR-mediated Ca2+ response in the dendritic spine as 
observed under AD conditions. 
2.2.3.1 Glutamate excitotoxicity in AD 
An excessive extracellular glutamate concentration will cause a mild, chronic activation of 
glutamate receptors, especially NMDARs, and lead to neurodegeneration, which is also called 
excitotoxicity (Danysz and Parsons 2012). Several studies have shown that a dysfunctional 
glutamatergic system in AD could be a critical upstream event, which leads to the 
overactivation of NMDARs and pathological NMDAR-mediated Ca2+ influx into the neuron 
that, subsequently, triggers apoptotic pathways (Li, Hong et al. 2009, Hardingham and Bading 
2010). An elevated resting level of extracellular glutamate has been found in AD patients 
(Talantova, Sanz-Blasco et al. 2013). Researchers have linked Aβ to upregulation in 
glutamate availability and excitotoxicity in AD, suggesting that Aβ is the culprit behind 
enhanced excitotoxicity, either by increasing glutamate release or by reducing glutamate 
uptake by transporters (Butterfield and Pocernich 2003, Ondrejcak, Klyubin et al. 2010, 
Danysz and Parsons 2012). 
Aβ is suggested to promote glutamate release from presynaptic terminal (Bobich, Zheng et al. 
2004, Chin, Ma et al. 2007, Kabogo, Rauw et al. 2010). Aβ may participate and act as a 
positive regulator in the glutamate release under healthy conditions (Abramov, Dolev et al. 
2009). In aged neurons, Aβ23-25 has been found to augment glutamate release (Arias, Arrieta et 
al. 1995). Puzzo, Privitera et al. (2008) reported that a picomolar level of Aβ42 could enhance 
LTP by increasing neurotransmitter release, whereas low nanomolar levels of Aβ42 lead to 
synaptic depression. Palop and Mucke (2010) proposed a bell-shaped relationship between 
extracellular Aβ and the synaptic transmission that low and high levels of Aβ depress the 
postsynaptic transmission while intermediate levels facilitate the presynaptic vesicle release. 
In addition, Aβ is suggested to potentiate the release of glutamate from glia cells (Noda, 
Nakanishi et al. 1999, Orellana, Shoji et al. 2011). Aβ induces excitotoxic levels of glutamate 
release from astrocytes, which can lead to the activation of extrasynaptic NMDARs and 
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synaptic loss (Barger and Basile 2001, Talantova, Sanz-Blasco et al. 2013). This may be a 
result of the abnormal Ca2+ signalling in the glia cells observed in AD (Kuchibhotla, Lattarulo 
et al. 2009). 
In contrast, Aβ oligomers may disturb glutamate clearance mechanisms by affecting the 
glutamate transporters (Harris, Carney et al. 1995, Harris, Wang et al. 1996, Parpura-Gill, 
Beitz et al. 1997, Fernández-Tomé, Brera et al. 2004, Matos, Augusto et al. 2008). A number 
of studies have revealed reduced levels of vesicular glutamate transporters (VGLUT) and 
excitatory amino acid transporters (EAAT) in AD (Masliah, Hansen et al. 1996, Masliah, 
Alford et al. 2000, Kirvell, Esiri et al. 2006). Moroever, the decreased glutamate transporter 
activity found in AD is suggested to be associated with this excitotoxicity and 
neurodegeneration (Masliah, Hansen et al. 1996). The lack of transporters and/or reduced 
activity of these transporters contributes to the increase in glutamate availability in the 
synaptic cleft and extrasynaptic space (Danysz and Parsons 2012). Persistent activation of 
postsynaptic NMDAR may lead to receptor desensitisation and affect synaptic functions, such 
as synaptic plasticity (Li, Hong et al. 2009), whereas prolonged extrasynaptic NMDAR 
promotes neuronal Aβ production (Bordji, Becerril-Ortega et al. 2010, Bordji, Becerril-Ortega 
et al. 2011). 
2.2.3.2 Dysregulation on NMDAR in AD 
Several research studies have shown the colocalisation of Aβ oligomers with NMDARs, 
suggesting that they may directly interact with NMDARs (Dewachter, Filipkowski et al. 
2009, Alberdi, Sanchez-Gomez et al. 2010, Texidó, Martín-Satué et al. 2011). Aβ oligomers 
are reported to directly interact with NMDARs (De Felice, Velasco et al. 2007) and activate 
NR2B-NMDAR, leading to an increase in cytosolic Ca2+ levels (Ferreira, Bajouco et al. 
2012). The precise underlying mechanisms are yet to be uncovered. Besides, Aβ may also 
cause a slowed desensitisation by disturbing the cellular prion protein-mediated NMDAR 
activity (You, Tsutsui et al. 2012). Furthermore, the increase of NMDAR activity may inhibit 
the α-cleavage of APP and promotes the amyloidogenic processing of APP (Kamenetz, 
Tomita et al. 2003, Lesné, Ali et al. 2005, Hoe, Fu et al. 2009). 
Aβ oligomers may also disturb the distribution of NMDARs (Snyder, Nong et al. 2005). 
Interestingly, the full-length APP is found to increase surface NR2B containing NMDAR (but 
not NR2A-containing one) and decrease its internalisation in primary hippocampal neurons 
(Hoe, Fu et al. 2009). However, following exposure of Aβ25–35 and full-length Aβ1–40 deposits, 
a decrease in the number of NMDARs positive cells is observed in the immediate surrounding 
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of Aβ25–35 and full-length Aβ1–40 deposits in mature hippocampal slice cultures (Johansson, 
Radesäter et al. 2006). Pretreatment of cultured hippocampal neurons with Aβ1–42 
significantly reduces surface expression of NR1, without affecting the total NR1 expression 
(Goto, Niidome et al. 2006). Treatment of mature hippocampal cells with Aβ oligomers 
rapidly decreases the expression of surface NMDARs (Lacor, Buniel et al. 2007). In cultured 
cortical neurons, Aβ1–42 has been shown to reduce the surface expression of NR1 and NR2B 
subunits of the whole cell as well as at the synaptic site, without any changes in the total level 
of synaptic NMDARs (including both internal and surface receptors) (Snyder, Nong et al. 
2005). Similarly, a decrease in the surface expression of synaptic NR2B containing NMDAR 
is observed in primary hippocampal neurons pre-incubated with Aβ oligomers and in APP 
transgenic mice (Dewachter, Filipkowski et al. 2009). In contrast, extrasynaptic NMDARs are 
not affected by the presence of Aβ oligomers (Snyder, Nong et al. 2005).   
In addition, Aβ-induced surface expression of NMDAR can be restored by the γ-secretases 
inhibitor (Snyder, Nong et al. 2005). Taken all together, it is suggested that Aβ may play a 
role in mediating the trafficking of NMDARs, especially by promoting synaptic NR2B-
NMDAR endocytosis. Aβ can bind to 7α-nicotinic acetylcholine receptors (nAchRs) with 
high affinity (Wang, Lee et al. 2000). Snyder, Nong et al. (2005) hypothesised that the Aβ-
dependent endocytosis of NMDARs is initiated by Aβ binding to the nAchRs, which leads to 
activation of protein phosphatase 2B and dephosphorylation and activation of  tyrosine 
phosphatase STEP. The activation of STEP may promote dephosphorylation of the 
phosphotyrosine residue Tyr1472 of NMDAR, which locates in a region which regulates 
NMDAR endocytosis and interaction with synaptic scaffolding proteins. Kessels, Nabavi et 
al. (2013) showed that Aβ oligomers promote the switch in subunit composition from NR2B- 
to NR2A-NMDAR, which normally occurs during development.  
The loss of synaptic NMDARs may also contribute to the depression of glutamatergic 
transmission and reductions in memory formation. Aβ is reported to decrease NMDAR-
mediated synaptic responses and inhibit NMDAR-dependent LTP (Chen, Wei et al. 2002, Li, 
Jin et al. 2011).  However, to some extent, the internalisation of synaptic NMDARs may be a 
neuroprotective mechanism against the glutamate-induced neurotoxicity and excessive Ca2+ 
influx (Chuang, Gao et al. 1992, Goto, Niidome et al. 2006). 
2.2.4 Dysregulation of ER Ca2+ handling in AD  
The ER, as the major Ca2+ storage compartment, has been studied with the focus on its effects 
in Ca2+ signalling in AD (Popugaeva and Bezprozvanny 2013, Liang, Kulasiri et al. 2015). 
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Research carried on stabilizing ER Ca2+ signalling in AD cells or animal models have offered 
new strategies for the prevention of disease progression (Ito, Oka et al. 1994, Lee, Hwang et 
al. 2006, Thibault, Gant et al. 2007, Chakroborty, Briggs et al. 2012). The mechanism causing 
these alterations in ER Ca2+ signalling is not fully understood, while current research is 
mainly on the disturbing effects from mutations in presenillin or/and deposition of Aβ 
oligomers.  
2.2.4.1 Disruption of ER Ca2+ homeostasis by the Aβ peptide 
Aβ can affect the ER Ca2+ signalling by promoting an influx of extracellular Ca2+ through the 
plasma membrane (Demuro, Mina et al. 2005, Kawahara, Ohtsuka et al. 2011). For example, 
there is growing evidence that links overactivation of NMDARs to ER Ca2+ dysregulation 
(Kelly and Ferreira 2006, Costa, Lacor et al. 2012). Aβ oligomers can induce ER stress 
through interaction with NMDARs, resulting in a massive Ca2+ influx (Costa, Lacor et al. 
2012). This will subsequently activate downstream NADPH oxidase (NOX)-mediated 
superoxide production and, consequently, impair ER Ca2+ homeostasis and even trigger ER 
stress-mediated apoptotic pathway (Ferreiro, Resende et al. 2006). Costa et al., have 
demonstrated that Aβ-induced ER stress can be effectively inhibited by ifenprodil, an 
antagonist of NR2B subunits, which could be a potential therapeutic strategy for AD (Costa, 
Lacor et al. 2012). 
Intracellular Aβ oligomers are also shown to directly disrupt Ca2+ handling of intracellular 
Ca2+ stores, especially ERs (Figure 2.4) (Demuro and Parker 2013). They are believed to be 
produced from APP residing on the ER and in other intracellular compartments, as well as by 
uptake from the extracellular space (Mohamed and Posse de Chaves 2011). The accumulation 
of intracellular Aβ oligomers has been observed prior to the presence of extracellular Aβ 
deposition in the cerebral cortex and hippocampus in AD brains, suggesting that intracellular 
Aβ42-induced Ca2+ dysregulation may play a crucial role in early AD pathogenesis (Gouras, 
Tsai et al. 2000, Oddo, Caccamo et al. 2006).  
 
 
22 
 
 
Figure 2.4. Mechanisms that might contribute intracellular Ca2+ dysregulation in AD. 
Evidences show that Aβ oligomers may disturb intracellular Ca2+ homeostasis and result 
in ER stress, by disturbing membrane conductance, forming Ca2+-permeable pores as 
well as perturbing ER Ca2+ handling. Aβ oligomers may directly modulate activity of 
IP3Rs and RyRs. Aβ oligomers are also suggested to accelerate the production of IP3, 
therefore, induce IP3Rs opening and Ca2+ release from ER. Besides, Aβ oligomers may 
promote ER Ca2+ transmission to mitochondria via MAM and lead to mitochondrial 
dysfunction. Furthermore, alteration of intracellular Ca2+ homeostasis may in turn 
promote the production of Aβ peptides. This figure is produced using Servier Medical 
Art (http://www.servier.com/Powerpoint-image-bank).  
 
 
Aβ42 oligomer pores can also be formed in the membranes of intracellular organelles and 
result in Ca2+ leakage into the cytosol; the disruption is comparatively mild (Demuro, Mina et 
al. 2005, Demuro and Parker 2013). Most research has demonstrated that Aβ oligomers 
enhance Ca2+ liberation from the ER, mainly by altering Ca2+ release via IP3Rs and RyRs 
(Kelliher, Fastbom et al. 1999, Ferreiro, Oliveira et al. 2004, Stutzmann, Smith et al. 2006, 
Schapansky, Olson et al. 2007). Pereira’s group suggested an ER-specific apoptotic pathway 
trigged by Aβ-induced perturbation of ER Ca2+ homeostasis (Ferreiro, Resende et al. 2006). 
Their research showed that continuous production could induce ER stress, perturb ER Ca2+ 
homeostasis and lead to increased levels of cytosolic Ca2+. Together with other Aβ-induced 
alterations, such as increased activity of caspase-3, it would further affect mitochondrial 
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function and, ultimately, trigger the apoptotic pathway and lead to neuronal death.  
Aβ exposure has been shown to disturb IP3R-regulated Ca2+ handling by promoting IP3-
mediated Ca2+ release from the ER in neurons (Schapansky, Olson et al. 2007). Similarly, 
Lopez et al. observed that the accumulation of intracellular Aβ in a 3xTg-AD mouse model 
enhanced Ca2+ release via IP3R on the ER as well as increased Ca2+ influx on the plasma 
membrane, which potentially can lead to a large elevation of resting cytosolic free Ca2+ level 
(Lopez, Lyckman et al. 2008). In addition, the Aβ has also been reported to affect Ca2+ flux 
via IP3Rs indirectly by modulating upstream events. For example, Aβ directly interacts with 
IP3 and promotes binding of IP3 ligands to their receptors in rats (Cowburn, Wiehager et al. 
1995). Increased levels of both astrocytic mGlu5 receptor mRNA and protein have been 
observed in Aβ40 treatment in vitro (Casley, Lakics et al. 2009). Likewise, Renner et al. 
reported that Aβ oligomers altered the lateral diffusion of mGluR5 within the plasma 
membrane and stimulated their signalling activity which, therefore, affected downstream IP3 
production (Renner, Lacor et al. 2010). Aβ oligomers can bind to cellular prion proteins and 
active mGluR5, which may also lead to increased production of IP3 (Um, Kaufman et al. 
2013). In addition, recent research has reported that intracellular Aβ42 oligomers induce Ca2+ 
liberation from the ER via IP3Rs by stimulating PLC-mediated IP3 production in Xenopus 
oocytes (Demuro and Parker 2013). Another study demonstrated that Aβ42-induced Ca2+ 
release from ER may mostly depend on activating PLC and, subsequent, IP3 generation rather 
than by direct interaction with IP3Rs (Allan, Bultynck et al. 2013).  
Similarly, intracellular Aβ42 oligomers also disrupt RyR-regulated Ca2+ signals. Aβ42 
oligomers appear to increase the channel open probability of RyRs and change their gating 
kinetics, leading to enhanced Ca2+ liberation from the ER. Shtifman et al. demonstrated that 
Aβ can directly modify and activate RyR type1 by reconstituting RyR in a planar lipid bilayer 
to study inclusion body myositis, a skeletal muscle disorder, which may share a similar 
pathogenesis with AD (Shtifman, Ward et al. 2010). This is consistent with their earlier study 
on the inclusion body myositis showing that Aβ overexpression increases RyRs’ sensitivity to 
the agonist caffeine and susceptibility to CICR (Christensen, Shtifman et al. 2004). In 
addition, the elevation of RyR expression has also been reported to result in the accumulation 
of intracellular Aβ oligomers. For example, Supnet et al. reported increased levels of RyR 
type3 in non-TgCRND8 neurons after treatment with Aβ42 oligomers, suggesting that Aβ42 
may potentiate Ca2+ release from the ER and disturb intracellular Ca2+ homeostasis by directly 
increasing RyR expression (Supnet, Grant et al. 2006, Supnet, Noonan et al. 2010).  
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Moreover, Aβ oligomers also upregulate the MAM function in post-mortem AD brains and 
APPSwe/Lon mice (Hedskog, Pinho et al. 2013). Increased expression of MAM-associated 
proteins and a number of contact sites have been observed in primary hippocampal neurons. 
This may, consequently, promote Ca2+ transmission from the ER to mitochondria and may 
lead to mitochondrial dysfunction and AD pathology. 
Interestingly, the APP intracellular domain (AICD), which is generated together with Aβ by 
γ-secretases cleavage, may also be associated with ER signalling. AICD has been suggested to 
be involved in regulating IP3-mediated Ca2+ signalling, although the precise mechanism is 
unknown (Smith, Green et al. 2005). AICD may promote the expression of IP3R based on its 
transcriptional activity (Kasri, Kocks et al. 2006). Alternatively, in another study, AICD was 
shown to activate glycogen synthase kinase-3β (GSK3β), a modulator of the IP3R expression, 
which may be a potential mechanism by which AICD mediated ER Ca2+ signalling (Ryan and 
Pimplikar 2005). In addition, Oule's et al. observed disrupted ER Ca2+ homeostasis 
contributed to the increased expression of RyR levels in APP-overexpressing transgenic mice, 
suggesting AICD may also mediate RyR expression (Oule`s, Del Prete et al. 2012).  
2.2.4.2 Presenilin mutation and its roles in ER Ca2+ homeostasis 
Presenilins (PSs), a family of highly conserved membrane proteins with multi-transmembrane 
domains, are primarily located in the ER membrane and can be found in the cell body and in 
the dendrites of neurons (Brunkan and Goate 2005). Missense mutations in the genes 
encoding presenilin-1 (PSEN1) and presenilin-2 (PSEN1) account for the majority of the 
inherited forms of AD, FAD (Shen and Kelleher 2007, Supnet and Bezprozvanny 2011). 
PSEN1 mutations are the most common genetic cause and, to date, 185 PSEN1 mutations 
have been identified in patients with FAD, listed on the Alzheimer Disease & Frontotemporal 
Dementia Mutation Database (Cruts, Theuns et al. 2012). In contrast, the PSEN2 mutation is a 
relatively rare cause of FAD, with only 13 mutations have been identified (Cruts, Theuns et 
al. 2012). Mutations in PS genes are suggested to play a causal role in the cognitive 
impairment and pathogenesis of FAD (Saura, Choi et al. 2004). Much research has reported 
that both mutations in both PSEN1 and PSEN2 are associated with the dysregulation of Ca2+ 
signalling, disturbance of Aβ production and neuronal death, although the underlying 
mechanisms are still under investigation. Proposed effects of PS mutation are summarizes in 
Figure 2.5. 
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Figure 2.5. Proposed effects of PS mutation. PS mutation affects both its γ-secretase-
dependent function and γ-secretase-independent function. Mutant PS disturbs the 
proteolytic cleavage of the APP and promotes Aβ production. Inside of the neuron, 
mutant PS may physically associate with ER membrane receptors and SERCA pumps to 
disturb their functions. Furthermore, PS is proposed to function as an ER Ca2+ leak 
channel. Mutations on it may diminish this function and lead to ER Ca2+ dysregulation. 
This figure is produced using Servier Medical Art (http://www.servier.com/Powerpoint-
image-bank). 
 
However, unlike FAD, causes of SAD are much more complex, involving both genetic and 
environmental risk factors. Therefore, it remains a great challenge to study the key factors in 
SAD (Young and Goldstein 2012). Research on microRNA (miRNA) may be helpful to 
explain the pathogenesis of SAD as well as FAD. miRNAs are small noncoding RNAs, which 
negatively regulate gene expression at the posttranscriptional level (He and Hannon 2004). 
Dysregulation of several miRNAs have been observed in AD brains and are suggested to 
relate to AD pathology (Van den Hove, Kompotis et al. 2014). Increase in hallmark genes 
such as APP and PSEN1 observed in SAD brains may be a result of dysregulation in miRNAs 
which target these genes (reviewed in (Maes, Chertkow et al. 2009)). Thus, abnormal level of 
miRNAs may indirectly affect Ca2+ signalling and Aβ production in AD. Therefore, Identify 
specific miRNAs for AD, especially SAD, will be useful for modelling SAD in the 
laboratory, which remains underdeveloped. Besides miRNAs may serve as potential 
biomarkers in AD, which may contribute to the early diagnosis and therapeutic research 
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(Young and Goldstein 2012). 
2.2.4.2.1 Role of PS as a subunit of γ-secretases 
The PS protein is synthesized in the ER and can be transported to the plasma membrane or 
endosomal structure compartments to form a catalytic subunit of γ-secretases, together with 
nicastrin, APH-1 and PEN-2 (Nelson, Supnet et al. 2011). γ-secretases mediate the proteolytic 
cleavage of the APP via the amyloidogenic pathway to release Aβ peptide fragments. PS 
mutations are suggested to promote the amyloidogenic processing of APP and can result in 
the increasing formation of Aβ42 relative to Aβ40, which has been found both in the fibroblasts 
of AD patients and animal models (De Strooper, Iwatsubo et al. 2012). Compared with Aβ40, 
Aβ42 is less soluble and is considered to be the most toxic, pathogenic form of Aβ, which 
contributes to synaptic dysfunction, neuronal toxicity and the formation of senile plaques 
(Hardy and Selkoe 2002). Likewise, Shen and Kelleher proposed in the presenilin hypothesis 
that the loss of γ-secretase cleavage function in PS mutations in AD may lead to increased 
production of Aβ42 relative to Aβ40 (Shen and Kelleher 2007). The effects of Aβ on ER Ca2+ 
regulation are discussed in later sections. 
2.2.4.2.2 Roles of PS mutations in ER Ca2+ signalling 
At it is independent of the γ-secretase activity, PS is also suggested to play other 
physiological roles，including mediation of neurotransmitter release and regulation of 
intracellular Ca2+ homeostasis (Nelson, Supnet et al. 2011, De Strooper, Iwatsubo et al. 2012). 
This review will focus on its role relating to ER Ca2+ signalling.  
Early research on fibroblasts from asymptomatic members of AD families linked the PS 
mutation to enhanced Ca2+ release from the ER (Ito, Oka et al. 1994). Alterations in ER Ca2+ 
signalling have been consistently observed in later research on cells expressing mutant PS 
(Leissring, Paul et al. 1999) or tissues from animal models expressing mutant PS genes 
(Leissring, Akbari et al. 2000, Stutzmann, Caccamo et al. 2004). Mutations in PS are also 
reported to directly attenuate SOCE. Normal presenillins may negtively regulate SOCE, 
which could explain the attenuated SOCE found in cells with FAD PS mutations (Leissring, 
Akbari et al. 2000, Herms, Schneider et al. 2003, Bojarski, Herms et al. 2008). Furthermore, 
Bojarski et al. have demonstrated that FAD mutations in PS affect the cellular levels of 
STIM1 and STIM2 differently and result in the attenuation of SOCE (Bojarski, Pomorski et 
al. 2009). They suggest that SOCE in the neurons of FAD patients may be affected by the 
disturbed expression of STIM genes or proteins. A recent study in mutant presenilin mice 
showed that downregulation of STIM2 protein impaired the SOCE in mature spines (Sun, 
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Zhang et al. 2014). 
Inhibited SOCE, together with the reduced ER Ca2+ content by PS mutations, would 
ultimately result in disruption of intracellular Ca2+ homeostasis (Giacomello, Barbiero et al. 
2005). Increased vulnerability of neurons to excitotoxicity, to mitochondrial impairment and 
to apoptosis have been observed in PS1 mutant knock-in mice, which are suggested to be 
associated with enhanced Ca2+ release from the ER (Guo, Fu et al. 1999). Presenilins have 
also been observed to be highly enriched in MAM (Area-Gomez, de Groof et al. 2009). This 
suggests a potential role for PS in ER–mitochondria Ca2+ cross-talk and possible links 
between FAD mutations in PS to mitochondrial dysfunctions, which could be another key 
deficit in AD (Zampese, Fasolato et al. 2011, Area-Gomez, Del Carmen Lara Castillo et al. 
2012). FAD mutations in PS have shown to upregulate MAM function and ER-mitochondria 
communication, which may play central role in AD pathogenesis (reviewed in (Schon and 
Area-Gomez 2013)). 
The mechanisms by which PS mutations disturb intracellular Ca2+ signalling remain 
controversial. Current research focused on the influence of PS mutations on Ca2+ uptake or 
leak functions by the ER, suggests that the dysregulation is caused by an enhanced expression 
of ER Ca2+ release channels or alterations in the properties of Ca2+ channels and pumps by 
FAD mutants in PS1 or PS2 (Cheung, Shineman et al. 2008, Rybalchenko, Hwang et al. 2008, 
Cheung, Mei et al. 2010). Enhanced IP3-evoked Ca2+ responses related to PS mutation have 
been observed in several cell lines and brain slices from AD animal models (Guo, Sopher et 
al. 1997, Leissring, Paul et al. 1999, Chan, Mayne et al. 2000, Cheung, Mei et al. 2010). 
Increased proportions of neurons responding to the IP3 have also been observed in cortical 
neurons of mutant PS1 knock-in mice (Stutzmann, Caccamo et al. 2004). Rather than 
changing the level of IP3Rs, both of FAD mutants, PS1 and PS2, have been observed to 
strongly enhance the gating activity for Ca2+ release of IP3Rs, which might be a potential 
mechanism for how PS mutations alters ER Ca2+ signalling. PSs have been shown to influence 
the activity of IP3Rs by physically interacting with them directly to enhance IP3R-evoked Ca2+ 
signalling (Cheung, Shineman et al. 2008). Kevin Foskett and collaborators found the 
sensitivity of IP3R to a low level of cytosolic IP3 increased in cells from FAD patients and 
PS1-AD mice (Cheung, Shineman et al. 2008, Cheung, Mei et al. 2010). They suggested that 
the mutations in PS activate IP3R gating and shift it toward a high open-probability burst 
mode by affecting the gating kinetics through IP3R-PS interaction. Mattson’s group observed 
that PS1 mutations in rat neural cells perturbed ER Ca2+ regulation by activating IP3Rs and 
this may further sensitize neurons to apoptosis and increase neuronal vulnerability to 
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excitotoxic and ischemic injury (Guo, Sopher et al. 1997, Mattson, Zhu et al. 2000). A recent 
study in PS FAD mouse models demonstrated that reduction of IP3R1 expression can rescue 
neuron from exaggerated Ca2+ release and attenuate Aβ and tau accumulation (Shilling, 
Müller et al. 2014). 
Similar to IP3R, PS1 has been reported to physically interact with RyRs and may regulate 
intracellular Ca2+ signalling through modulation of the RyR ion channel gating by protein-
protein interactions (Rybalchenko, Hwang et al. 2008). Goussakov et al. suggested that the 
reduced CICR threshold for RyR-mediated Ca2+ signalling in mutant PS neurons could be 
responsible for the enhanced RyR-evoked Ca2+ response and increased basal Ca2+ level 
(Goussakov, Miller et al. 2010). In addition to the alteration of RyRs activity, many 
researchers have demonstrated the upregulation of RyR expression levels in cells expressing 
PS mutations (Chan, Mayne et al. 2000, Stutzmann, Smith et al. 2007, Rybalchenko, Hwang 
et al. 2008, Zhang, Sun et al. 2010). For example, enhanced expression of RyR type 3 with an 
increased amplitude of caffeine-induced Ca2+ release has been observed in rat neural cells 
with the PS1 mutation and primary hippocampal neurons from PS1 mutant knock-in mice 
(Chan, Mayne et al. 2000). Likewise, increased Ca2+ release through RyRs has been observed 
with increased RyR expression across all ages in FAD-PS1 knock-in mice, which may be 
responsible for the dysregulation of cytosolic Ca2+ homeostasis (Stutzmann, Smith et al. 2006, 
Stutzmann, Smith et al. 2007). Lee et al. reported increased RyR expression in mutant PS2 
transgenic mice and demonstrated that PS2 mutations sensitized neurons by enhancing Ca2+ 
release through RyRs and, ultimately, activating the caspase-3-dependent apoptotic pathway 
(Lee, Hwang et al. 2006). Surprisingly, recent research has found reduced levels of RyR 
proteins with an unaffected mRNA expression level in hippocampal slices from PS 
conditional double (PS1 and PS2) knock-out mice (Wu, Yamaguchi et al. 2013). They 
concluded that PS mediates intracellular Ca2+ homeostasis via regulation of RyR expression 
and function, while the underlying mechanism is undetermined. They suggested that PS 
regulates RyR expression but not at the mRNA transcription level.  
PS also has been reported to physically associate with the SERCA pump and may act as a 
positive modulator for the normal functioning of this Ca2+ pump (Green, Demuro et al. 2008). 
La Ferla’s group reported that overexpression of wild-type PSs (PS1 and PS2) and FAD PS1 
mutations could stimulate SERCA activity and lead to Ca2+ overfilling in the ER, and the 
absence of both types of presenilins would affect SERCA function (Green, Demuro et al. 
2008). The opposite results by another group showed that both wild-type and mutant PS2 
could reduce SERCA activity (Brunello, Zampese et al. 2009). They suggest PS2 is stronger 
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in inhibiting SERCA activity compared with PS1. These different conclusions may be 
because of the different cell types they used or other unknown mechanisms involved.  
2.2.4.2.3 PS as a Ca2+ leaking channel of the ER  
Besides interaction with ER Ca2+ channels and pumps, it has been proposed by 
Bezprozvanny’s group that PSs themselves may act as Ca2+-leak channels on the ER 
membrane (Tu, Nelson et al. 2006). FAD mutations in PS may diminish this function and lead 
to ER Ca2+ dysregulation. They observed Ca2+ permeable channel formation in planar lipid 
bilayers by wild-type PS1 and PS2 (but not FAD mutants). They suggested PSs might act as 
low-conductance, passive Ca2+ leak channels at the ER membrane in hippocampal neurons, 
whereas FAD PS mutations might disrupt this function and lead to overfilling of ER Ca2+ 
stores (Tu, Nelson et al. 2006, Zhang, Sun et al. 2010). They also observed that the cysteine 
point mutations in selected transmembrane (TM) of PS1 in mouse models led to a loss of its 
ER Ca2+ leak function, suggesting that the hydrophilic water-ﬁlled catalytic cavity (between 
TM6 and TM7) of PS may play a role in forming a low conductance Ca2+-permeable pore 
(Nelson, Supnet et al. 2011). In Bezprozvanny’s latest review (Bezprozvanny 2013), he points 
out that this hypothesis can be explained and supported by two other recent independent 
research papers on the crystal structure of an archaeal presenilin homolog PSH1 (Li, Dang et 
al. 2013) and a quantitative model of cellular Ca2+ signal combines with siRNA perturbations 
to identify key proteins in Ca2+ homeostasis regulation (Bandara, Malmersjo et al. 2013). 
Increased expression in RyRs has been observed to partially compensate for the loss of the ER 
Ca2+ leak function in PS, suggesting a protective role for RyRs in AD (Tu, Nelson et al. 2006, 
Zhang, Sun et al. 2010). This is consistent with a previous study carried by the Supnet group, 
which suggests that the observed upregulation of RyR type3 in neurons of TgCRND8 AD 
mice may protect neurons against the increased excitotoxicity in AD (Supnet, Grant et al. 
2006). The results from their subsequent study have revealed that up-regulation of RyR type3 
does not affect neuronal health or global Ca2+ homeostasis, while knockdown of RyR type3 
promotes neuronal death of TgCRND8-cultured cortical neurons, but not in non-transgenic 
neurons, further supporting the hypothesis of the compensation and neuroprotective roles of 
RyRs in AD (Supnet, Noonan et al. 2010). This hypothesis could be an explanation for how 
neurons maintain Ca2+ homeostasis and neuronal function against the effects from mutations 
in the early stages of AD (Supnet and Bezprozvanny 2010). 
However, the hypothesis of PS is an ER Ca2+ leaking channel has been challenged by several 
recent studies. Cheung et al. argue that PS may not participate in the Ca2+ permeability of ER 
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membranes and, instead of a Ca2+ overload, FAD mutant PS reduced or had no effect on the 
Ca2+ levels in the ER (Cheung, Shineman et al. 2008). Likewise, Shilling et al. investigated 
ER Ca2+ filling rates, basal ER Ca2+ fill levels and ER Ca2+ leak rates from three different cell 
systems using different indicators, and concluded that the FAD mutant PS2 may not induce 
ER Ca2+ overfilling and PS may not function as an ER Ca2+ leak channel (Shilling, Mak et al. 
2012). A reduced ER Ca2+ load has also been reported for both PS1 and PS2 mutations in 
other research (Brunello, Zampese et al. 2009). Furthermore, a recent study carried by Wu et 
al. showed that in the hippocampus of PS conditional double knock-out mice, the ER Ca2+ 
level stayed at a normal level while the levels of RyR proteins were reduced with impaired 
RyR function for regulating Ca2+ release (Wu, Yamaguchi et al. 2013). 
2.2.5 ER alteration may influence Aβ production 
Alteration of intracellular Ca2+ homeostasis shows conflicting effects on the production of Aβ 
peptides. Sustained elevation in the cytosolic Ca2+ level has been reported to accelerate Aβ 
formation, which suggests that reduction of Ca2+ release from the ER could be a potential 
neuroprotective strategy against Aβ peptide neurotoxicity (Querfurth and Selkoe 1994, 
Ferreiro, Oliveira et al. 2004, Isaacs, Senn et al. 2006). Increased expression and activity of 
RyRs have been found in the brains of patients in the early stages of AD and also in mice 
models, and this may contribute to the progression of AD pathogenesis (Kelliher, Fastbom et 
al. 1999, Bruno, Huang et al. 2012, Chakroborty, Kim et al. 2012). Early research showed that 
the elevation of intracellular Ca2+ levels after treatment with Ca2+ ionophore led to increased 
Aβ generation in human cell lines (Querfurth and Selkoe 1994). Later, the same group 
reported that RyR activation by caffeine resulted in an elevation of intracellular Ca2+ level, 
which further enhanced the release of Aβ from APP in HEK293 cells (Querfurth, Jiang et al. 
1997). Likewise, a study of tissues from post mortem AD brains has shown the loss of RyRs 
is correlated with amyloid deposition (Kelliher, Fastbom et al. 1999). Recent research on 
Tg2576 mouse models has revealed that reduced RyR-mediated Ca2+ release after treatment 
with dantrolene, a RyR inhibitor, could reduce both intracellular and extracellular Aβ loads 
and slow down the loss of memory and cognitive function. This possibly resulted from the 
decreasing Thr-668-dependent APP phosphorylation and β- and γ-secretases activities by 
interaction with Ca2+ (Oule`s, Del Prete et al. 2012). However, there are conflicting results 
from other groups who reported that knock-out of RyR type3 neurons or ones after long-term 
exposure to RyR inhibitor, dantrolene, presented with an increased amyloid pathologic 
condition, suggesting a potential neuroprotective role for RyR (Supnet, Noonan et al. 2010, 
Zhang, Sun et al. 2010).  
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Likewise, IP3R and its regulation of cytosolic Ca2+ signalling may also affect the generation of 
Aβ. Cheung et al. reported reduced Aβ production in IP3R-deficient cells, which suggested 
that amyloidogenic processing of APP might be closely related to IP3R-mediated Ca2+ release 
(Cheung, Shineman et al. 2008). Pierrot et al. suggested increased Ca2+ liberation from the ER 
alone may not be enough to trigger intraneuronal Aβ production, which requires influx of 
extracellular Ca2+ and a sustained increase in cytosolic Ca2+ concentration (Pierrot, Ghisdal et 
al. 2004). This is consistent with results from a recent study, which investigated the 
interactions between genes of different Ca2+ channels in the AD pathway from a genetic 
perspective using an online database (Koran, Hohman et al. 2014) . In their study, Gene RYR3 
and CACNA1C have shown to interact significantly with each other, suggesting this 
interaction may result in Ca2+ dysregulation, leading to enhanced Aβ production and 
deposition.  
However, there are studies which shows increase in the cytosolic Ca2+ level reduces Aβ 
production. The role of IP3R in Aβ generation is controversial. Severely reduced levels of 
both IP3 and IP3Rs have been observed in AD brains, and the loss of IP3Rs is suggested to be 
important for amyloid production and deposition by altering Ca2+ homeostasis (Kurumatani, 
Fastbom et al. 1998). Other studies have demonstrated that the elevation of intracellular Ca2+ 
can decrease amyloid production and promote the anti-amyloidogenic processing of APP 
(Buxbaum, Ruefli et al. 1994, Dreses-Werringloer, Lambert et al. 2008). For example, an 
increased level of cytosolic Ca2+ followed treatment with high levels of thapsigargin, an 
inhibitor of SERCA, leading to decreased Aβ formation (Buxbaum, Ruefli et al. 1994). This is 
consistent with results from a recent study, which suggests increase Ca2+ influx via SOCE 
significantly by overexpression of STIM1 can actually inhibit Aβ secretion (Zeiger, Vetrivel 
et al. 2013). These contradicting observations may result from different experimental 
conditions, such as cell lines chosen, or different detection methods (Kurumatani, Fastbom et 
al. 1998). 
In addition, Dreses-Werringloer et al. identified a gene called Ca2+ homeostasis modulator 1 
(CALHM1), which was mostly expressed in the hippocampus and was located in AD linkage 
regions (Dreses-Werringloer, Lambert et al. 2008). It encodes a multipass transmembrane 
glycoprotein, CALHM1, the majority of which is localized in the ER and plasma membrane. 
CALHM1 may function as a component of a cerebral Ca2+ channel, which controls cytosolic 
Ca2+ concentrations and APP processing (Dreses-Werringloer, Lambert et al. 2008, Gallego-
Sandin, Alonso et al. 2011). A recent study showed CALHM1 P86L polymorphism modulates 
Aβ levels in the cerebrospinal fluid of cognitively healthy individuals at risk of AD, which 
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further confirmed that CALHM1 is involved in AD pathogenesis (Koppel, Campagne et al. 
2011). Dreses-Werringloer et al. also proposed that a P86L polymorphism in the CALHM1 
gene may interfere with CALHM1-mediated Ca2+ permeability to increase Aβ production, and 
may be associated with SAD (Dreses-Werringloer, Lambert et al. 2008). This notion is 
supported by subsequent research carried out in populations from countries such China (Cui, 
Zheng et al. 2010), Spain (Boada, Antunez et al. 2010) and Iran (Aqdam, Kamali et al. 2010). 
However, it has been challenged by studies carried out in Caucasian (Minster, Demirci et al. 
2009) and Asian populations (Tan, Ho et al. 2011), which were unable to show an association 
between CALHM1 polymorphism and the risk of AD. Lambert et al. suggested CALHM1 
P86L polymorphism may modulate the age of onset of AD by interacting with the ε4 allele of 
the apolipoprotein E gene, rather than be an independent risk genetic determinant of AD 
(Lambert, Sleegers et al. 2010).  
2.3 Modelling Ca2+ dynamics in dendritic spines  
A number of models for the Ca2+ dynamics in the dendritic spines have been proposed for 
different types of neurons. Some of them have been modified and extended to study Ca2+-
mediated downstream events, such as the induction of different types of synaptic plasticity 
(De Schutter and Smolen 1998). These Ca2+ models generally contain similar components, 
such as Ca2+ influxes from extracellular spces and/or release from an internal Ca2+ source, 
Ca2+ extrusion from the cytosol and interactions between Ca2+ and various intracellular 
proteins. In multi-compartment models, which take the geometry of the spine head and 
dendrite into consideration, and simulate the whole model as a series of compartments, among 
which Ca2+ ions diffuse. In this section, we review the exsiting models related to the 
NMDAR-mediated Ca2+ response in dendritic spines regarding these components. 
2.3.1 Simulation of membrane Ca2+ influx from extracellular spaces 
2.3.1.1 Simulation of glutamate release, uptake and diffusion 
There are a number of models for presynaptic neurons that contain components related to 
glutamate vesicle release with different levels of detail (Senn, Markram et al. 2001, Nadkarni, 
Bartol et al. 2010) that are beyond the scope of this thesis. In contrast, most models of the 
postsynaptic Ca2+ response to the presynatpic stimualtion assume the release of glutamate 
from a vesicle is instantaneous and, thus, uses a constant glutamate concentration per release 
(Barbour and Häusser 1997). Other models use simple equations to represent glutamate 
release from a vesicle as a non-instantaneous process (Rusakov and Kullmann 1998).  
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The spatiotemporal profile of the glutamate concentration in the synaptic cleft and the 
extrasynaptic space following release are due to their diffusion and uptake. The transient of a 
single pulse of glutamate at certain locations can be simply modelled as a process with a fast 
rise time and a slow decay time or a square-wave pulse (Sterratt, Graham et al. 2011). 
Complex models make an approximation of the synaptic cleft and the extracellular space. 
They then simulate the gluamate concentration using diffusion equations, which are either 
partial differential equations or analytical solutions for them. The synaptic cleft can be 
approximated as a two-dimensional disc or a three-dimensional flat cylinder whereas the 
extrasynaptic space is a spherical, isotropic porous medium containing obstacles (Barbour and 
Häusser 1997, Rusakov and Kullmann 1998). The diffusion space is divided into different 
small diffusion compartments, such as concentric cylindrical or spherical shells  (Rusakov 
2001) and, in the diffusion compartments of the extrasynaptic space, the gluatmate 
concentration with time is simulated as a diffusion-reaction process, which accounts for the 
diffusion of glutamate as well as the uptake of glutamate by gluatmate transporters in the 
adjacent glia. The kinetics of binding glutamate to different glutamate transporters can be 
modelled as a chain reaction (Rusakov and Kullmann 1998); or follow the proposed schemes 
that contain more reaction details (Grewer, Gameiro et al. 2008).  
2.3.1.2 Simulation of kinetics of glutamate receptors 
The Ca2+ influx depends on the number of opened Ca2+ channels as well as the difference 
between the membrane potential and the reversal potential. Markov’s kinetic models are 
mostly used to describe the state-transtion of AMPAR and NMDAR by glutamates. The 
receptor between the different states includes a closed state, a ligand-binding state (single-
bound and double-bound, respectively), a desensitisation state and an open state, which are 
determined by various rate constants. The values of these rate constants are estimated by 
fitting the specific model schemes to the single-channel experimental data. For example, there 
are six-state (Patneau and Mayer 1991), seven-state (Jonas, Major et al. 1993) and twelve-
state (Nielsen, DiGregorio et al. 2004) models for AMPAR,  and a five-state model (Lester 
and Jahr 1992) for NMDAR. In these models, the fully bound receptors by two glutamate can 
directly transition to the open state. In contrast, there are a number of NMDAR models that 
take into consideration the conformational changes of the fully bound receptors by including 
two desensitised states before moving to the open state (Banke and Traynelis 2003, Popescu, 
Robert et al. 2004, Erreger, Dravid et al. 2005, Schorge, Elenes et al. 2005, Kussius and 
Popescu 2009). Most NMDAR models only consider the glutamate binding-steps and exclude 
the coagonist binding-steps by fitting the data obtained from experiments under the condition 
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of a saturated concentration of glycine (Ambert, Greget et al. 2010). 
The relief of the Mg2+ blockage of NMDAR is generally treated as a instantaneous event and 
the model proposed by Jahr and Stevens (1990) is widely used for simulating it as a membrane 
voltage-dependent process. Morover, there are few models that simulate the relief of Mg2+ 
blockage as a slow component and include it into their kinetic models (Kampa, Clements et 
al. 2004, Vargas-Caballero and Robinson 2004).     
2.3.2 Simulation of Ca2+ release from ER  
ER as an important compartment appears in numerous synaptic and neuronal models, because 
of its crucial role of internal Ca2+ source and its ubiquitous distribution across the neuron. In 
synaptic level, models mostly include Ca2+ ions flux via proteins (such as NMDARs and 
sodium Ca2+ exchangers) on the post synaptic plasma membrane and Ca2+-mediated 
membrane electrical activity as the aspect of contribution from Ca2+ dynamics (Holmes and 
Levy 1990, Holcman, Schuss et al. 2004, Rubin, Gerkin et al. 2005). In spite of this, several 
synaptic models include ER as an internal Ca2+ source to study its response to synaptic Ca2+ 
fluctuation during the signal transduction process in synapses (Schiegg, Gerstner et al. 1995, 
Volfovsky, Parnas et al. 1999, Doi, Kuroda et al. 2005). In contrast, ER as an internal 
compartment is generally includes in the most models to study its contribution on cytosolic 
events such as intracellular propagation of Ca2+ waves (Sneyd, Girard et al. 1993, Fink, 
Slepchenko et al. 2000).  
In Ca2+ signalling models of the ER, the uptake mechanism is basically governed by 
modelling the gating behavior of its two Ca2+ channels, IP3R and RyR. At molecular level, 
different kinetic schemas have been developed for these channels. 
Models of the IP3R-regulated Ca2+ release have been the focus of many research on account of 
their significance in Ca2+ oscillations and synaptic plasticity. Modelling of the IP3R shows 
more complexity in its dynamics as a result of its activation and inhibition, and the 
involvement of a G protein-coupled receptor-induced IP3- production process. The first model 
for IP3-induced Ca2+ release was proposed by De Young and Keizer, which assumed that there 
were three equivalent and independent subunits of IP3R involved and all of them have to be in 
particular conducting states to open the channel (De Young and Keizer 1992). Similar to De 
Young and Keizer’s four-state model, there were other models that used Markov kinetic 
schemes to describe transitions between states. They are based on the assumption that each 
subunit of the IP3R receptor has different multiple transitional states; for example, three (Gin, 
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Kirk et al. 2006) and seven transitional states (Doi, Kuroda et al. 2005). A well-known 
simplified two-state model based on De Young and Keizer’s model was developed by Li and 
Rinzel, who used Hodgkin-Huxley style equations based on the assumption of instantaneous 
activation following slow inactivation of IP3R by Ca2+ (Li and Rinzel 1994). Many follow-up 
models have been developed based on, or influenced by, the De Young–Keizer model or the 
Li-Rinzel simplified model. In addition, the models have been also developed based on other 
different assumptions such as sequential binding behavior (Bezprozvanny 1994), receptor 
conformation changes (Dawson, Lea et al. 2003), adaptation of IP3R and saturable fashion of 
IP3 (Dawson, Lea et al. 2003), or built to investigate different aspects, such as open 
probability of IP3R on steady states (Kaftan, Ehrlich et al. 1997, Mak, McBride et al. 2001) 
and IP3 metabolism (LeBeau, Yule et al. 1999). The development of IP3R models has been 
reviewed in detail by Sneyd and Falcke (Sneyd and Falcke 2005). 
RyR-regulated Ca2+ signalling has been ignored in some models of intracellular Ca2+ 
dynamics, since IP3R itself is enough to be responsible for CICR as it is sensitive to both IP3 
and Ca2+ ions. However, it is important to include RyRs to simulate the Ca2+ signalling more 
realistically. For example, by using Chemesis, a neural simulation software, Blackwell and 
Kotaleski demonstrated that the involvement of RyR channels affects the model simulation 
behavior of Ca2+ wave propagation (Blackwell and Kotaleski 2003). The models, which 
included RyR-regulated Ca2+ signalling, have considered that both RyR and IP3R contribute to 
Ca2+ release from the ER and the CICR is governed by RyR (De Schutter and Smolen 1998, 
Nakano, Yoshimoto et al. 2013). Similar strategies to IP3R modelling have been applied in 
RyR models. For example, there are models of RyRs using Markov kinetic schemes which 
describe the transitions between activated and inactivated states or multi-states (Sachs, Qin et 
al. 1995, Keizer and Levine 1996, Saftenku, Williams et al. 2001).  
2.3.3 Simulation of Ca2+ pumps and membrane leakage 
Ca2+ pumps include plasma membrane Ca2+ pumps, which remove Ca2+ from the cytosol, and 
SERCA pumps, which are the only contributors to the elevation of ER Ca2+ levels. These 
pumps have been present in cytosolic Ca2+ signalling models and been shown to modify Ca2+ 
transient and oscillation. In most models, they have been modelled as unidirectional pumps 
that are activated by the increase in cytosolic Ca2+ and defined by a simple Hill equation or 
Michaelis-Menten kinetics with a Hill coefficient (Zador, Koch et al. 1990, Blaustein and 
Lederer 1999, Schuster, Marhl et al. 2002, Bondarenko, Szigeti et al. 2004). A few complex 
models have taken into consideration the multiple transition states of SERCA activation 
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(Matsuoka, Sarai et al. 2003, Yano, Petersen et al. 2004) or the effect of Ca2+-buffering on 
SERCA (Higgins, Cannell et al. 2006). A leak influx of Ca2+ through the membrane into the 
cytosol is always used to balance the Ca2+ eflux through the pumps in the resting state. The 
membrane leakage is modelled  as either a constant leak influx (Zador, Koch et al. 1990) or as 
a process with a constant rate and in proportion to the concentration gradient across the 
membrane (Shannon, Ginsburg et al. 2000). 
2.3.4 Simulation of Ca2+ buffering and diffusion 
Ca2+ ions also interact with a variety of buffer proteins, such as calmodulin and calbindin, and 
fluorescent dyes in both the cytosolic space and the ER lumina (Berridge, Bootman et al. 
2003). In order to study the buffering effects on Ca2+ dynamics and make the simulation more 
reliable, various assumptions relating to buffering behavior have been made and added to the 
Ca2+ signalling model. It would obviously make the model more complex and larger to 
include details of binding events, such as the effects from different buffers. Therefore, 
simplified theories for Ca2+ buffering have been applied. For example, excess buffer 
approximation (EBA) and rapid buffer approximation (RBA) are two important 
simplifications, which assume the mobile buffers are exceeded and cannot be saturated, and 
binding of Ca2+ ions to buffers is much faster compared with the changes in cytosolic Ca2+ 
concentration, respectively (Sterratt, Graham et al. 2011). Besides, diffusion of Ca2+ ions has 
been included in some models which consider the effect of concentration gradients from 
geometry facts (Volfovsky, Parnas et al. 1999). The intracellular compartment is divided into 
multi-pool and movement of Ca2+ ions between two adjacent subcompartments is driven by 
Brownian motion (Sterratt, Graham et al. 2011). Radial and/or longitudinal diffusion will be 
considered based on model assumptions. Either deterministic or stochastic strategies can be 
applied to simulation of diffusion processing by using partial differential equations 
(Blackwell 2013). 
2.3.5 Simulation software 
There are a great deal of simulation tools available to date, and they can be generally 
classified into two categories: general purpose software and biological simulation software 
(reviewed in (Alves, Antunes et al. 2006, Brette, Rudolph et al. 2007, Blackwell 2013)) 
(Table A.1 in Appendix A). Tools that belong to the former category, such as MATLAB, 
XPPAUT, Mathematica and Python, require the user have some programming capability. The 
power of these tools provides the user great opportunities to analyze the model freely. Tools 
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that fall into the second category include common biological simulation tools such as 
CellDesigner, VCell, MCell and COPASI, as well as specific software packages for neuron 
simulation, such as GENESIS and NeuroRD. These tools have built-in capabilities for 
simulation on biological processes and are widely used by biologists. Most of these softeware 
have friendly graphical user interface (GUI) for model development, while others have 
Command-line interface (CLI) or require scripting languages (Figure A.1 in Appendix A). 
2.4 Modelling intracellular signalling related to AD 
Modelling intracellular signalling in computational neuroscience has been used to study 
complex temporal and spatial characteristics of nerve systems for decades. Well-established 
modelling methods of Ca2+ signalling provide good foundations for modelling studies of AD 
and Ca2+-related disease. However, only a few models have been developed to simulate or 
partly simulated the dysregulation of Ca2+ signalling in neurons related to AD. There has been 
some progress in the mathematical modelling of Aβ-induced alterations as a function of ion 
channels in neuronal plasma membranes. For example, based on the observation that Aβ 
induced a voltage-dependent decrease in membrane conductance in rat hippocampal neurons, 
Good and Murphy developed a mathematical model of Aβ-mediated blockages of fast-
inactivating K+ channels (Good and Murphy 1996). The simulation results show good 
agreement with experiments in the aspect of stimulation responses and Ca2+ buffering 
capacity. Through simulation they hypothesized that blockages of a fast-inactivating K+ 
current by Aβ as an early event plays a crucial role in the neurotoxicity of Aβ in AD and 
could lead to increased intracellular Ca2+ levels and membrane excitability resulting in 
neuronal neurotoxicity and, eventually, death. A recently published model based on Good and 
Murphy’s model has been developed to further explore Aβ-induced blockages of fast-
inactivating K+ channels as well as to study the Aβ-induced increase of membrane 
conductance during Aβ-neuron interaction in a short time-scale (Wilson, Gates et al. 2013). 
This model included the voltage-clamp and the membrane conductance mechanisms, which 
enabled it to simulate Aβ-neuron interactions under various experimental conditions, make 
comparisons with available data and generate predictions. Good’s group also utilized 
mathematical kinetic analysis methods to study the potential mechanism underlying Aβ-
induced G protein activation (Wang, Kazantzi et al. 2003). By using experimental rate data to 
examine the proposed underlying mechanisms, four possible different mechanisms have been 
tested to find the best fit of the rate expression with experimental data. Based on the results, 
they suggested that Aβ oligomers activate the G protein while excessive Aβ aggregation 
might inhibit further GTPase activity. In addition, models using simulation software packages 
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such as NEURON have been constructed to simulate the effects of Aβ on the neuronal 
membrane. For example, Kidd and Sattelle used NEURON to construct a model neuron to 
study the blockage effects by Aβ on A-type K+ currents of Drosophila larval cholinergic 
neurons and made predictions on their firing properties related to the alteration of the steady-
state properties of the A-type K+ current (Kidd and Sattelle 2006). Similarly, Morse et al. also 
used NEURON to analyze the hyper-excitability induced by Aβ via blocking A-type K+ 
currents observed in proximal dendrites in AD animal models (Morse, Carnevale et al. 2010). 
Through simulation they hypothesized the disruption Aβ-induced blockage of A-type K+ 
currents at oblique branches may be most vulnerable and may play an important role in 
the decline of cognitive function in the early stage of AD. 
Although dysregulation of intracellular Ca2+ signalling has been widely studied 
experimentally, little work has been done on computational model development in this area. 
Tiveci et al. developed a model of brain energy metabolism by including Ca2+ dynamics to an 
existing hemodynamic model of the brain (Tiveci, Akin et al. 2005). This model is able to 
investigate the effects of the existence of Ca2+ dynamics on the blood oxygenation level 
dependent (BOLD) signal based on experimental observations. They also used this model to 
simulate AD cases and, based on the simulation results, they suggested the cerebral blood 
flow changes observed in AD cases might be the cause of negative BOLD effects and 
increased cytosolic Ca2+ level. As well as modelling Ca2+ dynamics in neurons, there are also 
several models of Ca2+ signalling in astrocytes, the predominant glial cells in the central 
nervous system. Toivari et al. developed a computational stochastic model of Ca2+ signalling 
in rat cortical astrocytes, (Toivari, Manninen et al. 2011). This model was used to study the 
effects of Aβ25-35 and transmitters on intracellular Ca2+ signalling in astrocytes. The simulation 
results were consistent with their experimental findings on Aβ25-35 and transmitters induced 
Ca2+ transient. Another example is a model constructed by Riera et al. This model was based 
on spontaneous Ca2+ oscillations in astrocytes and used it to simulate Ca2+ dynamics in wild-
type (WT) and Tg2576 mice (Riera, Hatanaka et al. 2011). Through simulations, they 
suggested an increased Ca2+ influx from the extracellular space in APP transgenic mice might 
be activate astrocytes and play a crucial role in intracellular Ca2+ dysregulation. Furthermore, 
De Caluwé and Dupont recently developed a simple theoretical model to study the positive 
feedback loop between Aβ and cytosolic Ca2+ (De Caluwé and Dupont 2013). Despite this 
being a simplified model, which has excluded detailed molecular mechanisms, it was still able 
to reveal a bistable switch between ‘healthy’ and the ‘pathological’ states, depending on the 
concentration of Aβ and cytosolic Ca2+. A model which concentrated more on the effects of 
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Aβ on Ca2+ signalling in a single neuron is yet to be developed. 
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shows differential disturbances on the activities of NMDARs with different subunit 
composition and at different locations (see Chapter 2.3.2). Therefore, we include location-
specific and NR2 subunit-specific characteristics in this model to understand the Aβ–induced 
dysregulation of intracellular Ca2+ and its relationship with the balance between synaptic and 
extrasynaptic NMDARs (sNMDARs and eNMDARs) in the dendritic spine of the pyramidal 
neurons.  
Under experimental conditions, Aβ is usually given at a much higher concentration than that 
in human brains with AD (Sebollela, Freitas-Correa et al. 2012). It is inappropriate to study 
the concentration dependence of Aβ disturbances based on the results of these experiments; 
therefore, we mimic the disturbances of Aβ by perturbing key related parameters and 
observing the alterations in model behaviour. The perturbation in the parameters represents 
the degree of Aβ disturbance at different stages of AD pathology. 
The main contribution of this model is that it allows us to investigate different motifs of   
disturbance from Aβ on glutamatergic signalling and NMDAR-mediated postsynaptic Ca2+ 
dynamics. Specific numbers and subtypes of NMDAR at three locations are chosen, based on 
the literature, to demonstrate typical conditions in the CA1 pyramidal neurons. In this chapter, 
we develop the model in Section 3.1. In Section 3.2 we present the calibration and the 
estimation of unknown parameters with respect to the experimental findings based on the 
healthy condition. In Section 3.3, we discuss the model performance under healthy conditions. 
In Section 3.4 we use the model to mimic the Aβ-dependent disturbances in synaptic 
transmission and receptor distribution under AD conditions. In Section 3.4, we give a brief 
discussion and conclusions. 
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Figure 3.1. Disturbances in glutamatergic synaptic transmission by Aβ in AD. Referring 
to the arrow labels: ○1  Aβ inhibits glutamate clearance by the glutamate transporters; 
and ○2 and ○3  Aß promotes glutamate vesicle release from the presynaptic terminal and 
ambient astrocytes, respectively; and ○4 Aβ also mediates the internalisation of surface 
receptors at the synaptic site. ○1 , ○2  and ○3  result in an increase in extracellular 
glutamate concentration and, ultimately, may lead to the over activation of synaptic 
glutamate receptors or of receptors at distant locations from the release site. In contrast, 
○4 leads to a decrease in functional synaptic receptors may depress synaptic activity. 
This figure is produced using Servier Medical Art (http://www.servier.com/Powerpoint-
image-bank).  
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3.1 Model overview 
To model NMDAR-mediated glutamate-induced Ca2+ dynamics in a single synaptic spine and 
the adjacent dendritic shaft of a CA1 pyramidal neuron, we construct a mathematical model 
consisting of three parts: (1) glutamate release, diffusion and uptake (Figure 3.2A); (2) 
glutamate receptor state transition (Figure 3.2B); and (3) Ca2+ dynamics (Figure 3.2C). In this 
section, we present the model development in detail. 
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Figure 3.2. Conceptual framework of the three parts of the model. (A) After presynaptic stimulation, glutamate is released from the 
presynaptic terminal into the synaptic cleft. It is then diffused across the synaptic cleft and into the extrasynaptic space. Through diffusion, 
glutamate can bind to the glutamate receptors (GluRs) at different locations. (B) NMDAR and AMPAR are the most common ionotropic 
GluRs. NMDAR is the major Ca2+ channel; Ca2+ influx via NMDAR requires both the binding of glutamate to NMDAR and the removal of its 
Mg2+ blockage. The latter can be achieved by membrane depolarisation after the activation of AMPARs. (C) A four-compartment Ca2+ model 
of the dendritic spine and its adjacent dendritic shaft includes the mechansims for Ca2+ influx, extrusion and buffering in each compartment 
and diffusion between the two neighbouring compartments. 
 
 
 
(A) (B) (C) 
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3.1.1 Glutamate release, diffusion and uptake 
We simulate the glutamate release from the presynaptic terminal and diffusion inside the 
synaptic cleft, and in the extrasynaptic space, based on the model of Rusakov and Kullmann 
(1998). The schematic two-dimensional profile of the glutamate diffusion model is given in 
Figure 3.3. The spine head and the presynaptic terminal are modelled as two opposite 
hemispheres with the same radius and there is no glutamate diffusion within them. The 
synaptic cleft is a flat cylinder between these two hemispheres, with a height of 20 nm. We 
assume the volume of the spine head is 0.1 μm3, which gives a radius of 363 nm for the 
synaptic cleft and the two opposite hemispheres. The extrasynaptic space is a spherically 
isotropic porous medium surrounded by the two hemispheric obstacles. 
 
Figure 3.3. Schematic two-dimensional profile of the glutamate diffusion model. 
Glutamate is released at the centre of the synaptic cleft and diffused across the synaptic 
cleft and into the extrasynaptic space. The synaptic cleft is assumed to be a flat cylinder 
with 20 thin concentric shells. The extrasynaptic space is  a porous medium with 
spherical concentric shells. The arrows denote the diffusion direction of the glutamate. 
Glutamate transporters are homogenously distributed in the extrasynaptic space. Three 
grey areas (marked with ○1 , ○2  and ○3 ) represent the synaptic (PSD), perisynaptic and 
extrasynaptic sites. The glutamate concentration at each site is used for calculating local 
receptor activity in the NMDAR and AMPAR models. 
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The glutamate vesicle release site is assumed to be a point source and is placed in the centre 
of the presynaptic terminal surface. Each vesicle contains 100 mM glutamate, which is about 
1500 glutamate molecules (Meldrum 2000). Single and multiple vesicular release events can 
be simulated by changing the total number of glutamate molecules released. The time course 
of a single glutamate vesicle release is modelled by the function 
 𝜙(𝑡) =  𝜎2𝑡 𝑒𝑥𝑝 (−𝜎𝑡) (3.1) 
where 𝜙(𝑡) is the fraction of all glutamate molecules in a single that is released at time 𝑡 and 
σ = 39 ms-1 is the release time constant (Rusakov and Kullmann 1998).  Once released, 
glutamate molecules diffuse through the flat cylindrical cleft. After they escape from the cleft 
into the extrasynaptic space, the effective glutamate diffusion coefficient (DGlu) is reduced by 
a tortuosity factor λ, from DGlu to DGlu
∗ =
DGlu
λ2
 . Before moving to the extrasynaptic space, the 
glutamate concentration in the last cylinder shell of the cleft is scaled by 
1
α
, where α is the 
extracellular volume fraction (see Appendix B for the explanation). The spherical 
extrasynaptic space is modelled as 50 concentric shells with a thinness of 20 nm. The resting 
level of glutamate concentration in the extrasynaptic space is set to 0.25 μM (Herman and 
Jahr 2007, Talantova, Sanz-Blasco et al. 2013). The glutamate concentration in the last 
cylinder shell, which is 1.36 μm from the release site, is fixed at resting level (open boundary 
condition).  
Uptake of glutamate is governed by glial glutamate transporters. We assume that there are no 
glutamate transporters inside the synaptic cleft. In the extrasynaptic space, glutamate 
transporters are distributed homogenously at a concentration (Btotal) of 0.5 mM (Rusakov 
2001). A gap between the glial sheath and spine head is considered and, thus, the distribution 
of glutamate transporters starts at 20 nm from the edge of the dendritic cleft. A simple kinetic 
scheme is applied to the glutamate binding and uptake by glial transporters 
 𝐺𝑙𝑢 + 𝑇𝑟
𝑘1𝑓; 𝑘1𝑏
↔    𝐺𝑙𝑢 − 𝑇𝑟
𝑘2
→ 𝑇𝑟,  
where 𝐺𝑙𝑢 is the glutamate, 𝑇𝑟 is the unbound surface transporter and 𝐺𝑙𝑢 − 𝑇𝑟 is the 
glutamate-transporter complex (Rusakov and Kullmann 1998). The reactions include a rapid 
reversible binding between Glu and Tr with rate constants k1f and k1b and a relatively slow 
translocation from the surface into the glial cell at rate constant,  k2. The values of the 
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parameters are listed in Table 3.1. The reaction is assumed to obey mass action kinetics (see 
Appendix C.1 for the explanation), and the model eqations for transporters are in Appendix 
D.1. To track the glutamate concentration after release at different locations, we define the 
PSD site, and perisynaptic and extrasynaptic sites as follows: the surface of  the PSD region 
and the perisynaptic zone are set from 0 to 150 nm and 365 nm away from the centre of the 
postsynaptic surface, respectively (Newpher and Ehlers 2008) (Figure 3.3 ○1  and ○2 ). The 
extrasynaptic space is set beyond the outside border of the perisynaptic zone and we assume 
that the extrasynaptic receptors are located at the dendritic shaft. Based on the model 
geometry data in Table 3.1, the extrasynaptic site is about 826 nm away from the release point 
(Figure 3.3 ○3 ). 
Table 3.1. Model geometry and glutamate transmission related parameters. 
Description Symbol Value Reference 
Volume of spine head  0.1 μm3  
Volume of PSD  0.01 μm3  
Radius of PSD r𝑃𝑆𝐷 150 nm (Rusakov and 
Kullmann 1998, Sorra 
and Harris 2000) 
Height of cleft ℎ𝑐𝑙𝑒𝑓𝑡 20 nm 
Radius of cleft 𝑟𝑐𝑙𝑒𝑓𝑡 363 nm  
Length of dendritic neck 𝑙𝑛𝑒𝑐𝑘 750 nm (Holmes and Levy 
1990, Sorra and Harris 
2000) 
Radius of dendritic neck 𝑟𝑛𝑒𝑐𝑘 50 nm 
Length of dendritic shaft 𝑙𝑠ℎ𝑎𝑓𝑡 1000 nm (Holmes and Levy 
1990, O'Donnell, 
Nolan et al. 2011) 
Radius of dendritic shaft 𝑟𝑠ℎ𝑎𝑓𝑡 500 nm 
Distance of the glial sheath from the 
synaptic cylinder surface 
 20 nm (Rusakov 2001) 
Thickness of cylinder shell (cleft) 𝑑𝑟1 10 nm  
Thickness of sphere shell 
(extrasynaptic space) 
𝑑𝑟2 20 nm  
Glutamate vesicle content Glu0 1500 molecules (Meldrum 2000) 
Glutamate diffusion constant in the 
cleft 
DGlu 0.2 μm
2 ms-1 
 
(Rusakov and 
Kullmann 1998) 
(20-24 °C) Tortuosity factor λ 1.34 
Extracellular volume fraction α 0.12 
Transporter concentration Btotal 0.5 mM 
Binding rate constant k1f 0.1 ms
-1 
Unbinding rate constant k1b 5 mM
-1 ms-1 
Translocation rate k2 0.1 ms
-1 
Resting glutamate concentration  0.25 μM (Herman and Jahr 
2007, Talantova, 
Sanz-Blasco et al. 
2013) 
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3.1.2 Activation of the ionotropic glutamate receptors: NMDARs and AMPARs 
Glutamate receptors are located at the synaptic, perisynaptic and extrasynaptic membrane 
surfaces and have various receptor numbers (Table 3.2). For each receptor, the local 
glutamate concentration it receives depends on its distance from the release site. Because the 
number of glutamates is much greater than the number of these receptors, we do not consider 
the glutamate uptake by these receptors in the glutamate diffusion model. After computing the 
local glutamate concentrations at the location of the different receptors from the glutamate 
diffusion model, we input these glutamate concentrations into the receptor state kinetic 
models to investigate the dynamics of these receptors. We assume each receptor is 
independent of each other. Therefore, to get the total number of receptors opened by ligand at 
each time point, we first calculate the fraction of a single receptor in the open state and 
multiply it by the total number of receptors at each particular location. The multi-state kinetic 
schemes of each type of receptor are described by groups of deterministic ordinary differential 
equations (ODEs) with reaction rate constants. Differential equations are numerically solved 
using ode15s in Matlab. The set of ODEs are in Appendix E. 
3.1.2.1 Distribution of receptor numbers 
Both AMPAR and NMDAR are not fixed on the plasma membrane. They undergo trafficking 
from the intracellular synthesis sites to function sites on the surface of the plasma membrane. 
They are inserted into the membrane by exocytosis; move between different sites via lateral 
diffusion on the membrane; and can be internalised by endocytosis (Li, Jin et al. 2011). 
Although the trafficking of receptors play important roles in mediating postsynaptic activity, 
we have not included it in this model because it is a relatively slower process compared to the 
reactions in this model. Therefore, we assume the numbers of all receptors at different 
locations are constant during each simulation. 
The NMDAR number per synapse is relatively stable, about 20, among the different sizes of 
synapses (Newpher and Ehlers 2008, Chua, Kindler et al. 2010). A hippocampal slice study 
suggests that the ratio of eNMDARs to synaptic ones is around 1:2, with no exchange 
between them (Harris and Pettit 2007). Moreover, only about 25% of eNMDARs are located 
at the perisynaptic site (Hardingham and Bading 2010).  
NMDAR consists of two NR1 subunits and two NR2 subunits. The subunit composition of 
NMDARs at different locations changes during postnatal development (reviewed in (Petralia 
2012)). The ratio of NR2A to NR2B increases at the synaptic site and decreases at the 
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extrasynaptic site, respectively, during postnatal development. In mature synapses, NR2A-
NMDARs are predominant at the synaptic sites, which takes about 60% of the total synaptic 
NMDARs (Cheng, Hoogenraad et al. 2006). In contrast, perisynaptic NMDARs and 
extrasynaptic NMDARs are mainly NR1/NR2B-NMDARs (pNR2B-NMDAR and eNR2B-
NMDAR). Based on the experimental observations we select numbers for each type of 
NMDAR at different locations to represent NMDAR distribution in a mature synapse, as 
listed in Table 3.2.  
Unlike NMDARs, the number of AMPARs depends on the spine geometry and is positively 
correlated with the PSD size (Takumi, Ramirez-Leon et al. 1999, Newpher and Ehlers 2008). 
The average density of AMPARs is suggested to be uniformly distributed at different 
synapses and will be of a much higher density in synaptic sites rather than in extrasynaptic 
sites (Tanaka, Matsuzaki et al. 2005). We assume that the functional AMPARs are 
homogenously located in the membrane of PSD and at the dendritic shaft with different 
densities, and there is no AMPAR in the rest of the membrane of the spine. The number of 
AMPARs per spine is critical for the generation of the temporary depolarisation of the 
postsynaptic membrane potential after stimulation, which is also called the excitatory 
postsynaptic potential (EPSP). We estimate the AMPAR numbers in PSD based on the 
established experimental data in Section 3.2.3. The number of AMPARs at the dendritic shaft 
is low and stable, and is calculated based on the membrane surface area. The receptor density 
in Table 3.2 is taken from (Tanaka, Matsuzaki et al. 2005).  
3.1.2.2 Kinetic model of a single NMDAR 
NMDARs are heteromeric tetramers and the activation of an NMDAR requires both the 
binding of glutamate molecules to the NR2 subunits and the binding of coagonists (d-serine or 
glycine) to the NR1 subunits (Papouin, Ladepeche et al. 2012). In this study, we simulate the 
state transition of NMDAR by using a subtype specific kinetic model (Erreger, Dravid et al. 
2005) (Figure 3.4 A). We assume that the two NR1 subunits are always occupied by 
coagonists. Therefore, the activation of the receptor depends only on the glutamate 
concentration. In this model, NR1/NR2A-NMDAR and NR1/NR2B-NMDAR share the same 
activation schemes but with different reaction rate constants (Table 3.2), which allows us to 
investigate the effects of the different types of NMDAR. This eight-state kinetic scheme 
incorporates separate binding steps of two glutamate molecules, two desensitised states (D1 
and D2) and two conformational change stages (RA2f and RA2s) before opening (O). 
Channel opening requires both faster and slower conformational changes in the NR1 and NR2 
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subunits, respectively. These two transition processes are independent and can happen in any 
order. The dynamics of this kinetic scheme is simulated by seven ODEs (see Appendix E.2). 
Therefore, by solving the ODEs, the open fraction of a single NMDAR, 𝑃𝑜𝑁𝑀𝐷𝐴𝑅(𝑡), is 
calculated from the fraction of NMDARs at state O and at time 𝑡. 
3.1.2.3 Kinetic model of  AMPAR 
The dynamics of a single AMPAR is simulated by a seven-state model (Figure 3.4 B) (Jonas, 
Major et al. 1993). This model contains binding states of one and two glutamate molecules 
(RAG and RAG2), the open state (OA), and their corresponding desensitised states (D1, D2, Do). 
We apply the same simulation procedure as for the NMDAR dynamic simulation to obtain the 
open fraction of AMPAR, 𝑃𝑜𝐴𝑀𝑃𝐴𝑅(𝑡) , by solving six ODEs (see Appendix E.3). 
3.1.2.4 Differential contribution of AMPAR and NMDAR in Ca2+ signalling 
NMDAR is the major Ca2+ channel on the neuron membrane that contributes to the Ca2+ 
influx from the extracellular space during the synaptic activation in CA1 pyramidal neurons 
(Bloodgood and Sabatini 2007). The full opening of a NMDAR depends on both the ligand 
concentration and the membrane voltage. In this section we discuss the ligand concentration-
dependent property of NMDARs. Modelling of the voltage-dependent property of NMDAR is 
presented in Section 3.1.4. Experimental evidence shows that AMPAR has a low Ca2+ ion 
permeability (Tempia, Kano et al. 1996), thus, we have not included AMPAR as a Ca2+ 
channel. However, AMPAR indirectly mediated the Ca2+ dynamics leading to membrane 
depolarisation after activation. This will remove the Mg2+ blockage of NMDARs, as well as 
activate the voltage-dependent Ca2+ channels (VDCCs) on the membrane, and allow 
extracellular Ca2+ ions to enter into the neuron. 
 
   
 
  

52 
 
 
Table 3.2. NMDAR and AMPAR parameters 
Receptor type Location Number Reference 
NR1/NR2A–
NMDAR 
PSD (sNR2A-NMDAR) 12 (Cheng, 
Hoogenraad et 
al. 2006, 
Harris and 
Pettit 2007, 
Chua, Kindler 
et al. 2010) 
Perisynaptic site 0 
Extrasynaptic site 0 
NR1/NR2B-
NMDAR 
PSD 
(sNR2B-NMDAR) 
8 
Perisynaptic site 
(pNR2B-NMDAR) 
3 
Extrasynaptic site 
(pNR2b-NMDAR) 
8 
AMPAR PSD (sAMPAR) 85 receptors  
Extrasynaptic site 
(eAMPAR) 
20 receptors/μm2 (Tanaka, 
Matsuzaki et 
al. 2005) 
Receptor type Reaction rate constants Value Reference 
NR2A–NMDARs 
(20-24 °C) 
kon 0.0316 µM
-1 ms-1 (Erreger, 
Dravid et al. 
2005) 
koff 1.01 ms
-1 
kd1+ 0.0851 ms
-1 
kd1− 0.0297 ms
-1 
kd2+ 0.23 ms
-1 
kd2− 0.00101 ms
-1 
kf+ 0.230 ms
-1 
kf− 0.178 ms
-1 
ks+ 3.140 ms
-1 
ks− 0.174 ms
-1 
NR2B–NMDARs 
(20-24 °C) 
 
kon 0.00283 µM
-1 ms-1 
koff 0.0381 ms
-1 
kd1+ 0.550 ms
-1 
kd1− 0.0814 ms
-1 
kd2+ 0.112 ms
-1 
kd2− 0.00091ms
-1 
kf+ 0.048 ms
-1 
kf− 0.23 ms
-1 
ks+ 2.836 ms
-1 
ks− 0.175 ms
-1 
AMPAR  
(22 °C) 
 
k11 0.00459 µM
-1 ms-1 (Jonas, Major 
et al. 1993) k10 4.26 ms-1 
k21 0.0284 µM
-1 ms-1 
k20 3.26 ms
-1 
k31 0.00127 µM
-1 ms-1 
k30 0.0457 ms
-1 
α 4.24 ms-1 
β 0.9 ms-1 
α1 2.89 ms
-1 
β1 0.0392 ms
-1 
α2 0.172 ms
-1 
β2 0.000727 ms
-1 
α3 0.0177 ms
-1 
β3 0.004 ms
-1 
α4 0.0168 ms
-1 
β4 0.1904 
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3.1.3 Membrane potential 
The removal of the Mg2+ blockage of NMDARs and the activation of VDCC depends on the 
membrane depolarisation after stimulation. We build an electrical model (Figure 3.5) of a 
single spine and its adjacent dendritic shaft to capture the dynamics of the membrane 
potential. We construct the electrical model based on the morphological features, as described 
in Section 3.1.1. 
 
Figure 3.5. Passive electrical model of a dendritic spine and the adjacent dendritic shaft 
of a CA1 pyramidal neuron. The spine head and dendritic shaft are modelled as 
separate compartments, with membrane capacitances, Chead and Cd, and resistances, 
Rhead and Rd, respectively. Rreceptor,1 and Rreceptor,2  are the resistance of receptors in the 
membrane of the spine head and the dendritic shaft, respectively. The spine head and 
dendritic compartments are connected by the spine neck, with neck resistance, Rneck.. 
The dendritic shaft is modelled as a series of identical cylindrical compartments. The 
resting potential, Erest, is assumed to be the same in all compartments (Erest =-70 mV). 
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3.1.3.1 Spine head and spine neck 
The spine head is modelled as an isopotential hemispherical compartment. Its membrane 
capacitance and resistance can be calculated by its surface area (Aℎ𝑒𝑎𝑑), the specific 
membrane resistance (Rm) and the specific capacitance (𝐶𝑚) (Koch 1998) 
Rhead =
Rm
Aℎ𝑒𝑎𝑑
, 𝑎𝑛𝑑 
𝐶ℎ𝑒𝑎𝑑 = 𝐶𝑚Aℎ𝑒𝑎𝑑 . 
Therefore, the postsynaptic membrane potential is 
 𝐶ℎ𝑒𝑎𝑑
𝑑𝑉ℎ𝑒𝑎𝑑
𝑑𝑥
=
𝐸𝑟𝑒𝑠𝑡 − 𝑉0
𝑅ℎ𝑒𝑎𝑑
− 𝐼𝑠𝑦𝑛 + 𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,1, (3.2) 
where 𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,1 represents the current of receptors on the spine head and 𝐼𝑠𝑦𝑛 represents the 
current flow through the spine neck. Based on Ohm’s law, 𝐼𝑠𝑦𝑛 can be calculated as the 
voltage drop from the spine head (𝑉ℎ𝑒𝑎𝑑) to the dendrite shaft (𝑉𝑑) across the spine neck 
resistance (𝑅𝑛𝑒𝑐𝑘) 
𝐼𝑠𝑦𝑛 =
𝑉ℎ𝑒𝑎𝑑 − 𝑉𝑑
𝑅𝑛𝑒𝑐𝑘
. 
3.1.3.2 Spine neck resistance 
The spine neck is simulated as an electrical cylindrical resistor of length 𝑙𝑛𝑒𝑐𝑘 and 
radius 𝑟𝑛𝑒𝑐𝑘, therefore, its resistance is  
Rneck = R𝑖𝑙𝑛𝑒𝑐𝑘πr𝑛𝑒𝑐𝑘
2  
 
where R𝑖 is the specific axial resistance (or specific cytoplasmic resistivity). In the CA1 
pyramidal neuron, the values of neck length and width range from 0.157 μm to 1.8 μm and 
0.059 μm to 0.292 μm, respectively (Sorra and Harris 2000). If we assume a specific axial 
resistance of R𝑖=200 Ω cm, the neck resistance ranges from 13.4 MΩ to 330 MΩ. The large 
resistance of the spine neck between the compartments of the spine head and dendritic shaft 
determines the decrement of the EPSP amplitude from the spine head to its parent dendritic 
shaft after stimulation. It is suggested that the Rneck is negatively correlated to the EPSP 
amplitude of the dendritic shaft membrane potential after stimulation (Araya, Jiang et al. 
2006). Therefore, we calibrate the size of spine neck to generate realistic electrical results 
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according to the literature (see Section 3.2.2) 
3.1.3.3 Dendritic shaft 
The dendritic shaft is simulated as a long passive cylinder that is divided into several identical 
compartments (Sterratt, Graham et al. 2011). Each compartment has a length of 𝜆 and a 
diameter of 𝑑. The current can flow between neighbouring compartments, which is expressed 
as the voltage drop between neighbouring compartments across the axial resistance. 
Therefore, for compartment, j, its membrane potential (𝑉𝑑,𝑗) is  
 𝐶𝑑,𝑗
𝑑𝑉𝑑,𝑗
𝑑𝑡
=
𝐸𝑟𝑒𝑠𝑡−𝑉𝑑,𝑗
𝑅𝑑,𝑗
+
𝑉𝑑,𝑗+1−𝑉𝑑,𝑗
𝑟𝑎
−
𝑉𝑑,𝑗−𝑉𝑑,𝑗−1
𝑟𝑎
+ 𝐼𝑠𝑦𝑛,𝑗 + 𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,2, 
(3.3) 
where 𝐶𝑑,𝑗, and 𝑅𝑑,𝑗 are the membrane capacitance and membrane resistance of the dendritic 
compartments and 𝑟𝑎 is the axial resistance between the neighbouring dendritic 
compartments. They can be calculated from the specific resistances, R𝑚 and R𝑎, and the size 
of the compartment. Thus, Eq. (3.3) can be written as 
𝜋𝑑𝜆𝐶𝑚
𝑑𝑉𝑑,𝑗
𝑑𝑡
=
𝐸𝑟𝑒𝑠𝑡 − 𝑉𝑑,𝑗
𝑅𝑚
𝜋𝑑𝜆
+
𝑉𝑑,𝑗+1 − 𝑉𝑑,𝑗
𝑅𝑎
𝜋 (
𝑑
2)
2 𝜆
−
𝑉𝑑,𝑗 − 𝑉𝑑,𝑗−1
𝑅𝑎
𝜋 (
𝑑
2)
2 𝜆
+ 𝐼𝑠𝑦𝑛,𝑗𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,2. 
Multiply both sides by 𝑅𝑚/𝜋𝑑𝜆 and then 
𝜏𝑚
𝑑𝑉𝑑,𝑗
𝑑𝑡
= 𝐸𝑟𝑒𝑠𝑡 − 𝑉𝑑,𝑗 +
𝑅𝑚𝑑
4𝑅𝑎
(
𝑉𝑑,𝑗+1 − 2𝑉𝑑,𝑗 + 𝑉𝑑,𝑗
𝜆2
) +
𝑅𝑚
𝜋𝑑𝜆
(𝐼𝑠𝑦𝑛,𝑗 + 𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,2). 
Let the compartment length 𝜆 =  √
R𝑚𝑑
4R𝑖
. 
Then 
𝜏𝑚
𝑑𝑉𝑑,𝑗
𝑑𝑡
= 𝐸𝑟𝑒𝑠𝑡 − 𝑉𝑑,𝑗 + (𝑉𝑑,𝑗+1 − 2𝑉𝑑,𝑗 + 𝑉𝑑,𝑗) + √
4R𝑚R𝑖
𝜋2𝑑3
(𝐼𝑠𝑦𝑛,𝑗 + 𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,2). 
In the last term, 𝐼𝑠𝑦𝑛,𝑗 is the total input current by the attached spine necks 
𝐼𝑠𝑦𝑛,𝑗 = 𝜎𝐼𝑠𝑦𝑛 
where 𝜎 is the density of the attached spines per compartment. 𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,2 represents the 
current of the receptors on the dendritic shaft. We assume 𝜎 = 1 because we focus on the 
stimulation on a single dendritic spine rather than the co-activation between neighbouring 
spines. 
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In this study, the basal dendrite is represented as a series of cylindrical compartments with 
sealed ends on both sides. The sealed end boundary condition assumes that the resistance of 
the compartment is very high; therefore, the exit current flow via the end is negligible. We 
assume only one spine is attached to the middle point of the dendrite. Therefore, for N 
dendritic compartments, the change in voltages are 
 𝜏𝑚
𝑑𝑉𝑑,1
𝑑𝑡
= 𝐸𝑟𝑒𝑠𝑡 − 𝑉𝑑,1 + 2𝑉𝑑,2 − 2𝑉𝑑,1 +√
4R𝑚R𝑖
𝜋2𝑑3
(𝐼𝑠𝑦𝑛,𝑗 + 𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,2), 
(3.4) 
 𝜏𝑚
𝑑𝑉𝑑,𝑗
𝑑𝑡
= 𝐸𝑟𝑒𝑠𝑡 − 𝑉𝑑,𝑗 + (𝑉𝑑,𝑗+1 − 2𝑉𝑑,𝑗 + 𝑉𝑑,𝑗), 𝑗 = 2…𝑁 − 1, 𝑎𝑛𝑑 
(3.5) 
 𝜏𝑚
𝑑𝑉𝑑,𝑁
𝑑𝑡
= 𝐸𝑟𝑒𝑠𝑡 − 𝑉𝑑,1 + 2𝑉𝑑,𝑁−1 − 2𝑉𝑑,𝑁. 
 
(3.6) 
3.1.3.4 Receptor current 
The total input current of the spine head and the shaft are a summation of the current of both 
local NMDARs and AMPARS: 
𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,1 = 𝐼𝑁𝑀𝐷𝐴𝑅,𝑃𝑆𝐷 + 𝐼𝑁𝑀𝐷𝐴𝑅,perisynaptic + 𝐼𝐴𝑀𝑃𝐴𝑅,𝑃𝑆𝐷, 𝑎𝑛𝑑 
𝐼𝑟𝑒𝑐𝑒𝑝𝑡𝑜𝑟,2 = 𝐼𝑁𝑀𝐷𝐴𝑅,𝑑 + 𝐼𝐴𝑀𝑃𝐴𝑅,𝑑. 
The receptor current at a specific location 𝑖 (INMDAR,i and IAMPAR,i) is 
 𝐼𝑁𝑀𝐷𝐴𝑅,𝑖 = 𝑃𝑜𝑁𝑀𝐷𝐴𝑅,𝑖𝐺𝑁𝑀𝐷𝐴𝑅,𝑖𝐵(𝑉𝑖)(𝑉𝑖 − 𝑉𝑟,𝑁𝑀𝐷𝐴𝑅), 𝑎𝑛𝑑 (3.7) 
 𝐼𝐴𝑀𝑃𝐴𝑅,𝑖 = 𝑃𝑜𝐴𝑀𝑃𝐴𝑅,𝑖𝐺𝐴𝑀𝑃𝐴𝑅,𝑖 (𝑉𝑖 − 𝑉𝑟,𝐴𝑀𝑃𝐴𝑅), (3.8) 
where Vr,NMDARand Vr,AMPAR are the reversal potentials for NMDAR and AMPAR, 
respectively. PoNMDAR,i  and PoAMPAR,i are the fractions of the NMDARs and AMPARs in the 
open states at site 𝑖, respectively. 𝑉𝑖 is the membrane voltage of site 𝑖. 
GNMDAR,i and GAMPAR,i are the maximum conductances for the corresponding type of receptor 
at site 𝑖. These are the conductances when all NMDARs and AMPARs are saturated 
 𝐺𝑁𝑀𝐷𝐴𝑅,𝑖 = 𝑔𝑁𝑀𝐷𝐴𝑅 ∗ 𝑁𝑁𝑀𝐷𝐴𝑅,𝑖, 𝑎𝑛𝑑 
(3.9) 
 𝐺𝐴𝑀𝑃𝐴𝑅,𝑖 = 𝑔𝐴𝑀𝑃𝐴𝑅 ∗ 𝑁𝐴𝑀𝑃𝐴𝑅,𝑖, 
(3.10) 
where gNMDAR and gAMPAR are the single channel conductance of NMDARs and AMPARs, 
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respectively. 𝑁𝑁𝑀𝐷𝐴𝑅,𝑖and 𝑁𝐴𝑀𝑃𝐴𝑅,𝑖 are the total NMDAR and AMPAR numbers at site 𝑖.  
Eq. (3.7), B(Vi) describes the Mg
2+ blockage of NMDARs under Vi at each time step (Jahr and 
Stevens 1990) 
 B(Vi) =
1
1 +
[Mg]
3.57 exp (−0.062Vi)
, (3.11) 
where [Mg] is the extracellular magnesium concentration (1 mM). The values of the 
parameters in this section are listed in Table 3.3. 
 
Table 3.3. Membrane potential related parameters 
Description  Symbol Value Reference 
Specific resistance R𝑚 30 kΩ∙ cm
2 
(Mainen, Carnevale 
et al. 1996) 
 
Specific capacitance C𝑚 1 μF/cm
2 
Specific cytoplasmic 
resistivity 
R𝑖 100 kΩ∙ cm 
Membrane time constant  τ𝐸 R𝑚 ∙ C𝑚  
Resting membrane potential Erest -70 mV 
(Schiegg, Gerstner 
et al. 1995) 
Single channel conductance 
of NMDAR gNMDAR 
45 pS (20-24 °C) 
(Spruston, Jonas et 
al. 1995) 
Single channel conductance 
of AMPAR gAMPAR 
10 pS (20-24 °C) 
(Spruston, Jonas et 
al. 1995) 
Reversal potentials for 
NMDAR and AMPAR 
Vr,NMDAR 
Vr,AMPAR 
0 mV 
(Jahr and Stevens 
1990) 
Extracellular magnesium 
concentration [Mg] 
1 mM 
(Jahr and Stevens 
1990) 
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3.1.4 Compartmental model of Ca2+dynamics 
We construct a four-compartment model to represent a pyramidal neuron dendritic spine and 
its adjacent dendritic shaft. The four compartments are the PSD, cytosol, spine neck and 
dendritic shaft (Figure 3.6).The geometry of the spine is consistent with what is described in 
the diffusion model (Table 3.1). The spine head is assumed to be a hemisphere and is divided 
into PSD and cytosol compartments. The PSD compartment is a cylinder attached to the 
postsynaptic membrane and the rest of the spine head is in the cytosol compartment. We 
assume the volume of the spine head is 0.1 μm3 (radius = 0.363 μm) and PSD takes 10% of 
the total volume of the spine head (Harris, Jensen et al. 1992, Ventura and Harris 1999). 
Therefore, the compartment volumes of PSD and cytosol are 0.01 and 0.09 μm3, respectively. 
The radius of PSD is 150 μm and the height of its compartment is calculated from its volume, 
which is about 0.142 μm. The spine neck is represented as a long thin cylinder, which is 
coaxial with the spine head. The size of the spine neck is discussed in Section 3.2.2. The 
dendritic shaft is another cylinder that is attached to the bottom of the spine neck with a radius 
of 0.5 μm and a length of 1 μm. 
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Figure 3.6. Schematic diagram of Ca2+ dynamics at the dendritic spine head and its 
adjacent dendritic shaft, for a CA1 pyramidal neuron. The spine head is divided into 
two compartments, PSD and cytosol. A thin long spine neck links the spine head to the 
dendritic shaft, which allows Ca2+ to diffuse from the spine head to the dendrite. Ca2+ 
enters the PSD, cytosol and the dendritic shaft via NMDARs and is extruded by Ca2+ 
pumps at all compartments. Ca2+ buffers are distributed homogenously within each 
compartment. Diffusion of Ca2+ between compartments is also considered. This 
schematic diagram does not represent the actual scale of the model. 
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Extracellular Ca2+ions entering each compartment result from the local membrane Ca2+current 
that is then buffered by various Ca2+ buffer proteins extruded via membrane Ca2+ pumps and 
diffused from the spine head to the dendrite. We assume the molecules are well-mixed in each 
compartment and only diffusion of Ca2+ between the compartments is considered. The Ca2+ 
dynamics in PSD, spine head, spine neck and dendritic shaft are governed by  
 
𝑑[𝐶𝑎2+]𝑗
𝑑𝑡
= 𝐽𝐼𝐶𝑎,𝑗 + 𝐽𝑚𝑒𝑚,𝑗 + 𝐽𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑜𝑛,𝑗 − 𝐽𝑏𝑢𝑓𝑓𝑒𝑟,𝑗, (3.12) 
where 𝑗 indicates the compartment index (𝑗=1, PSD; 2, cytosol; 3, spine neck; 4, dendritic 
shaft). The values of the parameters are in Table 3.4. 
3.1.4.1 Ca2+influx by Ca2+current 
In Eq. (3.12), 𝐽𝐼𝐶𝑎,𝑗 is the Ca
2+ influx by the Ca2+ current, mediated by the membrane 
ionotropic receptors (NMDAR in this study). The Ca2+current at the spine head and dendritic 
shaft is assumed to be a fixed fraction of the total local input current. The fraction of the Ca2+ 
current in the total cation current through NMDARs is about 10% (Schiegg, Gerstner et al. 
1995) whereas, through AMPARs, is about 0.6% (Garaschuk, Schneggenburger et al. 1996). 
Therefore, the Ca2+influx into the spine head and dendritic shaft is mainly mediated by local 
NMDARs. We only consider the contribution of AMPARs to the depolarisation of the 
synaptic membrane and ignore the Ca2+ influx via AMPAR in this study. The Ca2+influx via 
NMDAR is given by 
 𝐽𝑁𝑀𝐷𝐴𝑅,𝑖 = −
𝐼𝑁𝑀𝐷𝐴𝑅,𝑖
𝑍𝐶𝑎 𝐹 𝑉𝑜𝑙𝑖
, 
(3.13) 
where 𝐼𝑁𝑀𝐷𝐴𝑅,𝑖 is the NMDAR current calculated in Eq. (3.7), fCa = 10% is the fraction of 
Ca2+ current carried by NMDAR (Schiegg, Gerstner et al. 1995), F= 96485.3 C Mol−1 is 
Faraday’s constant, ZCa = 2 is the valence of Ca
2+ ions and Volj is the volume of 
compartment 𝑖. JICa,j  is not valid when j = 3. 
3.1.4.2 VDCCs 
VDCCs are located at both the spine head and the dendritic shaft. We calculate the Ca2+ 
current by VDCCs as 
𝐼𝑉𝐷𝐶𝐶,𝑖 = 𝐺𝑉𝐷𝐶𝐶,𝑖𝑚ℎ(𝑉𝑖 − 𝑉𝑟
𝐶𝑎2+), 
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where 𝐺𝑉𝐷𝐶𝐶,𝑖 and 𝑉𝑖 are the maximum conductance of VDCC and membrane potential at site 
I, respectively. 𝐺𝑉𝐷𝐶𝐶,𝑖 is estimated in Section 3.2.2. 𝑉𝑟
𝐶𝑎2+  is the membrane reversal potential 
of the Ca2+ ions 
 
𝑉𝑟
𝐶𝑎2+ =
𝑅𝑇
𝑍𝑐𝑎𝐹
𝑙𝑛
𝐶𝑎𝑜
𝐶𝑎𝑖
, (3.14) 
where 𝑅 is the ideal gas constant, 𝑇 is the absolute temperature in Kelvin, 𝑍𝑐𝑎is the valence of 
Ca
2+
 and 𝐹 is the Faraday constant. Ca𝑜 represents the extracellular Ca
2+ concentration 
(Ca𝑜 =100 μM) and Ca𝑖 represents the cytosolic Ca
2+ concentration in compartment i, 
respectively. 𝑚 𝑎𝑛𝑑 ℎ represent the activation and deactivation of VDCC, and they are 
calculated as 
𝑑𝑚
𝑑𝑡
= (1 − 𝑚)𝛼𝑚 −𝑚𝛽𝑚, 𝑎𝑛𝑑 
𝑑ℎ
𝑑𝑡
= (1 − ℎ)𝛼ℎ − ℎ𝛽ℎ, 
where 
𝛼𝑚 =
8.5
1 + exp (−
𝑉𝑖 − 8
12.5 )
, 
𝛽𝑚 =
35
1 + exp (
𝑉𝑖 + 74
14.5 )
, 
𝛼ℎ =
0.0015
1 + exp (
𝑉𝑖 + 29
8 )
, 𝑎𝑛𝑑 
𝛽ℎ =
0.0055
1 + exp (−
𝑉𝑚 + 23
8 )
. 
3.1.4.3 Ca2+ pumps and leakage  
We assume there is no ER in the dendritic spine, therefore, Ca2+ extrusion from the cytosol of 
CA1 pyramidal neurons is mainly mediated by two types of membrane pump: the plasma 
membrane Ca2+ ATPase (PMCA) and the sodium Ca2+ exchanger (NCX). PMCA has about a 
10-fold higher affinity for Ca2+ but a lower turnover rate than the NCX. We follow the model 
62 
 
 
of Schiegg, Gerstner et al. (1995) to simulate Ca2+ extrusion using first–order Michaelis-
Menten kinetics (see Appendix C.4 for the explanation). They are modelled as 
 𝐽𝑚𝑒𝑚,𝑗 = −∑
𝐴𝑗
𝑉𝑗
𝑃𝑠𝑛𝑉𝑚𝑎𝑥,𝑛
[𝐶𝑎2+]𝑗
[𝐶𝑎2+]𝑗 + 𝐾𝑑,𝑛
𝑛
+
𝐴𝑗
𝑉𝑗
𝐽𝑙𝑒𝑎𝑘,𝑗, (3.15) 
where the maximum pumping velocity of pump 𝑛, (𝑛 = 1, 𝑃𝑀𝐶𝐴; 2, 𝑁𝐶𝑋) at compartment, 𝑗 
is calculated by the multiplication of the maximum turnover rates of Ca2+ of pump 𝑛, 𝑉𝑚𝑎𝑥,𝑛, 
by its surface density, 𝑃𝑠𝑛, and the ratio of surface area to volume of compartment 𝑗, 
𝐴𝑗
𝑉𝑗
. 𝐾𝑑,𝑛 
is the dissociation constant for pump 𝑛. 𝐽𝑙𝑒𝑎𝑘,𝑗 is the Ca
2+ leakage flux via the membrane, 
which balances the Ca2+concentration at the resting level. The densities of pumps at different 
locations are difficult to be precisely estimated from experimental data; therefore, we estimate 
the values of them in Section 3.2.4 using a Markov chain Monte Carlo (MCMC) (see 
Appendix F.1) from the experimental data (Sabatini, Oertner et al. 2002). 
3.1.4.4 Diffusion 
We simulate the Ca2+ diffusion between compartments using Fick's first law (Sterratt, Graham 
et al. 2011). The concentration change of Ca2+ in compartment 𝑗 due to diffusion is  
 
𝐽𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑜𝑛,𝑗 = −
𝐷𝐶𝑎
𝑉𝑗
[(
𝐴
𝛿
)
𝑗,𝑗−1
([𝐶𝑎2+]𝑗 − [𝐶𝑎
2+]𝑗−1)  
− (
𝐴
𝛿
)
𝑗+1,𝑗
([𝐶𝑎2+]𝑗+1 − [𝐶𝑎
2+]𝑗)], 
(3.16) 
where 𝐷𝐶𝑎 is the diffusion coefficient of Ca
2+, and 𝑉𝑗 is the volume of compartment 𝑗. 
(
𝐴
𝛿
)
𝑝,𝑞
=
𝐴𝑝𝑞 
∆𝑙𝑝𝑞
 describes the movement of Ca2+ ions from compartment 𝑝 to 𝑞, 
where 𝐴𝑝𝑞 is the cross-sectional area of the two compartments and ∆𝑙𝑝𝑞 is the distance 
between the midpoints of compartments 𝑝 and 𝑞. 
3.1.4.5 Buffering 
In each compartment, we include a general form of an endogenous immobile Ca2+ buffer 
protein and two mobile buffer proteins: calbindin (CaD) and calmodulin (CaM).The buffers’ 
capacity for Ca2+ decides the shape of the decay in the cytosolic Ca concentration after 
reaching a peak. The last part in Eq. (3.12) is Ca2+ buffering by all types of endogenous 
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buffers. The concentration of immobile buffer protein in each compartment is estimated in 
Section 3.2.2. The simulation details of immobile Ca2+ buffer, CaD and CaM are in Appendix 
D.2. 
 
Table 3.4. Parameters for the spine compartment model 
Description  Symbol Value Reference 
Pump affinity (PMCA) 𝐾𝑀,1 0.2 μΜ (Sabatini, 
Oertner et al. 
2002) 
(Carafoli 1992, 
Blaustein and 
Lederer 1999) 
Turnover rate (PMCA) 𝑉𝑚𝑎𝑥,1 100 ms
-1(37 °C) 
Pump affinity (NCX) 𝐾𝑀,2 20 Μm 
Turnover rate (NCX) 𝑉𝑚𝑎𝑥,2 1000 ms
-1(37 °C) 
Ca2+ diffusion coefficient 𝐷𝐶𝑎 0.220 μm
2/ms 
(20-24 °C) 
(Allbritton, 
Meyer et al. 
1992) 
Forward rate constant of 
mobile buffer 
𝑘𝑏𝑓 0.176 μM
-1 ms-1 
MCMC 
estimated 
Backward rate constant of 
mobile buffer 
𝑘𝑏𝑏 0.624 ms
-1 
 
Total buffer concentration 
in compartment 𝑗 
[𝐵]𝑡𝑜𝑡𝑎𝑙,𝑗 108.78 μM (spine head) 
116.97 μM (dendritic 
shaft) 
 
3.2 Parameter calibration and estimation 
3.2.1 Temperature Coefficient (Q10) corrections 
Since most reaction and diffusion rates are affected by the environmental temperature, it is 
necessary to correct the values of the rate constants in regard to their temperature sensitivity. 
The temperature coefficient (Q10) measures the degree of temperature dependence when 
increasing the temperature by 10°C. It is calculated according to 
𝑄10 = (
𝑅2
𝑅1
)
10
𝑇2−𝑇1
, 
where 𝑅1and 𝑅2 are the rate constants at temperatures 𝑇1 and 𝑇2 (𝑇1 < 𝑇2), respectively. 
Therefore, the corrected value, 𝑅𝑠𝑖𝑚, of a parameter with original value, 𝑅𝑜, from the original 
temperature 𝑇𝑜 to simulation temperature 𝑇𝑠𝑖𝑚 is 
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𝑅𝑠𝑖𝑚 =
{
 
 𝑅𝑜 × 𝑄10
𝑇𝑠𝑖𝑚−𝑇𝑜
10 , 𝑇𝑠𝑖𝑚 > 𝑇𝑜
𝑅𝑜
𝑄10
𝑇𝑜−𝑇𝑠𝑖𝑚
10
,          𝑇𝑠𝑖𝑚 < 𝑇𝑜
. 
The values of Q10 for each type of parameter are listed in Table 3.5. The simulation 
temperature used in this chapter is 34°C. 
Table 3.5. Q10 values for biological processes 
Biological processes Q10 
Diffusion 1.3 
Glutamate transporter kinetics 3 
AMPAR kinetics 2.4 
AMPAR conductance 1.5 
NMDAR kinetics 3 
NMDAR conductance 1.6 
Pump kinetics 3 
Buffer kinetics 2.15 
VDCC gating kinetics 3 
VDCC conductance 1.5 
 
3.2.2 Resistance 
We explore the dependency of the spine neck size on the EPSPspine and the ratio of EPSP at 
the spine head to the dendrite shaft (EPSPspine/EPSPshaft). We vary the length and width of the 
spine neck in the physiological range (Sorra and Harris 2000) and investigate its effects on the 
EPSPspine and the EPSPspine/EPSPshaft  (Figure 3.7). The results are consistent with the 
experimental observation that as the increment in spine neck length, the EPSEspine decrement 
of the EPSP amplitude from the spine head to its parent dendritic shaft increases linearly. The 
longer spine neck results in a larger resistance and allows more EPSP to stay in the spine head 
with a higher EPSPpeak. In contrast, the spine head EPSP decrement decreases exponentially 
with the enlargement in the spine width.  
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(A) 
 
 
(B) 
 
 
(C) 
 
 
(D) 
 
Figure 3.7. Effect of spine neck size on the EPSP amplitude in the spine head and the 
spine-shaft EPSP ratio. (A) and (B) are simulated by varying the spine neck length from 
0.157 to 1.8 μm while fixing the radius to 0.086 μm. (C) and (D) are simulated by varying 
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the spine neck width from 0.059 to 0.292 μm while fixing the length to 0.689 μm. The 
model is simulated with a medium AMPAR density in PSD (AMPAR = 42)  
3.2.3 Synaptic AMPAR number and spine 
Based on experimental observation, we assume the EPSP amplitude at synaptic site is lower 
than 5 mV after a single synaptic stimulation (Kovalchuk, Eilers et al. 2000, Palmer and 
Stuart 2009). The EPSP is mainly AMPAR-dependent and partially NMDAR-dependent. 
Therefore, we adjust the number of AMPARs to generate the expected EPSP amplitude. The 
range of AMPAR numbers for testing is calculated based on the spine head size and the 
density of AMPAR (Tanaka, Matsuzaki et al. 2005). It has been reported that the AMPAR 
density in synaptic site ranges from 874 to 946 receptor per μm2 in single synapses in the 
immature cerebellum. The density rage is much wider in the adult cerebellum, 48 to 1210 
receptors per μm2 (Masugi-Tokita, Tarusawa et al. 2007). The area of PSD in this model is 
0.07 μm2 (r = 0.15 μm), which gives a range of AMPAR from three to 86. Figure 3.8 shows 
the number of AMPARs in PSD versus the EPSPpeak at the spine head. The EPSP amplitude 
increases linearly with the increasing AMPAR density. The simulation is based on Rneck =157 
MΩ, representing the resistance of a medium sized spine neck of CA1 pyramidal neurons 
(Sorra and Harris 2000). Therefore, we choose a medium sized spine neck with a radius of 
0.05 μm and a length of 0.75 and a large AMPAR density, which gives 85 AMPARs in PSD 
in this model. It causes an EPSPspine of 4.5 mV and an EPSPshaft  of 1.7 mV. 
 
Figure 3.8. AMPAR numbers in PSD positively relate to the EPSP amplitude in the 
spine head. 
 
3.2.4 VDCC, pump density and endogenous protein concentraintion 
The pump densities for VDCC, PMCA and NCX and the concentration, forward/backward 
reaction rates of the endogenous immobile buffer and its concentration in the dendritic and 
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spine locations are estimated according to the experimental observations in Sabatini, Oertner 
et al. (2002). They estimate the Ca2+dynamics at the dendritic spines of the CA1 pyramidal 
neurons and their parent dendrites by a single bAP in the condition of the absence of 
exogenous buffer (Ca2+ indicator) and the washout of mobile buffers. The results correspond 
to spines and small dendrites with surface-to-volume ratios of 4-20 μm-1 and 1-4 μm-1, 
respectively. The geometry of our model lies well in these ranges (spine: μm-1; dendrite: μm-
1). We choose four target data from the experiment by Sabatini, Oertner et al. (2002): the 
amplitudes of Ca2+ transient (∆[𝐶𝑎]𝑏𝐴𝑃) in response to a single bAP in the spine and dendrite, 
and the corresponding decay time constant 𝜏𝑑𝑒𝑐𝑎𝑦 (Table 3.6). All temperature-dependent rate 
constants are adjusted according to the temperature their experiments are conducted at 34°C 
(a near-physiological temperature). 
The bAP is simulated by injecting potential into the spine head and dendrite compartment of 
the passive electrical model to generate amplitudes of bAPs 66.4 and 66.7 mV, respectively 
(Palmer and Stuart 2009). The simulation detail of bAP stimulation is in Appendix G.2. This 
leads to Ca2+ influx via VDCC at the spine head or the dendritic shaft. According to the 
experimental conditions in the experiment by Sabatini, Oertner et al. (2002), we set the 
glutamate concentration at the resting level (0.5 mM)  to eliminate the NMDAR-dependent 
Ca2+ transient. Therefore, VDCCs provide the only Ca2+ source for the elevation of cytosolic 
Ca2+ level during bAP. Under this condition, the mobile buffers are significantly washed out. 
Therefore, we set the concentration of CaD and CaM in all compartments as zero. 
The clearance of cytosolic Ca2+ is mediated by the endogenous protein and membrane pumps. 
The ability of the clearance can be evaluated by measuring the Ca2+ decay time 
constant 𝜏𝑑𝑒𝑐𝑎𝑦. We calculated the value of 𝜏𝑑𝑒𝑐𝑎𝑦 according to the experiment of Sabatini, 
Oertner et al. (2002) by fitting a single exponential to the Ca2+ concentration after reaching 
the peak value and until t = 200 ms. The contribution of PMCA and NCX on Ca2+ extrusion 
in response to a single bAP in the dendritic spine is reported in Scheuss et al. (2006). We use 
the ratio of the fraction of Ca2+ removed by PMCA to NCX (
[𝐶𝑎]𝑃𝑀𝐶𝐴
[𝐶𝑎]𝑁𝐶𝑋
) in the spine and 
dendrites from their research as an additional target data for parameter estimation (Table 3.6). 
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Table 3.6. Values of target experimental data, means of MCMC samples and with the 
parameter set with the lowest mean absolute percentage error (MAPE) 
Target experimental data Target value 
Mean of MCMC 
samples 
Set with the lowest 
MAPE 
∆[𝐶𝑎]𝑏𝐴𝑃 in spine(μM) 1.7 (±0.6) 1.200 1.668 
∆[𝐶𝑎]𝑏𝐴𝑃 in dendrite(μM) 1.5 (±0.5) 1.248 1.471 
𝜏𝑑𝑒𝑐𝑎𝑦 in spine (ms) 12 (±4) 12.8772 11.8580 
𝜏𝑑𝑒𝑐𝑎𝑦 in dendrite (ms) 15(±5) 16.4846 14.9430 
[𝐶𝑎]𝑃𝑀𝐶𝐴
[𝐶𝑎]𝑁𝐶𝑋
 in spine 1.070 1.0716 0.9213 
[𝐶𝑎]𝑃𝑀𝐶𝐴
[𝐶𝑎]𝑁𝐶𝑋
 in dendrite 0.825 0.8064 0.5409 
MAPE  0.1097 0.0896 
 
 
We estimate values of these parameters using the MCMC method (Haario, Laine et al. , 
Haario, Saksman et al. 2001) (see Appendix F.1). We use the summation of the mean absolute 
percentage error (MAPE) to measure the goodness of fit 
𝑀 =∑ |
𝑥𝑛 − 𝑥𝑛
𝑡
𝑥𝑛
|
8
𝑛=1
 
where 𝑥𝑛and 𝑥𝑛
𝑡  are the stimulated values and target values, respectively. Based on this 
equation, the MCMC converges to a set of parameter values with a minimum summation of 
the MAPE. The ranges of parameter (Table 3.7) are selected from the established 
experimental literature.  
The range of VDCC density is calculated from the ∆[𝐶𝑎]𝑏𝐴𝑃 and 𝜏𝑑𝑒𝑐𝑎𝑦 in Sabatini, Oertner 
et al. (2002), which gives the numbers of Ca2+ ions entered via VDCC at compartments  the 
spine head and the dendritic shaft as about 1490-3116 and 13243-26486, respectively. 
The means of MCMC samples and the parameter set with the lowest MAPE are listed in the 
last two columns in Table 3.7. In comparing the simulation results using the mean of MCMC 
samples and parameter set with the lowest MAPE, the latter shows that ∆[𝐶𝑎]𝑏𝐴𝑃 in spine and 
dendrite are closer to the mean of the experimental data and show differences in the 
amplitudes in Ca2+ transients between these two locations (Table 3.6). Therefore, we choose 
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the parameters with lowest MAPE for our model. 
 
 
Table 3.7. Parameter ranges for MCMC and the estimated values by MCMC 
Parameter Range for MCMC 
Mean of MCMC 
samples 
Set with the 
lowest MAPE 
VDCC density in spine head 2.23 - 4.66 μm-2 3.577 μm-2 3.498 μm-2 
VDCC density in shaft 7.29 – 14.57 μm-2 11.106 μm-2 9.855 μm-2 
PMCA density in spine head 200 - 2000 μm-2 359.851 μm-2 236.554 μm-2 
PMCA density in shaft 200 - 2000 μm-2 577.689 μm-2 296.785 μm-2 
NCX density in spine head 10 - 700 μm-2 0.480 μm-2 258.991 μm-2 
NCX density in shaft 100 -1000 μm-2 733.058 μm-2 551.426 μm-2 
Immobile buffer concentration 
in spine head 
50 - 200 μM 138.069 μM 108.782 μM 
Immobile buffer concentration 
in shaft 
50 - 200 μM 142.134 μM 116.966 μM 
Forward rate constant of 
immobile buffer 
0.05 – 1 μM-1ms-1 0.205 μM-1ms-1 0.176 μM-1ms-1 
Backward rate constant of 
immobile buffer 
0.05 – 1 ms-1 0.569 ms-1 0.624 ms-1 
 
3.3 Model perfomance under healthy conditions 
In this section, we simulate the healthy condition/control condition using the values of 
parameters estimated in Section 3.2. We investigate the model performance in response to 
presynaptic stimulation (EPSP stimuli; see Appendix G.1 for the detailed explanation) from 
different aspects: the glutamate profile, the open fraction of receptors at different locations 
and, consequently, the Ca2+ dynamics in the spine head and its parent dendritic shaft. 
3.3.1 Glutamate profile and receptor activity 
After release from the vesicle, the glutamates diffuse rapidly from the synaptic cleft. This 
gives a peak concentration of 0.7 mM and a sharp decrease to the resting level of less than 1 
ms (Figure 3.9 A left panel). The maximum fractions of receptors opened are 0.37 (sNR2A-
NMDAR), 0.044 (sNR2B-NMDAR) and 0.25 (sAMPAR), respectively (Figure 3.9 B top 
panel). A single EPSP stimulus is too weak to activate receptors at the presisynaptic and 
extrasynaptic sites (Figure 3.9 B bottom panel) because of the large extrasynaptic volume in 
comparison with the synaptic cleft, and the long distance between them and the release site. 
Even for the presynaptic NMDARs, the local glutamate concentration peak is 33 µM (Figure 
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3.9 A middle panel), which gives a maximum open fraction lower than 0.0025 (Figure 3.9 B 
bottom left panel). 
 
 
 
 
(A) 
 
(B) 
 
Figure 3.9. (A) Glutamate concentration and (B) receptor response at different locations 
in response to a single EPSP stimulus under the healthy condition. 
 
3.3.2 Postsynaptic membrane depolarisation 
A single EPSP stimulus leads to maximums of 4.5 mV and 1.7 mV depolarisation at the spine 
head and the dendritic shaft, respectively (Figure 3.10). The depolarisation levels are not 
strong enough to open more VDCCs than under the resting conditions. The Ca2+ influx 
depends mostly on the opening of NMDARs by depolarisation and the glutamates diffused 
from the release sites. 
3.3.3 Mobile buffer proteins 
In Section 3.2, we removed the mobile buffers, CaD and CaM, by setting their concentration 
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to zero to satisfy the experimental conditions for parameter estimation. Before starting further 
simulation, we need to return them back to their standard levels (Table 3.4). In response to a 
single vesicle release event from the presynaptic terminal (a single EPSP stimulus), the Ca2+ 
peak amplitude in the spine head is lower (∆[𝐶𝑎]𝐸𝑃𝑆𝑃 = 0.5 𝜇M) with a slower decay time in 
the presence of CaD and CaM than in the absence (∆[𝐶𝑎]𝐸𝑃𝑆𝑃 = 1.8 𝜇M) (Figure 3.11). A 
large fraction of free Ca2+ ions are removed by the mobile buffers. The value of ∆[𝐶𝑎]𝐸𝑃𝑆𝑃 
lies in the range estimated under experimental conditions (Sterratt, Graham et al. 2011). A 
single EPSP stimulus limits the effect on cytosolic Ca2+ to the spine head only. The change in 
Ca2+ levels in the dendritic shaft is negligible. 
 
Figure 3.10. Membrane depolarisation by a single EPSP stimulus at (A) the spine head 
and (B) the dendritic shaft. 
 
 
Figure 3.11. Ca2+ transient in the spine head in response to a single pulse presynaptic 
stimulation in the presence and absence of mobile buffers 
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3.3.4 Multipulse stimulation 
We next simulate the model in response to different stimulation patterns: 1 s stimulation in 
LFS (10 Hz) and HFS (100 Hz) (see Appendix H for the detailed explanation). In both HFS 
and LFS conditions, glutamate transients at each stimulation pulse are well separated from 
each other because of the rapid diffusion. The peak concentrations induced by each 
stimulation are at the same level, with the only exception being at the extrasynaptic site. 
Under HFS, the peak glutamate concentration at the extrasynaptic site increases as more 
stimulation pulses arrive and approach a maximum concentration of around 0.47 µM in the 
HFS condition (Figure 3.12 B right panel).  
 
(A) 10 Hz 
 
(B) 100 Hz 
 
Figure 3.12. Glutamate concentration at different locations in response to (A) 1s of LFS 
(10 Hz) and (B) 1s of HFS (100 Hz). 
 
The maximum fraction of NMDARs in PSD increases in response to the first few pulses and 
then decreases to a lower level under both LFS and HFS (Figure 3.13A andd B). The sNR2B-
NMDAR shows a faster decrease in amplitude than under LFS and sNR2A-NMDAR. The 
decrease results in the fast desensitisation of NR2B-NMDAR. 
In the perisynaptic and extrasynaptic sites, a higher fraction of NMDARs open as more pulses 
arrive at the synapse. The maximum fraction and the increase in the peak fraction are higher 
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in HFS than in LFS, indicating that the temporal summation of HFS allows more glutamate to 
accumulate after escaping from the synaptic cleft. This leads to a higher open fraction of 
glutamate receptors; however, it causes a significant increase in receptor desensitisation 
because of the prolonged exposure to higher levels of glutamate than in the resting level. 
Consequently, the Ca2+ transient in the spine head rises to a maximum of 3 µM after the first 
seven to eight pulses and decreases to around 1 µM before 400 ms after the start of the 
stimulation (Figure 3.13A and B). 
(A) 
 
(B)  
 
 
(C) 
 
(D) 
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Figure 3.13. States transition of the receptors and Ca2+ transient in the spine head in 
response to 1s of LFS (10 Hz) and 1s of HFS (100 Hz). States transition of the receptors 
by type and location in response to LFS (A) and HFS (B). The Ca2+ ions transient in the 
spine head are induced by LFS (C) and HFS (D).  
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3.4 Computational experiments of Aβ-dependent disturbances 
In this section, we investigate the Aβ-dependent disturbances on glutamatergic transmission 
through various computational experiments. We mimic the effects of Aβ on the following 
aspects individually: glutamate release and diffusion (Section 3.4.1), glutamate receptor 
distribution (Section 3.4.2). In Section 3.4.3, we investigate these disturbances on a global 
level to identify the different contributions made by the factors tested in Sections 3.4.1 and 
3.4.2. The general procedure in the experiments is 
Step 1. We first set a reasonable range for the factor to be tested and pick one value at a time 
while keeping the other parameters at the standard levels.  
Step 2. We run the model for long enough without any stimulation input to reach a steady 
state, the values of which are used as the initial value for the experiment. 
Step 3. For each set of parameters, three types of presynaptic stimulation patterns are used as 
inputs of the model: (1) a single EPSP stimulus (1 pulse), (2) low frequency stimulation 
(LHS) at 10 Hz, and (3) high frequency stimulation (HFS) at 100 Hz (see Appendix G.1 for 
the detailed explanation). All stimulation patterns last for 1 s , thus , there are 1, 10 and 100 
pulses for each stimulation pattern, respectively. Simulation stops when the system returns 
back to the resting levels (initial state). 
The major outputs we are collecting after simulation are as follows:  
(1) Peak concentration of glutamate ([Glu]peak) at the synaptic site, the perisynaptic site and 
the extrasynaptic site. 
(2) The additional time for each receptor staying in the open/desensitised/bound states. We 
calculate the area under the curve of the fraction of receptors staying in a state against time 
and deduct the effects of the background fraction at resting level to get the total time in this 
state from the stimulation applied. The difference between this total time and the one 
produced from a standard value parameter set is the additional time of the receptor in this 
state after the change in testing factor. 
(3) Additional Ca2+ ions entered by each type of NMDAR. The Ca2+ current from a NMDAR 
can be transferred to the Ca2+ ion influx by the following equation: 
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𝐶𝑎2+𝑖𝑜𝑛 = −
𝐼𝑐𝑎2+(𝑡)
𝑍𝐶𝑎  𝐶
, 
 
where 𝐼𝑐𝑎2+(𝑡) is the Ca
2+ current at time t, 𝑍𝐶𝑎=2 is the valence of the Ca
2+ ion and C = 
6.24e18, where 1 C = 1 A ×1 s. We calculate the area under the curve of Ca2+ ion influx 
against time and deduct the effects of the background influx rate at resting level to get the 
total Ca2+ ions entered by the stimulation applied. Then, the difference between this total Ca2+ 
ions numbers and the one produced with a standard value parameter set is the additional 
number of Ca2+ ions entered through this type of receptor by the change in the factor tested. 
(4) Peak amplitude of intracellular Ca2+ transient ([Ca2+]peak) and peak amplitude of 
membrane depolarisation (Vpeak) in the spine head and dendritic shaft, respectively.  
(5) Dynamics of the intracellular Ca2+and membrane potential in the spine head and dendritic 
shaft, respectively. 
3.4.1 Aβ-dependent disturbance on glutamate transmission 
Experimental evidence suggests that the presence of Aβ may lead to an increase in the 
extrasynaptic glutamate levels by promoting the release of glutamate vesicles from the 
presynaptic terminal (Abramov, Dolev et al. 2009) inhibiting the glutamate uptake by glial 
glutamate transporters (Sheldon and Robinson 2007, Matos, Augusto et al. 2008), or inducing 
glutamate release from ambient astrocytes (Talantova, Sanz-Blasco et al. 2013). In this 
section, we investigate these disturbances one by one. 
3.4.1.1 Increase in presynaptic release of glutamate 
In this model, the number of vesicles per release is represented by the total number of 
glutamate molecules in the model. We vary the number of glutamates per release from 500 to 
10000 and keep other parameters at the standard values. Because of the fast diffusion of 
glutamate in synaptic cleft and the extrasynaptic space, HFS shows no or minor (at 
extrasynatpic site) additive impacts on the [Glu]peak. The [Glu]peak after a single pulse 
stimulation, LFS and HFS in three locations all linearly increase with the number of 
glutamate molecules released (Figure 3.14).  
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Figure 3.14. Maximum amplitudes of glutamate concentration at different locations with 
various amounts of glutamate released in response to three types of stimulation patterns. 
 
Multiple vesicle releases have little effect on the transition states of sNR2A-NMDAR (Figure 
3.15) and Ca2+ influx via it (Figure 3.16 A). For sNR2B-NMDAR, multiple vesicle releases 
lead to increases in its additional open time, additional desensitised time and additional bound 
time, however, these effects on its states transition are limited to conditions of  a 1 pulse 
stimulation and LFS (Figure 3.15) and lead to more Ca2+ influx under these conditions (Figure 
3.16 A). In contrast, the pNR2B-NMDAR shows an increase in additional open time, 
desensitised time, bound time and entered Ca2+ ions in response to all three tested stimulation 
protocols (Figure 3.15 and Figure 3.16 A). All these increases lead to a higher [Ca2+]peak in the 
spine head with increasing numbers of glutamate releases (Figure 3.16 B). Especially under 
HFS, the Ca2+ level rises to a peak of about 4.8 µM in 55 ms (almost 3-fold higher than it is 
under the healthy condition), but then rapidly decreases to less than 1 µM after 35 pulses (350 
ms), when increases the glutamate molecules per release to 10,000 (Figure 3.16 C). The 
decrease rate is positively correlated to the amount of glutamate per release, which is because 
of the desensitisation of NMDARs. Under multiple vesicle release conditions, each receptor 
stays longer in the desensitisation state and the increase in additional times of staying in the 
desensitisation state are more significant in comparison to the ones staying in the open state 
(Figure 3.15). 
The eNR2B-NMDAR is minorly affected by the number of glutamate molecules released in 
response to the presynaptic stimulation (Figure 3.15 and Figure 3.16 A). This may because 
that a large fraction of the glutamate molecules released from the presynaptic neuron is 
uptaken by the glutamate transporters before diffusing to the extrasynaptic site or the long 
distance between the eNR2B-NMDAR location and the release site. In Figure 3.16 B and C, 
the elevation in the amplitude of Ca2+ transient when large numbers of glutamates are released 
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is largely a result of Ca2+ diffusion from the spine head.  
When increasing the number of glutamate per release, sAMPAR but not eAMPAR stays in 
the open and desensitisation states for longer time under LHS and HFS. The Vpeak of the spine 
head and dendritic shaft both increase with the release of the number of glutamate molecules 
(Figure 3.16 B).The large increase in membrane depolarisation in the dendritic shaft is mainly 
transferred from the spine head by the spine neck. 
 
Figure 3.15. Additional times in the open and desensitisation states per receptor in 
response to various numbers of glutamate releases in comparison with the amount 
under control conditions (1500 molecules per release). sNR2A: synaptic NR2A-
NMDAR; sNR2B: synatpic NR2A; sAMPAR: synaptic AMPAR; pNR2B:  perisyantpic 
NR2B-NMDAR; eNR2B: extrasynaptic NR2B-NMDAR; eAMPAR: extrasynaptic 
AMPAR. 
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(A) 
 
(B)      (C) 
 
 
    
Figure 3.16. (A) Additional numbers of Ca2+ ions by NMDARs in response to various 
numbers of glutamate molecules released compared with the numbers under the 
standard condition (1500 molecules per release). (B and C) Ca2+ ions and the voltage 
responses in the spine head and dendritic shaft in response to a single pulse stimulation, 
LFS and HFS by various numbers of glutamate molecules released. sNR2A: synaptic 
NR2A-NMDAR; sNR2B: synatpic NR2A; pNR2B:  perisyantpic NR2B-NMDAR; 
eNR2B: extrasynaptic NR2B-NMDAR. 
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3.4.1.2 Inhibition in uptaking extrasynaptic glutamate by the glutamate transporter  
Experimental evidence suggests that Aβ may inhibit extrasynaptic glutamate uptake by 
reducing the number of glutamate transporters or their activities (Harris, Carney et al. 1995, 
Harris, Wang et al. 1996, Parpura-Gill, Beitz et al. 1997, Fernández-Tomé, Brera et al. 2004, 
Matos, Augusto et al. 2008. We examine if this down-regulation contributes to the abnormal 
opening of NMDARs by reducing the concentration of total glutamate transporter 
concentration (𝐵𝑡𝑜𝑡𝑎𝑙) from the standard value of 0.5 mM (0% reduction) to 0 mM (100% 
reduction) and then running the model under different stimulation patterns.  
The results show that there is no effect on the [Glu]peak at the postsynaptic site from reducing  
𝐵𝑡𝑜𝑡𝑎𝑙 whereas, when 𝐵𝑡𝑜𝑡𝑎𝑙 = 0 mM (100% reduction), the [Glu]peak  at the perisynaptic and 
extrasynaptic sites increases by about 3 µM and 1.5 µM (Figure 3.17 A), respectively, with 
slower decay to baseline (Figure 3.17 B). There are relatively minor effects on the transition 
state of the synaptic receptors in comparison with ones of pNR2B-NMDAR and eNR2B-
NMDAR, especially under HFS (Figure 3.18 A). These changes result in no obvious effects 
on Ca2+ dynamics in the spine head but increases in the peaks of Ca2+ transient in the dendritic 
shaft (Figure 3.18 B).  
We then increase the glutamate number per release from 1500 to 5000 to investigate if there 
are any significant changes in multi-vesicle release events by 𝐵𝑡𝑜𝑡𝑎𝑙. The results are consistent 
with the single-vesicle release experiment (Figure 3.19), suggesting that the down-regulation 
in glutamate uptake by glutamate transporters does not directly affect the postsynaptic spine 
in response to the presynaptic stimulations. Instead, it promotes Ca2+ influx via extrasynaptic 
receptors in the dendritic shaft, especially under HFS. 
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(A) 
 
(B) 
 
Figure 3.17. (A) Maximum amplitude and (B) time course of glutamate concentration at 
different locations with the reduction in transporter levels in response to three types of 
stimulation patterns. The x-axis denotes the degree of reduction in total glutamate 
transporter concentration (𝑩𝒕𝒐𝒕𝒂𝒍) from the standard value, 0.5 mM (0: no reduction; 1: 
fully reduction and 𝑩𝒕𝒐𝒕𝒂𝒍 = 𝟎 ). 
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(A)           (B) 
       
Figure 3.18. (A) Additional numbers of Ca2+ ions by NMDARs and (B) Ca2+ dynamics in 
the spine head and dendritic shaft with the reduction in transporter levels in response to 
three types of stimulation patterns. The glutamate number per release is 1500. sNR2A: 
synaptic NR2A-NMDAR; sNR2B: synatpic NR2A; pNR2B:  perisyantpic NR2B-
NMDAR; eNR2B: extrasynaptic NR2B-NMDAR.  
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(A)           (B) 
       
 
Figure 3.19. (A) Amplitudes of Ca2+ and voltage response and (B) Ca2+ dynamics in the 
spine head and dendritic shaft with the reduction in transporter levels in response to 
three types of stimulation patterns. The glutamate number per release is 5000. 
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3.4.1.3 Increase in the resting glutamate levels in the extrasynaptic space 
Elevation in the resting level of extrasynaptic glutamate ([Glu]rest) has been observed in the 
hippocampus of AD transgenic mice that overexpress human APP (Talantova, Sanz-Blasco et 
al. 2013). They reported that the resting level of 0.8 µM in 12-month-old mice is in contrast to 
0.25 µM in the control ones, and with an even higher level of 3.3 µM in 22 to 24-month-old 
mice. To examine how the [Glu]rest affects the system, we vary the [Glu]rest from 0.01 µM to 
100 µM and run the model for long enough to calculate the fraction of NR2A-NMDAR, 
NR2B-NMDAR and AMPAR in the open and desensitised bound states, respectively. Both 
NR2A- and NR2B-NMDAR reach the maximum open fractions (8% and 2%, respectively) 
when glutamate increases to about 2 µM (Figure 3.20 A). In contrast, the fraction of NR2A- 
NMDAR and NR2B-NMDAR in the desensitised state approaches a maximum of 81% at the 
same time (Figure 3.20 B). Only about 10% of receptors are not bound to glutamate (Figure 
3.20 C). This may reduce the sensitivity of the postsynaptic neurons in response to 
stimulation.  
The background opening of NR2B-NMDAR by [Glu]rest causes a persistent inward current 
and Ca2+ influx. When increasing the glutamate concentration to 10 µM, the background Ca2+ 
influx reaches the maximum of 580 (NR2A-NMDAR) and 160 (NR2B-NMDAR) Ca2+ ions 
per second, which is 5-10 Ca2+ ions per second under control conditions (Figure 3.20 D). 
The open fraction of AMPAR is less affected by the elevation of glutamate concentration 
while its desensitisation fraction increases gradually and when the glutamate reaches a high 
level greater than 90 µM, it is almost fully desensitised (Figure 3.20 B). 
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Figure 3.20. Effects of the resting level of extrasynaptic glutamate concentration [Glu]rest 
on the resting states of NR2A-NMDAR, NR2B-NMDAR and AMPAR. [Glu]rest increases 
from 0.01 µM to100 µM. Under control conditions [Glu]rest is 0.25 µM. 
 
In the experiment of presynaptic stimulation, the elevation in resting extrasynaptic glutamate 
concentration increases the desensitisation time of all receptors to different extents while 
shows neglectable effects on their open time (Figure 3.21 A). In the spine head sNR2A-
NMDAR, sNR2B-NMDAR and pNR2B-NMDAR are most affected, in terms of several 
milliseconds lower open time in comparison to the control conditions. Together with the 
increase in desensitisation time, especilly for pNR2B-NMDAR, this leads to fewer Ca2+ ions 
entering (Figure 3.21 B) and decreases in the [Ca2+]peak in the spine head (Figure 3.21 C). For 
the eNR2B-NMDAR, it stays in the states for a longer time by the elevation in [Glu]rest 
(Figure 3.21 A). The open time of the eNR2B-NMDAR and the number of Ca2+ ions entering 
via it are not affected. In addition, the high level of [Glu]rest results in a high background open 
fraction of eNR2B-NMDAR and small increases in response to the presynaptic stimulations 
(Figure 3.22).  
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(A) 
  
(B)     (C) 
 
Figure 3.21. (A) Additional times in the open and desensitisation states per receptor and 
(B) additional numbers of Ca2+ ions by NMDARs in response to presynaptic stimulation 
(a single pulse stimulation, LFS and HFS) under the conditions of the increased resting 
level of the extrasynaptic glutamate concentration ([Glu]rest) in comparison with the 
amount under standard conditions. (C) Amplitudes of Ca2+ and voltage response in the 
spine head and dendritic shaft at various [Glu]rest. sNR2A: synaptic NR2A-NMDAR; 
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sNR2B: synatpic NR2A; sAMPAR: synaptic AMPAR; pNR2B:  perisyantpic NR2B-
NMDAR; eNR2B: extrasynaptic NR2B-NMDAR; eAMPAR: extrasynaptic AMPAR. 
 
 
Figure 3.22. The fraction of eNR2B-NMDAR in the open state during simulation under 
HFS. The resting synaptic glutamate concentrations are 0.25 µM in the control 
condition (blue line) and 0.8 µM, 2 µM and 3.3 µM, representing the different stages of 
the disease. 
 
3.4.1.4 Non-synaptic release of glutamate 
Aβ has been found to induce glutamate release from astrocytes in AD transgenic mice 
(Talantova, Sanz-Blasco et al. 2013). The astrocyte stays close to the dendritic spine, which 
can potentially induce the extrasynaptic glutamate receptors. We simulate the astrocytic 
release of glutamate by applying a brief pulse of 1 mM glutamate to the extrasynaptic sites 
where eNR2B-NMDAR and eAMPAR are located. The lengths of the brief pulses are in the 
range of 1 ms to 20 ms. We assume the [Glu] in the synaptic cleft and presynaptic site will not 
be affected by this stimulation. The stimulation causes large amounts of Ca2+ to enter (Figure 
3.23 B), which is increased with the length of the stimulation pulse. The ∆ [Ca2+] in the 
dendritic shaft ranges from 13 to 17 nM and is not significantly increased by the longer 
stimulation (Figure 3.23 C). This is because the volume of the dendritic shaft is about 0.79 
µm3 in this model, about 8-fold the spine head volume, whereas the low number of eNR2B-
NMDA is similar to the dendritic ones. The Ca2+ ions entered are largely diluted by the 
volume, therefore the [Ca2+]peak is much less than in the spine head in response to the 
presynaptic stimulation. Moreover, the eAMPAR activated by the astrocytic glutamate release 
creates a 4 - 6 mV depolarisation (Figure 3.23 D). Because of the lower density of AMPAR in 
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the extrasynaptic site (20 receptor/μm2) than in synaptic location (up to 1000 receptor/μm2), 
even when increasing the stimulation time to 20 ms, it still fails to create a larger 
depolarisation to activate other voltage-dependent Ca2+ channels on the dendritic shaft 
membrane. 
 
Figure 3.23 Effects of eNR2B-NMDAR activation by the astrocytic release of glutamate. 
In response a pulse of 1 mM glutamate with various time durations (1 ms, 4 ms, 7 ms, 10 
ms and 20 ms). The fraction of eNR2B-NMDAR opens (A) and allows Ca2+ ions to enter 
the dendritic shaft (B). The corresponding Ca2+ transient and membrane depolarisations 
are shown in (C) and (D), respectively. 
 
3.4.2 Receptors 
3.4.2.1 Reduction in surface expression of NMDAR and AMPAR 
To investigate the inhibition of Aβ on the membrane surface expression of different types of 
receptors, we decrease the number of each receptor from the standard value to zero to mimic 
the degree of reduction in their surface expression. 
The reduction in sNR2A-NMDAR numbers shows negligible effects on the Ca2+ transient 
amplitude under a 1 pulse stimulus and LFS whereas, under HFS, the peak gradually 
decreases from 3 µM to nearly 0 µM with the increase in the reduction level (Figure 3.24a). It 
also shows minor effects on the depolarisation of the postsynaptic membrane (Figure 3.24c, 
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d). When setting the sNR2A-NMDAR number to zero, it causes about a 0.1 mV decrease in 
the depolarisation amplitude in comparison to the control conditions. The reduction in 
sNR2B-NMDAR number only affects the [Ca2+]peak in the spine head under HFS. This is 
about a 1 µM reduction in the [Ca2+]peak when sNR2B-NMDAR is fully removed (Figure 
3.24e). 
The reduction in sAMPAR number greatly affects the amplitude of the membrane 
depolarisation both in the spine head and the dendrite shaft. Completely removing the 
sAMPARs results in about a 5 mV and 2 mV lower Vpeak in comparison with the control 
conditions in the spine head and dendritic shaft membrane, respectively (Figure 3.24l). In 
addition, the decrease in sAMPARs will not completely abolish the transient Ca2+ but will 
reduce the peak fractionally (Figure 3.24 i, j).  
 
Figure 3.24. Effects of reduction on the number of synaptic glutamate receptors on the 
amplitudes of Ca2+ transient and membrane depolarisation in the spine head and 
dendrite shaft. 
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3.4.2.2 Reduction in desensitisation of synaptic receptors 
Under healthy conditions, NMDARs undergo desensitisation in response to prolonged 
presence of their agonists, to prevent excess Ca2+ influx (Mayer, Vyklicky et al. 1989). 
Slowed of NMDAR desensitisation has been observed in transgenic mice that overexpress 
large amounts of Aβ1-42 within neurons (You, Tsutsui et al. 2012). To investigate the 
inhibition of the desensitisation of synaptic glutamate receptors by Aβ, we decrease the 
desensitisation related parameters of each receptor by 0% to 100% of the standard value to 
mimic the degree of inhibition in their desensitisation in response to presynaptic glutamate 
release. 
The inhibition of the desensitisation of sNR2A-NMDAR and sNR2B-NMDAR shows no 
obvious or minor effects on the on the Ca2+ transient and membrane depolarization in the 
spine head under a 1 pulse stimulus and LFS (Figure 3.25 A (a)-(h), B and C).  Under HFS, 
the peak of Ca2+ transient increases significantly from 2.9 µM to 17.9 µM with the increase in 
the inhibition level of the sNR2A-NMDAR desensitisation (Figure 3.25 A (a)). When the 
desensitisation of sNR2A-NMDAR is fully inhibited, the cytosolic Ca2+ concentration in the 
spine head maintains at a high level after reaching a peak through the stimulation period 
(Figure 3.25 B). The inhibition of the sNR2B-NMDAR desensitisation also positively affect 
the Ca2+ transient in the spine head under HFS (Figure 3.25 A (e) and C). It leads to about 2 
µM increase in the [Ca2+]peak when the sNR2B-NMDAR desensitisation is fully inhibited. 
However, cytosolic Ca2+ concentration fails to maintain at a high level after reaching a peak 
(Figure 3.25 C). This is because of the desensitisation of sNR2A-NMDAR. 
The inhibition of the sAMPAR desensitisation has minor effects on the [Ca2+]peak (Figure 3.25 
A (i) and (j)) and it mainly affects the amplitude of the membrane depolarisation both in the 
spine head and the dendrite shaft. When its desensitisation is fully inhibited, it results in about 
a 1-2 mV and 0.5-1 mV increase in the Vpeak in comparison with the control conditions in the 
spine head and dendritic shaft membrane, respectively (Figure 3.25 A (k) and (l)). 
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(A) 
  
(B)               (C) 
 
 
Figure 3.25. (A) Effects of inhibition of the desensitisation of synaptic glutamate 
receptors on the amplitudes of Ca2+ transient and membrane depolarisation in the spine 
head and dendrite shaft. The Ca2+ time course in the spine head under LFS and HFS, 
with the desensitisation inhibition of sNR2A-NMDAR (B) and sNR2B-NMDAR (C), 
respectively. 
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3.4.3 Global sensitivity analysis 
Aβ is proposed to disturb the cytosolic Ca2+ dynamics through multiple targets. In this 
section, we study the difference in importance of the various factors globally. We select 15 
factors which have been tested in previous sections and eight outputs which represent the 
postsynaptic neuron response to presynaptic stimulation (Table 3.8). Two thousand perturbed 
factor sets are generated using Latin hypercube sampling (LHS) (McKay et al., 1979) 
according the range in Table 3.8. LHS makes sure each factor is evenly distributed in the 
given range and effectively reduces the correlation among the factors. 
We use a partial rank correlation coefficient (PRCC) to identify the most important or 
sensitive factors (Marino, Hogue et al. 2008). PRCC is useful to measure the nonlinear but 
monotonic relationships between outputs and parameters (see Appendix F.2 for the 
explanation). Therefore, the factor ranges are chosen according to Sections 3.4.1 and 3.4.2, to 
ensure there is not a non-monotonicity relationship between the selected factors and outputs. 
In each realisation, we run the model with one set from the factor matrix generated by LHS 
while keeping other parameters at the standard values. Both the LFS and HFS conditions are 
simulated. 
We calculate the PRCC value and the corresponding p-value for each factor against each 
output using a PRCC Matlab toolbox (Marino, Hogue et al. 2008). PRCC results if its 
corresponding p-value is greater than 0.05, which fails to reject the null hypothesis that no 
relationship exists between the factor and the output. The PRCC results are shown in Figure 3.26. 
Generally, we assume there is a correlation between the factor and the output when the absolute 
PRCC value is greater than 0.5. Based on this, we modified the results and, therefore, in Figure 
3.26, the white colour denotes that there is no correlation between corresponding factor and 
output.  
From the point of view of parameter contributions (read the Figure 3.26 in a vertical 
direction), all outputs, but not the Ca2+ ion number entering through sNR2B-NMDAR, are 
very sensitive to the amount of presynaptic released glutamate. The correlation levels 
decrease under HFS in comparison with under LFS, with the only exception being that the 
Ca2+ ion numbers entered through eNR2B-NMDAR show the highest correlation (PRCC = 
0.95) with the glutamate release number under both conditions. The resting extrasynaptic 
glutamate level positively contributes to the Ca2+ influx through eNR2B-NMDAR under LFS 
but not under HFS. The resting extrasynaptic glutamate level negatively contributes to the 
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Ca2+ influx through pNR2B-NMDAR under HFS, suggesting an elevation in [Glu]rest will 
cause a stronger desensitisation of pNR2B-NMDAR in response to HFS from rather than 
LFS. Only sNR2A-NMDAR is sensitive to sAMPAR, which infers that only sNR2A-
NMDAR, but not NR2A-NMDAR, is sensitive to membrane depolarisation under LFS and 
HFS. The transporter concentration, desensitisation of eNR2B-NMDAR and the eAMPAR 
show no relationship with any output, which suggests they are of less importance in the 
postsynaptic response to presynaptic stimulation while the other NR2B, including 
NMRDARs, show no relationship with the AMPARs. 
From the point of view of output sensitivity (read Figure 3.26 in a horizontal direction), the 
Ca2+ transient in the spine head is most sensitive to sNR2A-NMDAR followed by sNR2B-
NMDAR. Under HFS, the importance of sNR2B-NMDAR decreases, which suggests a 
relatively lower activity of sNR2B-NMDAR in HFS than under LFS. The AMPAR number 
becomes more important in comparison to LFS, indicating that depolarisation by HFS brings 
more Ca2+ ions into the spine head. The Ca2+ transient in the dendritic shaft is mostly sensitive 
to the amount of glutamate release, while eNR2B is only important under LFS. Surprisingly, 
it is also sensitive to the sNR2A-NMDAR number. This suggests that under HFS, large 
amounts of Ca2+ ion influx from NR2A, either by the increased release of glutamate numbers 
and/or activity or numbers of sNR2A-NMDAR, may lead to more ions diffusing to the 
dendritic shaft. Moreover the membrane depolarisation in the spine head and the dendritic 
shaft are determined by the glutamate release and sAMPMR numbers, with no dendritic 
receptor involved. This indicates that the dendritic receptors may be less involved in 
information transduction under presynaptic stimulation than the synaptic receptors.  
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Table 3.8. Fifteen factors and eight outputs selected for PRCC. (A) Factors and their 
biological meaning, standard values and ranges for PRCC; (B) Outputs and their 
biological meaning for PRCC. 
A. 
Factor Biological meaning Standard value PRCC ranges 
G0 Glutamate number per release 1500 500-10000 
Grest 
Rest extrasynaptic glutamate 
concentration 
0.25 uM 0 – 1 uM 
TP Glutamate transporter concentration 0.5 mM 0 – 1 uM 
Ds2A 
Inhibition on desensitisation of 
sNR2A-NMDAR 
0 0-1 
Ds2B 
Inhibition on desensitisation of 
sNR2B-NMDAR 
DsAMPAR 
Inhibition on desensitisation of 
sAMPAR 
Dp2B 
Inhibition on desensitisation of 
pNR2B-NMDAR 
De2B 
Inhibition on desensitisation of 
eNR2B-NMDAR 
DeAMPAR 
Inhibition on desensitisation of 
eAMPAR 
sNR2A sNR2A-NMDAR number 12 6-18 
sNR2B sNR2B-NMDAR number 8 4-12 
AMPAR sAMPAR number 85 43-130 
pNR2B pNR2B-NMDAR number 3 1-5 
eNR2B eNR2B-NMDAR number 8 4-12 
eAMPAR eAMPAR number 20/μm2 15 – 30 /μm2 
 
 
B. 
Output Biological meaning 
Ca2+ by sNR2A Ca2+ ions entered through of sNR2A-NMDAR 
Ca2+ by sNR2B Ca2+ ions entered through of sNR2B-NMDAR 
Ca2+ by pNR2B Ca2+ ions entered through of pNR2B-NMDAR 
Ca2+ by eNR2B Ca2+ ions entered through of eNR2B-NMDAR 
Peak Ca2@spine Peak concentration of Ca2+ transint in spine head 
Peak Ca2@shaft Peak concentration of Ca2+ transint in dendritic shaft 
PeakB@spine Peak membrane potential in spine head 
PeakB@shaft Peak membrane potential in dendritic shaft 
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(A)
 
(B)
 
Figure 3.26. Heat maps of PRCC results for the model in response to (A) LFS and (B) 
HFS. The PRCC values for 15 factors against eight outputs are represented by colours, 
with the corresponding PRCC values written in white. Red and blue denote the positive 
and negative correlations, respectively. Only PRCCs greater than 0.5 and with p-value < 
0.05 are shown in the figures. The white colour means there is no relationship between 
the corresponding factor and the output. 
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3.5 Discussion and conclusions 
In this chapter, we present a computational model of Ca2+ dynamics in the dendritic spine in 
response to the presynaptic stimulation, which is carefully developed according to the 
characteristics of the CA1 pyramidal dendritic spine. This model integrates three aspects: (1) 
AP-induced presynaptic glutamate release and diffusion; (2) glutamate receptor activation; 
and (3) Ca2+ dynamics within a single dendritic spine and its parent dendrite shaft for a CA1 
pyramidal neuron. We use this model to investigate the effects of Aβ-dependent disturbances 
on activation patterns of NMDARs with different subunit composition and at different 
locations and NMDAR-mediated Ca2+ dynamics in the dendritic spine and its parent dendrite 
shaft.  
Our model shows that the increase in the numbers of glutamate released leads to different 
levels of increases in the availability of glutamate to receptors at tested location. It predicts 
that increased glutamate availability in the synaptic cleft and perisynaptic zone after 
presynaptic stimulation leads to higher Ca2+ responses in the spine head. Global sensitivity 
analysis suggests a great sensitivity of the postsynaptic response to the glutamate amount 
released during presynaptic stimulation. This confirms that the Aβ-induced increase in 
synaptic glutamate release may play a major role in the over excitation and Ca2+ overload of 
postsynaptic neurons. However, the spill-over effect of glutamate from the synaptic cleft 
shows much lower effects on activation patterns of  extrasynaptic NMDARs than perisynaptic 
NMDARs. This is because of the fast diffusion of glutamate and the uptake by glial glutamate 
transporters before it reaches to eNMDAR. Therefore, it suggests that Aβ-induced multiple 
vesicle releases from presynaptic terminal alone may not be sufficient to cause an 
overactivation of the extrasynaptic receptors.       
In contrast, the results show that the inhibition of the ability to uptake extrasynaptic glutamate 
only affects peri- and extrasynaptic receptors in our model experiments. Furthermore, on a 
longer time scale, this inhibition may cause an accumulation of the glutamate released from 
the presynaptic neurons and astrocytes in the extrasynaptic space. Therefore, it may contribute 
to a gradual increase in the resting level of extrasynaptic glutamate.  
We have shown that elevation in the resting extrasynaptic glutamate concentration reduces the 
sensitivity of the postsynaptic neurons to the presynaptic signals, as a result of increased 
background opening under conditions of rest. The large background opening of eNMDARs 
will cause an especially high level of net Ca2+ ion influx into the dendritic shaft. As well, the 
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Aβ-induced astrocytic glutamate release also lead to a high level of Ca2+ ion influx in the 
absence of presynaptic stimulation. These findings are consistent with experimental 
observations, which show excitotoxicity results from Aβ-induced over activation of the 
extrasynaptic NMDAR, but not the synaptic NMDAR (Sobczyk, Scheuss et al. 2005), which 
may also, in turn, promote Aβ production (Bordji, Becerril-Ortega et al. 2010). Even though 
these abnormal Ca2+ influxes have failed to induce large amplitudes of Ca2+ transient in the 
dendritic shaft, due the dilution of its relatively large volume, it still may induce downstream 
pathways by affecting proteins located close to the receptors. Over a long time span, this may 
contribute to the Ca2+ overload and neuronal death in AD (Hardingham and Bading 2010). 
The experimental observations suggest that Aβ induced the internalisation of surface 
glutamate receptors, especially sNR2B-NMDAR, which may affect the synaptic transmission 
(Snyder, Nong et al. 2005, Li, Jin et al. 2011). Our simulation shows that sNR2B-NMDAR 
contributes less to the synaptic Ca2+ transient compared to sNR2A-NMDAR. Even when 
removing all sNR2B-NMDAR, the sNR2A-NMDAR can still lead to considerable Ca2+ 
transients. This seems to be in conflict with the experimental observations. In fact, besides its 
role as a Ca2+ channel, sNR2B-NMDAR binds to Ca2+ /calmodulin-dependent protein kinase 
II (CaMKII), a critical protein in LTP formation and, therefore, sNR2B-NMDAR are involved 
in downstream pathways mediating synapse strength and plasticity (Bayer, De Koninck et al. 
2001). Reducing the functional surface of sNR2B-NMDAR may affect the accessibility of 
CaMKII which, consequently, disturbs information transmission and memory formation. We 
discuss this further by combining the current model with a CaMKII transition model in 
Chapter 5. 
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spine in AD pathology. In particular, how different alterations affect the NMDAR-mediated 
Ca2+ signalling and how these effects may contribute to synapse dysfunction. In this chapter, 
we select three major alterations of ER reported in AD: (1) ER Ca2+ overload; (2) up-
regulation of RyR expression; and (3) reduction in SERCA pumps. Therefore, we investigate 
these alterations by plugging the ER submodel into the model described in Chapter 3. Using 
the extended model, we examine the interactions among the different Ca2+ sources between 
the healthy condition and the AD condition. By analysing the computational experimental 
results, it provides insights into the contribution of external and internal Ca2+ sources in 
synaptic transmission and how dysregulation of the ER function affects the postsynaptic Ca2+ 
response.  
In this chapter, we first describe the ER submodel in Section 4.1. In Section 4.2, we give the 
details of the model integration, including parameter calibration and estimation, and present 
the model performance under healthy condition. In Section 4.3, we investigate the effects of 
the ER Ca2+ overload and dysregulations in RyR and SERCA in AD conditions using the 
extended model and, in Section 4.4, we give a brief discussion and the conclusions. 
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Figure 4.1. Ca2+ signalling in an ER-containing spine. Ca2+ transient in the dendritic 
spine head is a production of Ca2+ fluxes from the external and internal Ca2+ sources via 
membrane Ca2+ channels (external: NMDAR and VDCC; internal RyR in this case), 
passive membrane leaking, binding of intracellular Ca2+ buffers and extrusion by 
membrane Ca2+ pumps (external: PMCA and NCX; internal SERCA). 
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4.1 Model development 
We extend the Ca2+ model from Chapter 3 with an intracellular ER component, as described 
in Figure 4.2. The ER consists of three parts: (1) Ca2+ release to the cytosol via membrane 
receptors and (2) membrane leaking, and (3) Ca2+ uptake by SERCA pumps. In hippocampal 
pyramidal CA1 neurons, RyRs are expressed throughout the axons, dendritic shaft and spines, 
whereas IP3Rs are primarily present in dendritic shafts and cell bodies, but absent in dendritic 
spines (Sharp, McPherson et al. 1993, Sabatini, Maravall et al. 2001, Hertle and Yeckel 
2007). Therefore, we set the location of RyRs in ER in the compartments of the spine head 
and dendritic shaft. We did not include IP3Rs in the dendritic shaft compartment in this 
model. This is because the presynaptic stimulation cannot induce high enough increase in the 
IP3 concentration to induce IP3R opening in the dendritic shaft.   
 
Figure 4.2. The conceptual framework of the extended model by including ER into the 
Ca2+ model in Chapter 3.  
 
We place the ER in the spine head compartment and in the adjacent dendritic shaft 
compartment. For reasons of simplicity, we assume there is no store in the spine neck 
compartment. To take the ER into consideration, we modified Eq. (3.12) by adding a new 
term, 𝐽𝐸𝑅,𝑗, to govern the Ca
2+ dynamics in the spine head and dendritic shaft: 
𝑑[𝐶𝑎2+]𝑗
𝑑𝑡
= 𝐽𝐼𝐶𝑎,𝑗 + 𝐽𝑚𝑒𝑚,𝑗 + 𝐽𝑑𝑖𝑓𝑓𝑢𝑠𝑖𝑜𝑛,𝑗 − 𝐽𝑏𝑢𝑓𝑓𝑒𝑟,𝑗 + 𝐽𝐸𝑅,𝑗 , (4.1) 
where 𝑗 = 2 or 4, indicates the compartment index (𝑗 =2, cytosol; 4, dendritic shaft). 𝐽𝐸𝑅,𝑗 
denotes the net ER Ca2+ flux to the cytosol, and is the balance between the outward Ca2+ flux 
via RyRs (𝐽𝑅𝑦𝑅) and membrane leakage (𝐽𝑙𝑒𝑎𝑘𝐸𝑅), and the inward Ca
2+ flux via SERCA 
pumps (𝐽𝑆𝐸𝑅𝐶𝐴): 
𝐽𝐸𝑅,𝑗 = 𝐽𝑅𝑦𝑅,𝑗 − 𝐽𝑆𝐸𝑅𝐶𝐴,𝑗 + 𝐽𝑙𝑒𝑎𝑘𝐸𝑅,𝑗, j = 2, 4. (4.2) 
102 
 
 
The Ca2+ dynamics of ERs are governed as follows: 
𝑑[𝐶𝑎2+]
𝐸𝑅,𝑗
𝑑𝑡
= 𝜌 𝐽𝐸𝑅,𝑗, 
(4.3) 
where 𝜌 is the ratio of ER volume to the cytosol volume. Parameters used in this section are 
summarised in Table 4.1. 
4.1.1 The RyR gating  
We simulate the RyR mediated CICR as: 
 𝐽Ry𝑅,i = V𝑅𝑦𝑅,𝑗𝑃𝑜𝑅𝑦𝑅,𝑗([𝐶𝑎
2+]𝐸𝑅 − [𝐶𝑎
2+]𝑗), (4.4) 
where V𝑅𝑦𝑅 is the rate constant of RyRs and is proportional to the number of RyRs. The 
opening of RyR by Ca2+ is simulated using the four-state model developed by Keizer and 
Levine (1996) (Figure 4.3).  
 
 
Figure 4.3. Schematic diagram of the model of RyR developed by Keizer and Levine 
(1996). This model contains two closed states, C1 and C2, and two open states, O1 and 
O2. The two open states are assumed to have the same single channel conductance. 
Therefore, the fraction of RyRs in the open state is the summation of the fraction of 
RyRs that are in state O1 and O2. The transition from C1  O1and O1  O2 are Ca2+ 
dependent. The transitions between C1 and O1 and between O1 and O2 are assumed to 
be fast (in milliseconds), and reach equilibrium rapidly. In contrast, the transition 
between C2 and O1 is assumed to be slow (in seconds).  
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𝑃𝑜𝑅𝑦𝑅,𝑗 is the fraction of RyR that is opened by cytosolic Ca
2+: 
𝑃𝑜𝑅𝑦𝑅,𝑗 = 𝑤𝑗
1 + (
[𝐶𝑎2+]𝑖
K𝑏
)
3
1 + (
K𝑎
[𝐶𝑎2+]𝑗
)
4
+ (
[𝐶𝑎2+]𝑗
K𝑏
)
3, (4.5) 
 
where 𝑤𝑗 denotes the fraction of channels not in state C2, and the three dissociation constants, 
K𝑖, are K𝑎
4 =
𝑘𝑎𝑏
𝑘𝑎𝑓
, K𝑏
3 =
𝑘𝑏𝑏
𝑘𝑏𝑓
, and K𝑐 =
𝑘𝑐𝑏
𝑘𝑐𝑓
. The change in 𝑤𝑗 with time is calculated as  
𝑑𝑤𝑗
𝑑𝑡
=
1
𝜏𝑤([𝐶𝑎2+]j)
(𝑤∞([𝐶𝑎
2+]𝑗) − 𝑤𝑗), (4.6) 
where  
𝑤∞([𝐶𝑎
2+]𝑗) =
1 +
K𝑎
4
[𝐶𝑎2+]𝑗
4 + 
[𝐶𝑎2+]𝑗
3
K𝑏
3
1 +
1
K𝑐
+
K𝑎
4
[𝐶𝑎2+]𝑗
4 + 
[𝐶𝑎2+]𝑗
3
K𝑏
3
 𝑎𝑛𝑑 𝜏𝑤([𝐶𝑎
2+]j) =
𝑤∞([𝐶𝑎
2+]𝑗)
𝑘𝑐𝑏
. 
 
4.1.2 The SERCA pump  
The activity of SERCA pump is modelled by a Hill equation with a Hill coefficient of 2 
(Lytton, Westlin et al. 1992): 
𝐽𝑆𝐸𝑅𝐶𝐴,𝑗 = 𝑣𝑆𝐸𝑅𝐶𝐴
[𝐶𝑎2+]𝑗
2
𝐾𝑆𝐸𝑅𝐶𝐴
2 + [𝐶𝑎2+]𝑖
2 (4.7) 
where 𝑣𝑆𝐸𝑅𝐶𝐴 is the maximum rate of Ca
2+ uptake by ER via the SERCA pump, and 𝐾𝑆𝐸𝑅𝐶𝐴 is 
the affinity of the SERCA pump for Ca2+ ions (see Appendix C.4 for the explanation). The 
value 𝑣𝑆𝐸𝑅𝐶𝐴 is proportional to the availability of SERCA and is estimated in the next section. 
4.1.3 Ca2+ passive leak 
The flux of the passive Ca2+ leak from the ER is described as:  
𝐽𝑙𝑒𝑎𝑘,𝑗 = 𝑣𝑙𝑒𝑎𝑘,𝐸𝑅 ([𝐶𝑎
2+]
𝐸𝑅,𝑗
− [𝐶𝑎2+]
𝑗
) (4.8) 
where 𝑣𝑙𝑒𝑎𝑘,𝐸𝑅 is the leak rate constant of ER.  
Therefore, we substitute Eq (4.4), (4.7) and (4.8) into Eq. (4.2) and get 
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𝐽𝐸𝑅,𝑗 = V𝑅𝑦𝑅𝑃𝑜𝑅𝑦𝑅,𝑖 ([𝐶𝑎
2+
]
𝐸𝑅
− [𝐶𝑎2+]
𝑗
) − 𝑣𝑆𝐸𝑅𝐶𝐴
[𝐶𝑎2+]𝑗
2
𝐾𝑆𝐸𝑅𝐶𝐴
2 + [𝐶𝑎2+]𝑗
2
+ 𝑣𝑙𝑒𝑎𝑘,𝐸𝑅 ([𝐶𝑎
2+
]
𝐸𝑅.𝑗
− [𝐶𝑎2+]
𝑗
) , 
(4.9) 
where j = 2 or 4. At the resting state (𝐽𝐸𝑅,𝑗 = 0), the Ca2+ leaking flux together with RyR-
mediated Ca2+ release balances the Ca2+ influx by the SERCA pumps, according to which we 
can calculate the corresponding value of 𝑣𝑙𝑒𝑎𝑘,𝐸𝑅. 
Table 4.1. Parameters values used in this chapter under healthy condition. 
Description Symbol Value Reference 
Ratio of ER volume to the cytosol 
volume 𝜌 
0.032 
(Cooney, Hurlburt et al. 
2002) 
RyR Ca2+ release rate 𝑉𝑅𝑦𝑅,2 0.005 ms-1 
(Keizer and Levine 
1996) RyR kinetic constants 
𝑘𝑎𝑓 1.5 μM-4 ms-1 
𝑘𝑎𝑏 0.0288 ms
-1 
𝑘𝑏𝑓 1.5 μM-3 ms-1 
𝑘𝑏𝑏 0.3859 ms
-1 
𝑘𝑐𝑓 0.00175 ms-1 
𝑘𝑐𝑏 0.0001 ms
-1 
Maximum rate of SERCA 𝑣𝑆𝐸𝑅𝐶𝐴 
0.9003 
μM/ms 
MCMC estimated 
Dissociation constant for SERCA 𝐾𝑆𝐸𝑅𝐶𝐴 0.27 μM 
(Lytton, Westlin et al. 
1992) 
Leak rate constant of ER 𝑣𝑙𝑒𝑎𝑘,𝐸𝑅 0.0004 ms
-1 MCMC estimated 
 
4.2 Model parameter estimation and calibration 
Keizer and Levine (1996) used different values for the relevant parameters for small and large 
ER, respectively. The 𝜌 they use for small ER, 0.02, is close to the ratio observed 
experimentally (3.2±0.2% (Cooney, Hurlburt et al. 2002)). Assuming the basal Ca2+ 
concentration of cytosol ([𝐶𝑎2+]cyto0) is 0.07 μM, then the basal Ca2+ concentration of ER 
([𝐶𝑎2+]𝐸𝑅0) is between 56.2 and 66.2 μM for different sized ERs, and is calculated based on 
these constraints as 
[𝐶𝑎2+]𝐸𝑅0 =
1
𝜌
([𝐶𝑎2+]
cyto0
− [𝐶𝑎2+]
𝑡𝑜𝑡𝑎𝑙
), 
where[𝐶𝑎2+]𝑡𝑜𝑡𝑎𝑙 is the total Ca
2+ concentration in the dendrites. We choose [𝐶𝑎2+]𝐸𝑅0 to be 60 
μM under control conditions and 𝜌 to be 0.032, which gives [𝐶𝑎2+]𝑡𝑜𝑡𝑎𝑙 as 1.99 μM. This is 
slightly higher than the value for the small ER used in the model of Keizer and Levine (1996), 
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1.2 μM, since the value for 𝜌 in our model is slightly higher than that in their model.  
We assume the densities of RyR and SERCA pump and the surface area to volume ratios of 
ER are the same in the spine head and the dendritic shaft. Therefore, the rate constants of 
RyRs, V𝑅𝑦𝑅 , in Eq. (4.4) shaft are the same in the spine head and dendritic shaft, which is 
assumed to be 0.005 ms-1 (Keizer and Levine 1996). The maximum rate of Ca2+ uptake by 
SERCA, 𝑣𝑆𝐸𝑅𝐶𝐴, can be calculated by 
𝑣𝑆𝐸𝑅𝐶𝐴,𝑗 = 𝑉𝑚𝑎𝑥𝑃𝑠𝑆𝐸𝑅𝐶𝐴
𝐴𝑗
𝑉𝑗
, 
where 𝑉𝑚𝑎𝑥 is the maximum turnover rate of Ca
2+ by SERCA, 𝑃𝑠𝑆𝐸𝑅𝐶𝐴 is its surface density 
and 
𝐴𝑗
𝑉𝑗
 is the ratio of surface area to the volume of compartment 𝑗. Based on our assumption, 
the value of 𝑣𝑆𝐸𝑅𝐶𝐴 in the spine head and the dendritic shaft are identical.  
4.2.1 Estimate parameter values using MCMC 
In Chapter 3, we estimate ten parameters using MCMC from the experimental data. The 
estimation is based on the assumption of the absence of ER, therefore, we need to re-estimate 
their values by considering the presence of ER.  
Sabatini, Oertner et al. (2002) observed that in response to a single bAP, about 30% of the 
Ca2+ ions are extruded from the cytosol via SERCA in the spine, while the rest are via PMCA 
and NCX. We add this as an additional target in the experimental data listed in Table 3.6 in 
Chapter 3 to estimate the value for 𝑣𝑆𝐸𝑅𝐶𝐴 as well as the other ten parameters (Table 4.2). The 
range of 𝑣𝑆𝐸𝑅𝐶𝐴 is from 0.1 to 1 μM ms
-1 (Keizer and Levine 1996). The procedure for 
estimation is the same as described in Section 3.2.4 in Chapter 3. The means of MCMC 
samples and the parameter set with the lowest MAPE are listed in the last two columns in 
Table 4.3. The simulation results show that the model with the parameter set with the lowest 
MAPE performs much better than the one using the mean of MCMC samples (Table 4.2). 
Therefore, we choose parameters with the lowest MAPE for our model under control 
conditions. 
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Table 4.2. Values of target experimental data, means of MCMC samples and the 
parameter set with the lowest mean absolute percentage error (MAPE) 
Target experimental data Target value 
Mean of MCMC 
samples 
Set with the 
lowest MAPE 
∆[𝐶𝑎]𝑏𝐴𝑃 in spine (μM) 1.7 (±0.6) 1.257 1.647 
∆[𝐶𝑎]𝑏𝐴𝑃 in dendrite (μM) 1.5 (±0.5) 1.277 1.606 
𝜏𝑑𝑒𝑐𝑎𝑦 in spine (ms) 12 (±4) 14.731 12.486 
𝜏𝑑𝑒𝑐𝑎𝑦 in dendrite (ms) 15 (±5) 17.803 14.862 
[𝐶𝑎]𝑃𝑀𝐶𝐴
[𝐶𝑎]𝑁𝐶𝑋
 in spine 1.070 2.464 1.200 
[𝐶𝑎]𝑃𝑀𝐶𝐴
[𝐶𝑎]𝑁𝐶𝑋
 in dendrite 0.825 1.425 0.826 
[𝐶𝑎2+]𝑆𝐸𝑅𝐶𝐴
[𝐶𝑎2+]𝑆𝐸𝑅𝐶𝐴 + [𝐶𝑎2+]𝑃𝑀𝐶𝐴 + [𝐶𝑎2+]𝑁𝐶𝑋
 
0.3 0.168 0.307 
MAPE  0.377 0.040 
 
Table 4.3. Parameter ranges for MCMC and the values estimated by MCMC 
Parameter Range for MCMC 
Mean of MCMC 
samples 
Set with the 
lowest MAPE 
VDCC density in spine 
head 
2.23 - 4.66 μm-2 3.630 μm-2 3.169 μm-2 
VDCC density in shaft 7.29 – 14.57 μm-2 11.661 μm-2 10.188 μm-2 
PMCA density in spine 
head 
200 - 2000 μm-2 555.014 μm-2 283.878 μm-2 
PMCA density in shaft 200 - 2000 μm-2 979.994 μm-2 490.837 μm-2 
NCX density in spine head 10 - 700 μm-2 0.350 μm-2 0.410 μm-2 
NCX density in shaft 100 -1000 μm-2 508.219 μm-2 433.938 μm-2 
Immobile buffer 
concentration in spine head 
50 - 200 μM 115.779 μM 83.871 μM 
Immobile buffer 
concentration in shaft 
50 - 200 μM 130.911 μM 102.409 μM 
Forward rate constant of 
immobile buffer 
0.05 – 1 μM-1ms-1 0.267μM-1ms-1 0.227 μM-1ms-1 
Backward rate constant of 
immobile buffer 
0.05 – 1 ms-1 0.520 ms-1 0.509 ms-1 
Maximum rate of SERCA 0.1 - 1 μM ms-1 0.684 μM ms-1 0.903 μM ms-1 
 
4.2.2 Model performance under control conditions 
In this section, we present the simulation results of the ER-included model under control 
conditions, using parameter values from Table 4.1. We evaluate the model performance in 
response to different types of presynaptic stimulation from aspects of the Ca2+ dynamics in 
the spine head and its parent dendritic shaft, and the contributions of the different Ca2+ 
sources to the Ca2+ dynamics.  
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4.2.2.1 A single bAP stimulation 
Sabatini, Oertner et al. (2002) applied the cyclopiazonic acid (CPA) to block the SERCA 
pumps to study the relative contribution of SERCA in Ca2+ transient in the spine head induced 
by a single bAP. The CPA is a specific inhibitor of SERCA pumps, and it will deplete the 
Ca2+ content of the ER. We mimic the block of SERCA pumps by CPA by letting vSERCA 
be zero and running the model long enough to let all variables reach their steady levels. We 
then use these steady levels as the initial values of each variable. The model is simulated 
under the conditions of the absence (immobile buffer only) and presence of mobile buffers 
(CaM and CaD), respectively. After the application of CPA, the peaks of the Ca2+ transients 
evoked by a single bAP in the spine head and shaft are not affected under either conditions 
(Figure 4.4 A) and the decay time constants to resting values are increased.These results are 
consistent with the experimental observations in Sabatini, Oertner et al. (2002).  
Figure 4.4 B show that the model performs well in predicting the contribution of different 
Ca2+ sources to the Ca2+ transients in response to a single bAP in comparison to the 
experimental observations (Sabatini, Oertner et al. 2002). The increase of cytosolic Ca2+ is 
mainly via VDCC in the spine head and shaft. There is only a minor Ca2+ release from ER by 
RyRs to the cytosolic Ca2+ transients (Figure 4.4 B middle), which is very similar to the 
experimental observation that CICR does not contribute to the Ca2+ elevation stimulated by bAP 
(Emptage, Bliss et al. 1999, Sabatini, Oertner et al. 2002). Moreover, about 30% and 35% of 
cytosolic Ca2+ extrusion are taken up by ER during the transient in the spine head and shaft, 
respectively (Figure 4.4 B bottom).  
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(A) 
 
(B) 
Spine head       Shaft 
 
Figure 4.4. Ca2+ response in the spine head and the adjacent dendritic shaft evoked by a 
single bAP. (A) Effects of block of Ca2+ uptake into ER via SERCA pumps in response 
to a single bAP. (B) Ca2+ trainsient (top), fractional contribution of Ca2+ influx from 
different sources (middle) and Ca2+ extrusion by different mechanisms (bottom) to the 
cytosolic Ca2+ transients in the spine head and the adjacent dendritic shaft. 
 
4.2.2.2 1 s of presynaptic stimulation 
CICR by ER can be triggered by Ca2+ influx via NMDAR in response to the presynaptic 
stimulation (Emptage, Bliss et al. 1999). We use the model to simulate the Ca2+ dynamics in a 
dendritic spine in response to 1 s of presynaptic stimulation at 1 Hz (1 pulse), 10 Hz (10 
pulses) and 100 Hz (100 pulses), respective, under healthy condition. At a 1 Hz stimulation, 
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the peak Ca2+ transient is about 0.48 μM in the spine head (Figure 4.5 A left) at the presence 
of mobile buffers, which is located in the range estimated under experimental conditions 
(Sterratt, Graham et al. 2011). The Ca2+ elevation is mainly by the Ca2+ influx via NMDARs 
and RyRs and ER membrane leakage show higher contributions to the Ca2+ elevation in 
response to a single presynaptic stimulation (Figure 4.5 B left) than in response to a single 
bAP stimulation (Figure 4.4 B and C). VDCCs does not contribute to the Ca2+ elevation 
because the small membrane depolarization is not sufficient to open them. About one-third of 
cytosolic Ca2+ ions is removed by SERCA pumps during the Ca2+ transient, while the rest is 
by the membrane pumps (PMCA and NCX) (Figure 4.5 C left). The Ca2+ response in the 
dendritic shaft is relatively less noticeable (Figure 4.5 A right), showing that the Ca2+ 
response to a single presynaptic stimulation is highly restricted to the spine head (Nevian and 
Sakmann 2004). Therefore, in following sections, we only focus on the Ca2+ dynamics in the 
spine hand. 
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(A). Ca2+ in the spine head 
 
(B) 
   
(C) 
 
Figure 4.5. Ca2+ response in the spine head and the adjacent dendritic shaft evoked by a 
single presynaptic stimulation. (A) Ca2+ concentration in the spine head and the 
adjacent dendritic shaft. Contributions of Ca2+ influx from different sources (B) and 
Ca2+ extrusion by different mechanisms (C) to the cytosolic Ca2+ transients in the spine 
head. 
 
At 10 and 100 Hz stimulation, the maximum Ca2+ levels are about 0.83 and 3.7 μM, 
respectively (Figure 4.6 A top and B top). At the 100 Hz stimulation, after reaches a peak, the 
Ca2+ concentration decreases and stays on a plateau at a lower level (about 1.1 μM) until the 
end of stimulation, which because of the large desensitisation of synaptic NMDAR by high-
frequency stimulation. RyRs show a larger contribution to the cytosolic Ca2+ transients at the 
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decay phase at a 10 stimulation than at a 100 one (Figure 4.6 A middle and B middle). The 
contribution of Ca2+ extrusion by different mechanisms to the cytosolic Ca2+ transients are 
very similar between at 10 and 100 Hz stimulation (Figure 4.6 A bottom and B bottom). 
 
        
(A). 10 Hz (B). 100 Hz 
  
  
 
Figure 4.6. Ca2+ response in the spine head and the adjacent dendritic shaft evoked by 1s 
of stimulation at 10 Hz (A) and 100 Hz (B), respectively. (Top) Ca2+ concentration in the 
spine head. The fractional contribution of Ca2+ influx from different sources (middle) 
and Ca2+ extrusion by different mechanisms (bottom) to the cytosolic Ca2+ transients in 
the spine head. 
 
4.3 Computational experiments  
We investigate the three selected effects of ER alterations on Ca2+ signalling in the dendritic 
spine individually and collectively, by simulating the model under the following four 
conditions: (1) ER Ca2+ overload (Section 4.3.1); (2) upregulation in RyR response (Section 
4.3.2); (3) combination effects of (1),(2) (Section 4.3.3); (4) SERCA pumps (Section 4.3.4); 
and (5) combination effects of (1),(4) (Section 4.3.5). Simulations are carried in response to a 
1 s presynaptic stimulation at 1 Hz (1 pulse), 10 Hz (10 pulses) and 100 Hz (100 pulses), 
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respectively. The results are compared with those of the control produced by the parameters in 
Table 4.1 and the ones used in Chapter 3. 
 
The outputs we choose to collect after simulation are as follows: 
(1) Ca2+ elevation in the spine head ([𝐶𝑎2+]𝑐𝑦𝑡𝑜). This includes [𝐶𝑎2+]𝑐𝑦𝑡𝑜 peaks in 
response to each stimulation pulse. 
(2) Ca2+ responses of RyR (𝐽𝑅𝑦𝑅; positive outward flux) and the SERCA pump (𝐽𝑆𝐸𝑅𝐶𝐴; 
negative, inward flux), ER membrane leaking (𝐽𝑙𝑒𝑎𝑘𝐸𝑅; positive outward flux), and the 
net Ca2+ flux from the ER to the cytosol (𝐽𝐸𝑅) (Eq.(4.9)). This indicates the role ER 
plays in the cytosolic Ca2+ dynamics. A positive 𝐽𝐸𝑅 indicates that the ER mainly acts 
as a Ca2+ source and a negative 𝐽𝐸𝑅 indicates it acts as a Ca
2+ sink. 
(3) The fraction of RyRs (𝑃𝑜𝑅𝑦𝑅) opened by cytosolic Ca2+ and the total open time. The 
total open time of RyR is calculated from the area under the 𝑃𝑜𝑅𝑦𝑅 curve against time. 
(4) The ratio of total Ca2+ ions enters via RyR to those via the NMDAR 
([𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio). This indicates the contribution between the internal 
and external Ca2+ sources to cytosolic Ca2+ elevation. The total Ca2+ ions is calculated 
from the area under the Ca2+ flux curve against time. 
 
4.3.1 ER Ca2+ overload 
An increase in the resting Ca2+ level of ER has been observed in AD neurons as well as in 
ageing neurons (Popugaeva and Bezprozvanny 2013). Several researches have linked the ER 
Ca2+ overload to mutations in PS (see Section 2.2.4.2 in Chapter 2). PS is suggested to serve 
as a Ca2+leak channel on the ER membrane, which balances the activity of the SERCA pumps 
and RyRs to maintain Ca2+ homeostasis of the ER at the resting level (Tu, Nelson et al. 2006). 
Therefore, PS mutation will diminish its leak function, leading to a Ca2+ overload in the ER 
and an alteration in Ca2+ homeostasis (Tu, Nelson et al. 2006, Nelson, Tu et al. 2007, Zhang, 
Sun et al. 2010, Nelson, Supnet et al. 2011). We mimic the alteration in ER Ca2+ by varying 
the resting Ca2+ of the ER ([𝐶𝑎2+]𝐸𝑅0) from 30 μM to 600 μM ([𝐶𝑎
2+]𝐸𝑅0 as the healthy 
condition is assumed to be 150 μM), and keep other parameters at standard values. 
113 
 
 
 
 
 
The ER Ca2+ leak rate constant, 𝑣𝑙𝑒𝑎𝑘,𝐸𝑅, is calculated by rearranging Eq.(4.9):  
𝑣𝑙𝑒𝑎𝑘𝐸𝑅  = V𝑅𝑦𝑅𝑃𝑜𝑅𝑦𝑅 − 𝑣𝑆𝐸𝑅𝐶𝐴
[𝐶𝑎2+]
𝑐𝑦𝑡𝑜
2
𝐾𝑆𝐸𝑅𝐶𝐴
2 + [𝐶𝑎2+]
𝑐𝑦𝑡𝑜
2
1
[𝐶𝑎2+]
𝐸𝑅
− [𝐶𝑎2+]
𝑐𝑦𝑡𝑜
. (4.10) 
 
For fixed values of RyR and the SERCA pump-related parameter and resting cytosolic Ca2+ 
concentration ([𝐶𝑎2+]𝑐𝑦𝑡𝑜), 𝑣𝑙𝑒𝑎𝑘𝐸𝑅 is negatively depending on the concentration gradient 
between the cytosol and ER ([𝐶𝑎2+]
𝐸𝑅
− [𝐶𝑎2+]
𝑐𝑦𝑡𝑜
) under resting conditions (Figure 4.7). 
 
Figure 4.7. The membrane Ca2+ leak rate constant of ER (𝒗𝒍𝒆𝒂𝒌𝑬𝑹) at various levels of 
resting Ca2+ levels of ER ([𝑪𝒂𝟐+]𝑬𝑹𝟎). The values of 𝒗𝒍𝒆𝒂𝒌𝑬𝑹 is calculated using Eq. 
(4.10). 𝑽𝑹𝒚𝑹 = 0.005 ms-1. 𝒗𝑺𝑬𝑹𝑪𝑨 = 0.9 μM ms-1. 𝑲𝑺𝑬𝑹𝑪𝑨 = 0.27 μM. [𝑪𝒂
𝟐+]𝒄𝒚𝒕𝒐 = 0.07 μM. 
𝑷𝒐𝑹𝒚𝑹 is calculated from Eq.(4.5) and Eq.(4.6) at steady state. 
 
The peak of [𝐶𝑎2+]𝑐𝑦𝑡𝑜 evelation in the postsynaptic spine head in response to a 1 Hz 
presynaptic stimulation increases with the rise in [𝐶𝑎2+]𝐸𝑅0 (Figure 4.8 A), from 0.32 μM at 
standard [𝐶𝑎2+]𝐸𝑅0 to 0.42 μM when [𝐶𝑎
2+]𝐸𝑅0 increases to 600 μM. At the standard and 
lower level of [𝐶𝑎2+]𝐸𝑅0, the net ER Ca
2+ flux is negative/inward during the rising of 
[𝐶𝑎2+]𝑐𝑦𝑡𝑜 and becomes positive during the Ca
2+ decay stage. In contrast, at high levels of 
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[𝐶𝑎2+]𝐸𝑅0 (300 and 600 μM), a positive peak appears during the rising stage of 
[𝐶𝑎2+]𝑐𝑦𝑡𝑜(Figure 4.8 B). This is mainly contributed to by the increasing level of RyR 
response (Figure 4.8 B and Figure 4.8 C). The peak RyR response increases linearly with 
increases in [𝐶𝑎2+]𝐸𝑅0 while the peak activity of the SERCA pump is nearly unaffected 
across the range of [𝐶𝑎2+]𝐸𝑅0 tested (Figure 4.8 C). This suggests that under a single 
presynaptic stimulation, when the ER is overfilled with Ca2+ at the resting level, it shifts its 
role from a Ca2+ sink, which attenuates the rising of [𝐶𝑎2+]𝑐𝑦𝑡𝑜, to an internal Ca
2+ source in 
addition to the extracellular one.  
When we apply 1 s presynaptic stimulations at 10 Hz and 100 Hz, respectively, the increase in 
normalised peak of [𝐶𝑎2+]𝑐𝑦𝑡𝑜 with [𝐶𝑎
2+]𝐸𝑅0 is attenuated from the second pulse onward 
(Figure 4.9 A and B). Under 100 Hz stimulation, there is no difference in peak [𝐶𝑎2+]𝑐𝑦𝑡𝑜 
upon simulation with different [𝐶𝑎2+]𝐸𝑅0 after the 10
th pulse (Figure 4.9 B). When 
[𝐶𝑎2+]𝐸𝑅0 is 150 μM and higher, the net ER Ca
2+ flux shows a positive spike in response to 
each stimulation pulse with a decrease in amplitude against time at a 10 Hz stimulation 
(Figure 4.9 C). The spike amplitudes in response to each stimulation pulse increase with 
[𝐶𝑎2+]𝐸𝑅0. Under a 100 Hz stimulation, the net Ca
2+ flux fluctuates around zero from the 
second pulse onward, without obvious differences between different levels of [𝐶𝑎2+]𝐸𝑅0 
(Figure 4.9 D). Moreover, the [𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio increases with the level of 
[𝐶𝑎2+]𝐸𝑅0 (Figure 4.9 E). The increment is slightly affected by the stimulation frequency. 
Under a 1 Hz stimulation, the [𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio shows a linear increase with 
V𝑅𝑦𝑅, whereas, the increment in the [𝐶𝑎
2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio by V𝑅𝑦𝑅 is attenuated 
under 10 Hz and 100 Hz stimulations. 
Under a 1 Hz stimulation, the peak of 𝑃𝑜𝑅𝑦𝑅 increases from around 0.38 at [𝐶𝑎
2+]𝐸𝑅0= 30 
μM to around 0.67 at [𝐶𝑎2+]𝐸𝑅0= 300 μM (Figure 4.10 A insert). At a 10 Hz stimulation, the 
𝑃𝑜𝑅𝑦𝑅 reaches a peak in response to the second stimulation pulse, and afterwards, the increase 
in 𝑃𝑜𝑅𝑦𝑅 with [𝐶𝑎
2+]𝐸𝑅0 is attenuated (Figure 4.10 B). At a 100 Hz stimulation, more than 
90% of RyRs open in response to the second pulse and gradually decrease to around 30% 
through the stimulation (Figure 4.10 C). There is no obvious difference in 𝑃𝑜𝑅𝑦𝑅 among the 
different values of [𝐶𝑎2+]𝐸𝑅0. The total open time of RyR increases with [𝐶𝑎
2+]𝐸𝑅0 at 1 Hz 
and 10 Hz stimulations, whereas at a 100 Hz stimulation, it decreases and rises again between 
451.2 and 453.5 ms (Figure 4.10 D). 
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The reasons cause these differences are the fast activation and slow inactivation of RyRs. 
Once a presynaptic stimulation pulse arrives at a resting synapse, it leads to a rapid Ca2+ 
elevation and immediate RyR response. When the time duration between the two stimulation 
pulses shortens under the higher frequency stimulation, this allows a fraction of RyR that is 
activated by the previous pulse to be still open when the next pulse arrives. This explains why 
higher 𝑃𝑜𝑅𝑦𝑅 peaks are obtained at a 100 Hz stimualtion (Figure 4.10 C) than at a 10 Hz 
stimualtion (Figure 4.10 B).  
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(A)  
 
(B) 
 
 
(C) 
 
Figure 4.8. Effects of rising [𝑪𝒂𝟐+]𝑬𝑹𝟎 on postsynaptic response by a single presynaptic 
stimulation pulse (1 Hz). (A) The [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 dynamics in the spine head and the 
relationship between [𝑪𝒂𝟐+]𝑬𝑹𝟎 and the [𝑪𝒂
𝟐+]𝒄𝒚𝒕𝒐 peaks (insert). The corresponding 
Ca2+ responses of RyR (𝑱𝑹𝒚𝑹) and the SERCA pump (𝑱𝑺𝑬𝑹𝑪𝑨), ER membrane leaking 
(𝑱𝒍𝒆𝒂𝒌𝑬𝑹), and the net Ca2+ flux from the ER to the cytosol (𝑱𝑬𝑹) are shown in (B). 
Arrows in the bottom panel indicate the direction of time flow. The peaks of 𝑱𝑹𝒚𝑹, 𝑱𝑺𝑬𝑹𝑪𝑨 
and 𝑱𝒍𝒆𝒂𝒌𝑬𝑹 at different levels of [𝑪𝒂
𝟐+]𝑬𝑹𝟎 are in (C).  
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(A). 10 Hz 
 
(B). 100Hz 
 
(C). 10 Hz 
 
 
(D). 100 Hz 
 
(E) 
 
Figure 4.9. Effects of rising [𝑪𝒂𝟐+]𝑬𝑹𝟎 on postsynaptic response under 1 s presynaptic 
stimulation at 10 Hz and 100 Hz, respectively. The [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks in response to 
different stimulation pulses at a 10 Hz (A) and a 100 Hz stimulation (B), respectively are 
normalised to the one with the lowest [𝑪𝒂𝟐+]𝑬𝑹𝟎 at each pulse. The colour density 
represents the values of [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks in the spine head. Under the 100 Hz 
stimulation, only the first 30 pulses are shown in the figure since there is no difference 
afterwards. The corresponding Ca2+ responses of RyR (𝑱𝑹𝒚𝑹) and the SERCA pump 
(𝑱𝑺𝑬𝑹𝑪𝑨), ER membrane leaking (𝑱𝒍𝒆𝒂𝒌𝑬𝑹), and the net Ca2+ flux from the ER to the 
cytosol (𝑱𝑬𝑹) are shown in (C) and (D), respectively. (E) Effects of rising [𝑪𝒂
𝟐+]𝑬𝑹𝟎 on 
[𝑪𝒂𝟐+]𝑹𝒚𝑹: [𝑪𝒂
𝟐+]𝑵𝑴𝑫𝑨𝑹 ratio.  
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(A). 1 Hz 
 
 
(B). 10 Hz 
 
 
(C). 100 Hz 
 
 
(D) 
 
Figure 4.10. Effects of rising [𝑪𝒂𝟐+]𝑬𝑹𝟎 on RyR opening. (A) The 𝑷𝒐𝑹𝒚𝑹 with time in the 
spine head and the relationship between [𝑪𝒂𝟐+]𝑬𝑹𝟎 and the 𝑷𝒐𝑹𝒚𝑹 peaks (insert) at a 1 
Hz stimulation. The heatmaps show the maximums of 𝑷𝒐𝑹𝒚𝑹 in response to different 
stimulation pulses at a 10 Hz (B) and a 100 Hz stimulation (C), respectively. The colour 
density represents the values of 𝑷𝒐𝑹𝒚𝑹 peaks in the spine head. Under the 100 Hz 
stimulation, only the first 30 pulses are shown in the figure since there is no difference 
afterwards. (D) The corresponding total opening times of RyR at stimulations with 
different frequencies. 
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4.3.2 Enhanced Ca2+ release via RyRs 
For a fixed maximum rate of a single receptor, the maximum rate of total RyRs is in 
proportion to the number of RyRs. In this section, we mimic the upregulation in RyR 
expression by increasing V𝑅𝑦𝑅 from its standard level of 0.005 ms
-1 to 0.3 ms-1. We also 
include lower levels of V𝑅𝑦𝑅 (below 0.005 ms
-1) in the computational experiments. 
Under a 1 Hz stimulation, the peak of [𝐶𝑎2+]𝑐𝑦𝑡𝑜 increases from 0.3 μM, when V𝑅𝑦𝑅 is 0.001 
ms-1 , to around 0.37 μM, when V𝑅𝑦𝑅 is 0.03 ms
-1 (Figure 4.11 A). Further increases in 
V𝑅𝑦𝑅 do not lead to a higher [𝐶𝑎
2+]𝑐𝑦𝑡𝑜 elevation. ER contributes mainly as a Ca
2+ sink at 
standard and lower levels of V𝑅𝑦𝑅, while, with an increase in V𝑅𝑦𝑅  , it is more like as an 
internal Ca2+ source during stimulation (Figure 4.11 B). The peak Ca2+ flux via RyR, 
increases dramatically with the value of V𝑅𝑦𝑅 and fluxtuates at high level of V𝑅𝑦𝑅, whereas the 
peak activity of the SERCA pumps is not affected (Figure 4.11 C). 
Under a 10 Hz stimulation, from the second pulse onward, both the normalised 
[𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak (Figure 4.12 A) and the 𝑃𝑜𝑅𝑦𝑅 peak (Figure 4.13 B) show a maximum value 
when V𝑅𝑦𝑅 is between 0.05 to 0.03 ms
-1
. Positive spikes in the net Ca2+ flux from ER, 𝐽𝑅𝑦𝑅, 
appear during stimulation (Figure 4.12 C). At 100 Hz, from the second pulse onward, the 
degree of increase in [𝐶𝑎2+]𝑐𝑦𝑡𝑜 peaks with V𝑅𝑦𝑅 being attenuated over time (Figure 4.12 B). 
There is no difference in [𝐶𝑎2+]𝑐𝑦𝑡𝑜 dynamics across the testing range of V𝑅𝑦𝑅 values after 
the 15th pulse. 𝐽𝐸𝑅 fluctuates around zero (Figure 4.12 D) and shows a balance between 
release and uptake of Ca2+ by ER.The 𝑃𝑜𝑅𝑦𝑅 does not show differences in response to a 100 
Hz stimulation across the tested ranges the testing ranges of V𝑅𝑦𝑅 from the second pulse 
onward (Figure 4.13 C). Moreoever, at all types of stimulation, the open time increases 
sharply with V𝑅𝑦𝑅 and when V𝑅𝑦𝑅 is below 0.01 ms
-1 (Figure 4.13 C). At 1 Hz and 100 Hz, the 
total open time is almost stable with minor increases whereas, at 10 Hz, it decreases gradually 
from 129 ms to 122s while V𝑅𝑦𝑅 increases from 0.01 ms
-1 to 0.3 ms-1. 
The [𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio generally increases with V𝑅𝑦𝑅, indicating a increasing 
contribution of RyR in Ca2+ entering the cytosol against NMDAR(Figure 4.12 E). Under 10 
Hz and 100 Hz stimulations, it dramatically rises to around 0.13 and 0.14, respectively, when 
increasing V𝑅𝑦𝑅 to 0.03 ms
-1, and then it gradually approaches 0.2 and 0.16, respectively. This 
suggests upregulation in RyR expression can increase the contribution of RyR to Ca2+ 
dynamics and the increase is larger at a lower frequency stimulation in comparison to a higher 
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(B) 
 
(C) 
 
Figure 4.11. Effects of 𝑽𝑹𝒚𝑹 on postsynaptic response by a single presynaptic stimulation 
pulse (1 Hz). (A) The [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 dynamics in the spine head and the relationship 
between 𝑽𝑹𝒚𝑹 and the [𝑪𝒂
𝟐+]𝒄𝒚𝒕𝒐 peaks (insert). The corresponding Ca2+ responses of 
RyR (𝑱𝑹𝒚𝑹) and the SERCA pump (𝑱𝑺𝑬𝑹𝑪𝑨), ER membrane leaking (𝑱𝒍𝒆𝒂𝒌𝑬𝑹), and the net 
Ca2+ flux from the ER to the cytosol (𝑱𝑬𝑹) are shown in (B). Arrows in the bottom panel 
indicate the direction of time flow. The peaks of 𝑱𝑹𝒚𝑹, 𝑱𝑺𝑬𝑹𝑪𝑨 and 𝑱𝒍𝒆𝒂𝒌𝑬𝑹 at different 
levels of 𝑽𝑹𝒚𝑹 are in (C).  
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(A).10 Hz 
 
(B). 100 Hz 
 
(C). 10 Hz 
 
(D). 100 Hz 
 
(E) 
 
Figure 4.12. Effects of 𝑽𝑹𝒚𝑹 on postsynaptic response under 1 s presynaptic stimulation 
at 10 Hz and 100 Hz, respectively. The [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks in response to different 
stimulation pulses at a 10 Hz (A) and a 100 Hz stimulation (B), respectively are 
normalised to the one with the lowest 𝑽𝑹𝒚𝑹 at each pulse. The colour density represents 
the values of [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks in the spine head. Under the 100 Hz stimulation, only the 
first 30 pulses are shown in the figure since there is no difference afterwards. The 
corresponding Ca2+ responses of RyR (𝑱𝑹𝒚𝑹) and the SERCA pump (𝑱𝑺𝑬𝑹𝑪𝑨), ER 
membrane leaking (𝑱𝒍𝒆𝒂𝒌𝑬𝑹), and the net Ca2+ flux from the ER to the cytosol (𝑱𝑬𝑹) are 
shown in (C) and (D), respectively. (E) Effects of rising 𝑽𝑹𝒚𝑹 on [𝑪𝒂
𝟐+]𝑹𝒚𝑹: [𝑪𝒂
𝟐+]𝑵𝑴𝑫𝑨𝑹 
ratio.  
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(A) 
 
(B). 10 Hz 
 
(C). 100 Hz 
 
(D) 
 
Figure 4.13. Effects of 𝑽𝑹𝒚𝑹 on RyR opening. (A) The 𝑷𝒐𝑹𝒚𝑹 with time in the spine head 
and the relationship between 𝑽𝑹𝒚𝑹 and the 𝑷𝒐𝑹𝒚𝑹 peaks (insert) at a 1 Hz stimulation. 
The heatmaps show the maximums of 𝑷𝒐𝑹𝒚𝑹 in response to different stimulation pulses 
at a 10 Hz (B) and a 100 Hz stimulation (C), respectively. The colour density represents 
the values of 𝑷𝒐𝑹𝒚𝑹 peaks in the spine head. Under the 100 Hz stimulation, only the first 
30 pulses are shown in the figure since there is no difference afterwards. (D) The 
corresponding total opening times of RyR at stimulations with different frequencies. 
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4.3.3 RyR upregulation at ER with various Ca2+ load 
Experiments with AD animal models suggest that the increase in RyRs expression may be 
because the neurons attempt to compensate for the ER Ca2+ overload (Zhang, Sun et al. 2010). 
However, the upregulation of RyR expression can cause pathogenic cytosol Ca2+ elevation by 
increasing the Ca2+ release from ER. Therefore, we examine the system responses at various 
levels of [𝐶𝑎2+]𝐸𝑅0 (30 – 600 μM) and V𝑅𝑦𝑅 (0.001 - 0.15 ms
-1). 
At a 1 Hz stimulation or the stimulation by the first pulse of multi-pulse stimulation, the 
[𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak generally increases with higher levels of [𝐶𝑎
2+]𝐸𝑅0 and V𝑅𝑦𝑅 (Figure 4.14A). 
At a 10 Hz stimulation, the [𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak increases with V𝑅𝑦𝑅 and reaches the first 
maximum level when V𝑅𝑦𝑅 is around 0.02 ms
-1 (Figure 4.14B). It then decreases with further 
increases in V𝑅𝑦𝑅; then when [𝐶𝑎
2+]𝐸𝑅0 is above 200 μM, it increases again with V𝑅𝑦𝑅. The 
[𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak-V𝑅𝑦𝑅 relationship is transformed from a single-peak to a double-peak, with 
the increase of the [𝐶𝑎2+]𝐸𝑅0. Under a 100 Hz stimulation the [𝐶𝑎
2+]𝑐𝑦𝑡𝑜 peaks show similar 
patterns in response to different simulation pulses from the second pulse onward (Figure 
4.14C). At each degree of [𝐶𝑎2+]𝐸𝑅0, the [𝐶𝑎
2+]𝑐𝑦𝑡𝑜 peak increases with V𝑅𝑦𝑅 when V𝑅𝑦𝑅 is 
below 0.02 ms-1, and is not affected by V𝑅𝑦𝑅 when V𝑅𝑦𝑅 is greater. In contrast, as the degree 
of [𝐶𝑎2+]𝐸𝑅0 becomes higher, the [𝐶𝑎
2+]𝑐𝑦𝑡𝑜 peaks increase across the tested ranges of V𝑅𝑦𝑅. 
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(A). 1 HZ or 1 pulse of multi-pulse stimulation 
  
(B). 10 HZ  
 
(C). 100 HZ 
 
Figure 4.14. Ca2+ response at various level of [𝑪𝒂𝟐+]𝑬𝑹𝟎 and 𝑽𝑹𝒚𝑹 at a (A) 1 Hz (A), (B) 
10 Hz and (C) 100 Hz stimulation. Figures (B) and (C) show [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks at selected 
stimulation pulse. The colour density represents the values of [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks in the 
spine head. 
 
The [𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio increases with [𝐶𝑎
2+]𝐸𝑅0 and V𝑅𝑦𝑅 at all tested 
stimulation frequencies (Figure 4.15 A). As the frequency is higher, the 
[𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio is easier to obtain a higher level than at a lower degree of 
[𝐶𝑎2+]𝐸𝑅0 and V𝑅𝑦𝑅. This suggests that ER, as the internal Ca
2+ source, makes a high 
contribution to the cytosolic response under conditions of RyR expression and ER Ca2+ 
overload. The results of the total open time of RyR under presynaptic stimulation (Figure 4.15 
B) show similar pattern to ones of the [𝐶𝑎2+]𝑐𝑦𝑡𝑜 peaks in Figure 4.14. Under 10 Hz 
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stimulation, a peak value appears when V𝑅𝑦𝑅 is around 0.02 ms
-1. At 100 Hz, RyR opens for a 
longer time as the increase in the [𝐶𝑎2+]𝐸𝑅0 and V𝑅𝑦𝑅, where when V𝑅𝑦𝑅 is above 0.03 ms
-1, it 
does not affect the open time with a fixed [𝐶𝑎2+]𝐸𝑅0.  
 
(A). [𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio  
   
 
(B). RyR opening time  
 
 
Figure 4.15. (A)[𝑪𝒂𝟐+]𝑹𝒚𝑹: [𝑪𝒂
𝟐+]𝑵𝑴𝑫𝑨𝑹 ratio and (B) RyR opening time at various level 
of [𝑪𝒂𝟐+]𝑬𝑹𝟎 and 𝑽𝑹𝒚𝑹. The colour density represents the values of the 
[𝑪𝒂𝟐+]𝑹𝒚𝑹: [𝑪𝒂
𝟐+]𝑵𝑴𝑫𝑨𝑹 ratio and the RyR opening time in the spine head, respectively. 
 
4.3.4 SERCA pump reduction 
We manipulate the maximum rate of SERCA pump, 𝑣𝑆𝐸𝑅𝐶𝐴, to see the effect of Ca
2+ uptake 
by ER on Ca2+ response. The [𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak decreases from 0.37 μM to 0.3 μM when 
the 𝑣𝑆𝐸𝑅𝐶𝐴 increases from 0.01 to 1.5 μM/ms (Figure 4.16 A) at 1 Hz stimulation. The net ER 
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Ca2+ flux is negative but has a lower amplitude as the value of 𝑣𝑆𝐸𝑅𝐶𝐴 increases (Figure 4.16 
B). The Ca2+ fluxes via SERCA pump as well as via RyR and membrane leaking are 
enhanced by larger 𝑣𝑆𝐸𝑅𝐶𝐴 (Figure 4.16 C). Under a 10 Hz stimulation, the normalised 
[𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak slightly increases with 𝑣𝑆𝐸𝑅𝐶𝐴 from the second pulse onward (Figure 4.17 
A), whereas with a 100 Hz stimulation, a reduced degree of reduction in the [𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak 
with 𝑣𝑆𝐸𝑅𝐶𝐴 from the second pulse onward, and after the 4
th pulse, there is no obvious 
difference in [𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak with 𝑣𝑆𝐸𝑅𝐶𝐴 (Figure 4.17 B). The net ER Ca
2+ flux is negative 
with decreasing amplitude when 𝑣𝑆𝐸𝑅𝐶𝐴 is below 0.9 under a 10 Hz stimulation (Figure 4.17 
C). At a high level of 𝑣𝑆𝐸𝑅𝐶𝐴 (1.5 μM/ms), positive spikes in the net ER Ca
2+ flux appear from 
the second stimulation pulse onward. This is because the RyR response to Ca2+ is greatly 
enhanced by a larger 𝑣𝑆𝐸𝑅𝐶𝐴 in comparison with the Ca
2+ flux via SERCA pumps and 
membrane leaking (Figure 4.17 E). In contrast, with a 100 Hz stimulation, the peak Ca2+ flux 
via SERCA pumps stays at around -1.5 μM/ms across the testing range of  𝑣𝑆𝐸𝑅𝐶𝐴 value 
(Figure 4.17 F), which is around -1 μM/ms at the 1 and 10 Hz stimulations. This is because of 
the high Ca2+ influx via NMDAR under a 100 Hz stimulation. which leads to a high inward 
net Ca2+ flux from the cytosol to the ER. The peak of the net flux decreases with  𝑣𝑆𝐸𝑅𝐶𝐴 
(Figure 4.17 D). Moreover, the [𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio shows a linear increase with 
𝑣𝑆𝐸𝑅𝐶𝐴 at all frequencies of stimulation, with a larger slope at the higher frequency (Figure 
4.18). 
The fraction of RyR opened by the 1 Hz stimulation shows a decrease in the peak, from 0.5 to 
0.34, when  𝑣𝑆𝐸𝑅𝐶𝐴 increases from 0.01 to 1.5 μM/ms (Figure 4.19 A). At 100 Hz, the 
maximum PoRyR increases to a peak of around 95% from the second stimulation pulse to the 
eighth one, and decreases gradually afterwards. There is no difference in the maximum of 
PoRyR from different PoRyR (Figure 4.19 C). However, under  the 10 Hz stimulation, the 
pattern of maximum PoRyR switches to increasing with 𝑣𝑆𝐸𝑅𝐶𝐴 from the second pulse onward 
(Figure 4.19 B). The total open time of RyR decreases by 4.4 ms and 5.3 ms when 
increasing 𝑣𝑆𝐸𝑅𝐶𝐴 from 0.01 to 1.5 μM/ms at 1 and 100 Hz stimulations, respectively (Figure 
4.19 D). Under 10 Hz stimulation, a bell-shaped relationship between the RyR open time and 
𝑣𝑆𝐸𝑅𝐶𝐴, with the peak value, appears when 𝑣𝑆𝐸𝑅𝐶𝐴 is around 0.6 μM/ms.  
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(A) 
 
(B). 
 
 
(C) 
 
Figure 4.16. Effects of 𝒗𝑺𝑬𝑹𝑪𝑨 on postsynaptic response by a single presynaptic 
stimulation pulse (1 Hz). (A) The [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 dynamics in the spine head and the 
relationship between 𝒗𝑺𝑬𝑹𝑪𝑨 and the [𝑪𝒂
𝟐+]𝒄𝒚𝒕𝒐 peaks (insert). The corresponding Ca2+ 
responses of RyR (𝑱𝑹𝒚𝑹) and the SERCA pump (𝑱𝑺𝑬𝑹𝑪𝑨), ER membrane leaking 
(𝑱𝒍𝒆𝒂𝒌𝑬𝑹), and the net Ca2+ flux from the ER to the cytosol (𝑱𝑬𝑹) are shown in (B). 
Arrows in the bottom panel indicate the direction of time flow. The peaks of 𝑱𝑹𝒚𝑹, 
 𝑱𝑺𝑬𝑹𝑪𝑨 and 𝑱𝒍𝒆𝒂𝒌𝑬𝑹 at different levels of 𝒗𝑺𝑬𝑹𝑪𝑨 are in (C). 
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(A). 10 Hz 
 
(B). 100 Hz 
 
(C). 10 Hz 
 
 
(D). 100 Hz 
 
E     F 
 
Figure 4.17. Effects of 𝒗𝑺𝑬𝑹𝑪𝑨 on postsynaptic response under 1 s presynaptic 
stimulation at 10 Hz and 100 Hz, respectively. The [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks in response to 
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different stimulation pulses at a 10 Hz (A) and a 100 Hz stimulation (B), respectively are 
normalised to the one with the lowest 𝒗𝑺𝑬𝑹𝑪𝑨 at each pulse. The colour density 
represents the values  of  [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks in the spine head. Under the 100 Hz 
stimulation, only the first 30 pulses are shown in the figure since there is no difference 
afterwards. The corresponding Ca2+ responses of RyR (𝑱𝑹𝒚𝑹) and the SERCA pump 
(𝑱𝑺𝑬𝑹𝑪𝑨), ER membrane leaking (𝑱𝒍𝒆𝒂𝒌𝑬𝑹), and the net Ca2+ flux from the ER to the 
cytosol (𝑱𝑬𝑹) are shown in (C) and (D), respectively. The peaks of 𝑱𝑹𝒚𝑹,  𝑱𝑺𝑬𝑹𝑪𝑨 and 
𝑱𝒍𝒆𝒂𝒌𝑬𝑹 at different levels of 𝒗𝑺𝑬𝑹𝑪𝑨 are in (E) and (F).  
 
 
 
Figure 4.18. Effects of 𝒗𝑺𝑬𝑹𝑪𝑨 on [𝑪𝒂
𝟐+]𝑹𝒚𝑹: [𝑪𝒂
𝟐+]𝑵𝑴𝑫𝑨𝑹 ratio at 1 Hz, 10 Hz and 100 
Hz stimulation, respectively. 
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(A) 
 
(B). 10 Hz 
 
(C). 100 Hz 
 
(D) 
 
Figure 4.19. Effects of 𝒗𝑺𝑬𝑹𝑪𝑨 on RyR opening. (A) The 𝑷𝒐𝑹𝒚𝑹 with time in the spine 
head and the relationship between 𝒗𝑺𝑬𝑹𝑪𝑨 and the 𝑷𝒐𝑹𝒚𝑹 peaks (insert) at a 1 Hz 
stimulation. The heatmaps show the maximums of 𝑷𝒐𝑹𝒚𝑹 in response to different 
stimulation pulses at a 10 Hz (B) and a 100 Hz stimulation (C), respectively. The colour 
density represents the values  of  𝑷𝒐𝑹𝒚𝑹 peaks in the spine head. Under the 100 Hz 
stimulation, only the first 30 pulses are shown in the figure since there is no difference 
afterwards. (D) The corresponding total opening times of RyR at stimulations with 
different frequencies. 
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4.3.5 Alteration in SERCA pumps at ER with various Ca2+ load 
Green, Demuro et al. (2008) reported that PS interacts with SERCA pump to modulate its 
function and lack of PS impaires the SERCA pumps function in Xenopus laevis oocytes. 
However, it is not clear how the PS mutation in AD will affect SERCA pumping. However,  
Brunello, Zampese et al. (2009) produced opposite results that both wild-type and mutant PS2 
could reduce SERCA activity. Therefore, we examine the system responses at various levels 
of [𝐶𝑎2+]𝐸𝑅0 (30 – 600 μM) and 𝒗𝑺𝑬𝑹𝑪𝑨 (0.01 – 1.2 μM/ms), to investigate the possible 
contribution of SERCA alteration in the Ca2+ elevation in the spine head. 
At a 1 Hz stimulation or the stimulation by the first pulse of multi-pulse stimulation, the 
[𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak increases with higher levels of [𝐶𝑎
2+]𝐸𝑅0 and lower levels of 𝑣𝑆𝐸𝑅𝐶𝐴 (Figure 
4.20 A). The results show similar pattern inresponse to the second pulse onward at 100 Hz 
stimulation, and C). In contrast, at a 10 Hz stimulation, the [𝐶𝑎2+]𝑐𝑦𝑡𝑜 peak from the second 
pulse onward increases with the decrease in 𝒗𝑺𝑬𝑹𝑪𝑨 when [𝐶𝑎
2+]𝐸𝑅0 belows 150 μM and shift 
to decrease with the decrease in 𝒗𝑺𝑬𝑹𝑪𝑨 at higher levels of [𝐶𝑎
2+]𝐸𝑅0 (Figure 4.20 B). 
At both 10 and 100 Hz stimulations, the [𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 ratio increases with 𝑣𝑆𝐸𝑅𝐶𝐴, 
but only increases with [𝐶𝑎2+]𝐸𝑅0 at lower levels of [𝐶𝑎
2+]𝐸𝑅0(Figure 4.21A). This suggests 
that the expression level of SERCA pumps promotes the role as an internal Ca2+ source by ER 
at variouse resting Ca2+ level of ER. Figure 4.21B shows that the results of the RyR opening 
time have simlar pattern to ones of the [𝐶𝑎2+]𝑐𝑦𝑡𝑜 peaks in Figure 4.20, in response to 
different simulation pulses. At 10 Hz stimualtion, lower levels of 𝑣𝑆𝐸𝑅𝐶𝐴 lead to higher levels 
of [𝐶𝑎2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅 when [𝐶𝑎
2+]𝐸𝑅0 belows 150 μM, while, at higer levels of 
[𝐶𝑎2+]𝐸𝑅0, higher levels of 𝑣𝑆𝐸𝑅𝐶𝐴 lead to higher levels of [𝐶𝑎
2+]𝑅𝑦𝑅: [𝐶𝑎
2+]𝑁𝑀𝐷𝐴𝑅. At a 100 
Hz stimualtion,  the RyR opening time generally increases with  [𝐶𝑎2+]𝐸𝑅0 and decreases 
with 𝑣𝑆𝐸𝑅𝐶𝐴.  
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(A). 1 HZ or 1 pulse of multi-pulse stimulation 
  
 
(B). 10 HZ  
 
 
(C). 100 HZ 
 
Figure 4.20. Ca2+ response at various level of [𝑪𝒂𝟐+]𝑬𝑹𝟎 and  𝒗𝑺𝑬𝑹𝑪𝑨 at a (A) 1 Hz (A), 
(B) 10 Hz and (C) 100 Hz stimulation. Figures (B) and (C) show [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks at 
selected stimulation pulse. The colour density represents the values  of  [𝑪𝒂𝟐+]𝒄𝒚𝒕𝒐 peaks 
in the spine head. 
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(A). [𝑪𝒂𝟐+]𝑹𝒚𝑹: [𝑪𝒂
𝟐+]𝑵𝑴𝑫𝑨𝑹 ratio 
 
 
 
(B). RyR opening time 
                   
 
 
Figure 4.21. (A) RyR opening time and (A)[𝑪𝒂𝟐+]𝑹𝒚𝑹: [𝑪𝒂
𝟐+]𝑵𝑴𝑫𝑨𝑹 ratio at various 
levels of [𝑪𝒂𝟐+]𝑬𝑹𝟎 and  𝒗𝑺𝑬𝑹𝑪𝑨. The colour density represents the values  of  the 
[𝑪𝒂𝟐+]𝑹𝒚𝑹: [𝑪𝒂
𝟐+]𝑵𝑴𝑫𝑨𝑹 ratio and the RyR opening time in the spine head, respectively. 
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4.4 Discussion and conclusions 
In this chapter, we use an extended model from the one in Chapter 3 to investigate the effects 
of the alteration of several of the main factors in ER in the postsynaptic response. We look at 
the relationship of Ca2+ transient levels, net ER Ca2+ fluxes, RyR opening and its contribution 
to cytosolic Ca2+ elevation and the relationship between them and selected alterations of ER 
function, as reported in AD. 
The simulation predicts that the ER Ca2+ overload and up-regulation in RyR expression will 
enhance its role as an internal Ca2+ source to amplify the external Ca2+ influx. This is on 
account of the longer open times of RyR or the reduction in Ca2+ uptake by SERCA pumps. 
The increase in RyR response suggests a reduced CICR threshold, which means RyR shows 
higher sensitivity to the NMDAR-mediated Ca2+ signal under these conditions. This alteration 
can promote the processing of amyloid precursor protein (APP) to facilitate the production of 
Aβ peptides (Querfurth, Jiang et al. 1997). In addition, experimental studies suggest that up-
regulation of RyR expression may be a compensatory mechanism to the Ca2+ overload in the 
ER in the early stages of AD (Del Prete, Checler et al. 2014). Our simulation predicts that at 
high levels of ER Ca2+, low levels of up-regulation in RyR expression will increase all 
outputs. However, when the up-regulation in RyR expression is higher, it shows less effect on 
all outputs. This suggests that, although an increase in RyR expression may be beneficial to 
ease the stress of ER from Ca2+ overloading, it may, however, make the cell more vulnerable 
by amplifying the cytosolic Ca2+ level. 
A stimulation frequency-dependant effects in the outputs has been observed when applying 
multiple stimulation pulses at various stimulation frequencies. The overall enhanced effect on 
the postsynaptic Ca2+ response is higher under low-frequency stimulation (10 Hz) in 
comparison with high-frequency stimulation (100 Hz). For example, manipulating the 
selected factors shows no obvious effects on the peak of Ca2+ elevation and maximum 
fraction of RyR opened in response to presynaptic stimulation at 100 Hz from the second 
pulse onward; whereas a clear pattern with the level of selected factors can be observed under 
10 Hz stimulation. This implies that the alteration is more likely to amplify the NMDAR-
mediated Ca2+ signal with a lower frequency and lower amplitude, consistent with the 
experimental observations (Chakroborty, Goussakov et al. 2009). This will affect the basal 
synaptic transmission or may bring the basal synaptic transmission to a long-term depression.  
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Less is studied on the alteration of SERCA pumps than of RyRs and ER Ca2+ load in ER. Green, 
Demuro et al. (2008) and  Brunello, Zampese et al. (2009) suggest opposites effects on SERCA 
pumps by PS and PS mutation in AD. Here, we predict opposite effects by the alteration of 
SERCA pumps in the Ca2+ signalling in the spine head, which shows an interesting  frequency-
dependence. Higher levels of SERCA pumps can increase the Ca2+ uptake by ER. At the same 
time, it leads to a faster refilling of Ca2+ by ER and thus, promotes the Ca2+ release from ER at 
the same time. At high-frequency stimulation, an increase in the level of SERCA pumps causes 
a shorter opening for RyR; however, it speeds up the replenishment of ER with Ca2+, leading 
to a higher Ca2+ release via RyR from ER. Even though the increase in SERCA will lead to an 
exceeding amount of Ca2+ ions removed from the cytosol to ER, this overcomes the effect of 
increasing Ca2+ release by RyR and accounts for the decreasing in the elevation of cytosol Ca2+ 
transients. At low-frequency stimulation, because the Ca2+ influx via NMDAR is lower than at 
high frequency, the Ca2+ uptake by ER enhanced by the upregulation in the SERCA pumps is 
not high enough to compromise the increasing Ca2+ release from ER. Therefore, the cytosolic 
Ca2+ signal is amplified by the upregulation in SERCA pumps.  
The simulation results suggest that inhibit SERCA pumps may rescue the spine head from 
dysregulation in Ca2+ signalling by ER Ca2+ overload. At low-level stimulation, inhibition of 
SERCA pumps will reduce the Ca2+ from ER by attenuating the refilling of Ca2+ by ER. At high 
stimulation, although inhibit SERCA pumps will increase the Ca2+ release from ER, long-term 
inhibition will decrease the Ca2+ load of ER. Besides, Green, Demuro et al. (2008) reported that 
decrease the SERCA function can reduce the production of Aβ, which may be a consequence 
of reduced ER Ca2+ signalling. 
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of synaptic strength, which is believed to contribute to memory formation (Malenka, Nicoll et 
al. 1999). The induction of LTP as a long-lasting increase in synaptic strength requires 
CaMKII activation; however, the mechanism of its maintenance is under debate (Barria and 
Malinow 2005, Lee, Escobedo-Lozoya et al. 2009, Lisman, Yasuda et al. 2012). The 
autophosphorylation of CaMKII, and its translation into the PSD in the CA1 region of 
hippocampal slices, have been observed after NMDAR-mediated Ca2+ transients (Fukunaga, 
Muller et al. 1995, Strack and Colbran 1998, Merrill, Chen et al. 2005). CaMKII is a 
holoenzyme consisting of 12 subunits that are autoinhibited at resting Ca2+ levels. The Ca2+ 
ions entering the cytosol will bind to calmodulin (CaM) to form the fully-bound Ca4CaM 
complex, Ca4CaM, which can activate CaMKII by binding to its CaM footprint. This leads to 
the exposure of the threonine 286 (Thr286) site of CaMKII and the subunit can then be 
autophosphorylated by active neighbouring subunits (Lisman, Schulman et al. 2002). The 
autophosphorylated CaMKII is CaM-independent and shows persistent activity long after the 
Ca2+ transients (Kennedy, Bennett et al. 1990, Hudmon and Schulman 2002).  
The translocation of CaMKII into PSD is also mediated by Ca4CaM. This process is 
reversible, while autophosphorylation of CaMKII at Thr286 can persist its presence in the 
PSD for a longer time. CaMKII in PSD can phosphorylate synaptic AMPARs, which can 
enhance their conductance and increase their numbers in the PSD by mediating their 
trafficking (Lisman, Schulman et al. 2002). This will, consequently, lead to an enhanced 
AMPAR-mediated transmission during LTP (Derkach, Barria et al. 1999). Once the CaMKII 
is translocated into the PSD, it can also bind to synaptic NR2B at the T-site (Bayer, LeBel et 
al. 2006). The CaMKII-NMDAR complex anchors AMPAR by creating new anchoring sites 
for additional synaptic AMPAR (Lisman and Zhabotinsky 2001, Sanhueza and Lisman 2013). 
We do not consider the binding of CaMKII to NR2A-NMDAR because of its lower affinity in 
comparison to NR2B-NMDAR (Barria and Malinow 2005). 
The role of synaptic NR2B in forming CaMKII-NMDAR complex in the PSD is independent 
from its role as a Ca2+ channel (Foster, McLaughlin et al. 2010). Given the dual role of 
NR2B-NMDAR in NMDAR-LTP formation and the differential disturbances in NR2A- and 
NR2B NMDARs in AD, it raises questions: how different disturbances of NMDAR reported 
in AD affect CaMKII ST? Which disturbance predominantly suppresses NMDAR-LTP 
formation? What pathological consequences in AD may these effects link to? To answer these 
questions, we incorporate a CaMKII state transition (ST) model into our Ca2+ model (Figure 
5.1A). In this chapter, we use the term Ca2+ model to refer to the model we present in Chapter 
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3 and 4.The simulation results show that both NR2A- and NR2B-NMDAR are necessary for 
CaMKII ST and it requires cooperation between them. The model provides insights into the 
potential contribution of the different roles of NMDAR in the formation of NMDAR-
mediated-LTP. The simulation results also suggest that the disturbance in synaptic NMDAR 
in AD could be a potential cause of other critical changes in the pathology of the disease, 
which are related to the learning and memory deficit in AD patients. 
In this chapter, we briefly introduce the CaMKII ST model by He, Kulasiri et al. (2015) and 
the integration of it to our Ca2+ model in Section 5.1. In Section5.2, we analyse the 
disturbance of the synaptic NMDAR numbers in the CaMKII-NMDAR complex formation 
and, in Section 5.3, we give a brief discussion and summary of the results. 
 
5.1 Model integration 
5.1.1 CaMKII state transition (ST) model 
The CaMKII ST model developed by He, Kulasiri et al. (2015) simulates the formation of the 
CaMKII-NMDAR complex in PSD in response to presynaptic stimulation. It consists of a 
series of key events: (1) formation of Ca4CaM complex; (2) activation and 
autophosphorylation of the CaMKII subunit; (3) translocation of the CaMKII holoenzyme 
into PSD; and (4) the formation of CaMKII-NMDAR complex in PSD. These events are 
downstream events of Ca2+ influx via NMDAR after stimulation. We have already included 
the event (1) in our Ca2+ model. Therefore, the Ca4CaM complex is a link between our Ca2+ 
model and the CaMKII ST model (Figure 5.1). Besides, the other link between the two model 
is the postsynaptic NR2B-NMDAR, which serves as a Ca2+ channel in the Ca2+ model and as 
a CaMKII binding partner in the CaMKII ST model. The complete CaMKII ST model and the 
parameters are in Appendix H. 
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Figure 5.1. Schematics of the model integration. Schematic diagram of the CaMKII state 
transition (ST) model. (He, Kulasiri et al. 2015) 
 
5.1.2 Adjustments and testing for model integration 
The stimulation patterns used in the CaMKII ST model are a tetanus of 100 pulses at low-
frequency (1, 10 Hz) and high-frequency (100 Hz), respectively. The Ca2+ dynamics in the 
dendritic spine ([𝐶𝑎2+]𝑐𝑦𝑡𝑜) in response to a stimulation tetanus is governed by 
 [𝐶𝑎2+]𝑐𝑦𝑡𝑜 = [𝐶𝑎
2+]𝑟𝑒𝑠𝑡 + 𝐴∑exp (−
𝑖
𝑓𝜏
)
𝑛
𝑖=1
 (5.1) 
where [𝐶𝑎2+]𝑟𝑒𝑠𝑡 is the cytosolic Ca
2+ concentration at the resting level, 𝐴 is the amplitude of 
Ca2+ concentration induced by one stimulation pulse, 𝜏 is the decay time constant, 𝑓 is the 
stimulation frequency and 𝑛 is the total number of the stimulation pulses (Zhabotinsky 2000). 
The intracellular Ca2+ dynamics in response to a 100-pulse tetanus at 100 Hz is in Figure 5.2 
A. The Ca2+ level increases with time during the stimulation until it reaches a maximum level 
of about 20 μΜ, and after the last pulse, it decreases exponentially back to the resting level 
exponentially (τ = 200 ms). We apply a high-frequency presynaptic stimulation (HFS; 100 
pulses at 100 Hz) and a high-frequency presynaptic stimulation paired with postsynaptic 
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stimulation (pairing HFS; 100 pulses at 100 Hz) to our Ca2+ model, respectively, and the 
results of the Ca2+ dynamics are shown in Figure 5.2 B. We use a paired pre/postsynaptic 
stimulation protocol because experimental evidence showed that postsynaptic membrane 
depolarisation triggered by presynaptic stimulation alone was not sufficient to induce LTP 
(Pike, Meredith et al. 1999, Mansvelder and McGehee 2000). Paired stimulation at both the 
presynaptic and postsynaptic neurons are used to create pairing of the EPSP and the bAP, 
which leads to a large depolarisation and Ca2+ elevation by NMDAR in the postsynaptic spine 
head (Caporale and Dan 2008). When simulate the pairing HFS protocol, a 2 ms-delayed bAP 
is introduced after each presynaptic stimulus pulse (the fomula for bAP was introduced in 
Chapter 3). 
The result produced by Eq. (5.1) did not show any desensitisation of NMDARs (Figure 5.2 
A). This may be because of assumptions that NMDARs are not the major Ca2+ channels, or 
that NMDARs recover from desensitisation completely between two pulses. Both of these 
assumptions conflict with the setting of our model that NMDARs are the major Ca2+ channels 
in the spine head and the experimental observation that both NR2A-NMDAR and NR2B-
NMDAR will be desensitised under high-frequency stimulation (Erreger, Dravid et al. 2005). 
The Ca2+ response of Ca2+ model to HFS and pairing HFS reaches a peak level, decreases, 
then stays on a plateau at a lower level until the end of stimulation, which reflects the large 
desensitisation of synaptic NMDAR by high-frequency stimulation (Figure 5.2 B).  Under the 
HFS, the elevation in [𝐶𝑎2+]𝑐𝑦𝑡𝑜 in much less than in the original Ca
2+ reponse. In contrast, 
under the pairing HFS, although the peak level of [𝐶𝑎2+]𝑐𝑦𝑡𝑜 can be above 40 μM and is 
higher than in the maximum [𝐶𝑎2+]𝑐𝑦𝑡𝑜 fo the original Ca
2+ response (around 20 μM), the 
plateau level (around 5 μM) is much lower than of the original response during the same 
stimulation time period. 
We next compare the levels of the CaMKII-NMDAR complex in the original and our Ca2+ 
results. Before simulation, we have made several adjustments before connecting the Ca2+ 
model to the CamKII ST model. In the CaMKII ST model all proteins are in units of particle 
numbers (#). The time-dependent changes in the concentration of these proteins are calculated 
in particle numbers and all concentration-based rate constants are in #-1s-1. Therefore, we 
convert the Ca4CaM concentration (in μΜ) from Ca2+ model into particle numbers (in #) 
before calculating the translocation of CaMKII. The conversion is according to the following 
formula 
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𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒 𝑛𝑢𝑚𝑏𝑒𝑟 = 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 ×  𝑁𝐴 ×  𝑉𝑜𝑙, 
where NA is the Avogadro constant (6.022140857×10
23 mol−1) and 𝑉𝑜𝑙 is the volume of the 
spine head (0.1fL). 
The rate constants used in the CaMKII ST model are based on 37°C, therefore, we adjust 
them to 34°C using a Q10 of 2.15 (Chiba, Schneider et al. 2008) to be consistent  with the 
conditions in the  previous chapters. The details of temperature correction on reaction rate 
constants are in Section 3.2.1. The simulation results of CaMKII ST model show a minor 
difference in the level of CaMKII-NMDAR complex formation at 34°C and 37°C (Figure 5.2 
C). 
Furthermore, we adjust the NR2B number in the CaMKII ST model from 20 to 8, which is the 
standard value based on our previous assumptions in Chapter 3. This decreases the level of 
the CaMKII-NMDAR complex by CaMKII ST model at t =300s by 1 (Figure 5.2 C). In 
contrast, the level of the CaMKII-NMDAR complex by our Ca2+ model in response to pairing 
HFS is about  0.7 (Figure 5.2 D) lower than in response to the original Ca2+ input (Figure 5.2 
C). The difference is because a larger fraction of NMDARs are desensitised during pairing 
HFS and this leads to fewer Ca2+ ions entering the spine than the original input in CaMKII 
ST. There is no CaMKII-NMDAR formation in response to presynaptic HFS alone, because 
fo the insufficient amount of Ca2+ ion entered into the cytosol. 
Moreover, we also use theta-burst stimulation (TBS) as an optional stimulation protocol in 
this chapter (See Appendix G.1 for the detail of TBS). In a train of TBS, pulses are grouped 
into several bursts, and the time duration (200 ms) between two bursts allows desensitised 
NMDARs to partially recover. TBS is considered to be a more physiologically relevant 
stimulus, which is close to the frequency of the endogenous hippocampal rhythm that triggers 
LTP (Lee, Barbarosie et al. 2000, Raymond 2007). One train of TBS consists of 10 stimulus 
bursts at 5 Hz (200 ms separation between bursts) and each burst consists of four pulses at 
100 Hz. A 2 ms-delayed bAP is introduced into the model after each presynaptic stimulus 
pulse. Four trains of TBS are delivered at 0.1 Hz (10 s separation between trains), which is 
used to induce LTP experimentally (Lee, Barbarosie et al. 2000). The changes of Ca2+ level in 
the spine head by four trains of TBS and the corresponding production of CaMKII-NMDAR 
complex are shown in Figure 5.2 E and Figure 5.2 F, respectively. The level of the CaMKII-
NMDAR complex shows a good agreement to that produced by the original Ca2+ input 
(Figure 5.2C).  
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(A     (B 
 
(C)      (D) 
        
(E)      (F) 
  
Figure 5.2. Ca2+ elevation and CaMKII-NMDAR complex formation in the spine head in 
response to presynaptic stimulation. Ca2+ dynamics in the spine head in response to Ca2+ 
by Eq. (5.1) (A), HFS and paring HFS (B) and 4 trains of TBS (E), respectively, and the 
coresponding CaMKII-NMDAR complex production (C, D and F). 
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5.2 Computational experiments  
In this section, we mimic disturbances in the availability of synaptic NMDAR in AD to 
investigate the consequential effects on CaMKII ST and study the contribution of NMDARs 
with different subunit compositions in CaMKII ST. For each experiment, we run the model 
under 1 s of pairing HFS (100 pulses at 100 Hz) and 4 trains of paring TBS (4 TBS), 
respectively. In both stimulation protocols, a 2 ms-delayed bAP is introduced into the model 
after each presynaptic stimulus pulse. All simulations are run for 300 s. 
After each simulation, we collect the Ca2+ elevation in the spine head ([Ca2+]spine) and 4 key 
outputs from the downstream events as following: 
(1) Numbers of Ca4CaM complexes. This is a determining factor for CaMKII activation and, 
subsequently, autophosphorylation. 
(2) Numbers of autophosphorylated CaMKII subunits. Because once a CaMKII is 
autophosphorylated, its activity is independent from CaM and it shows persistent activity 
after the removal of stimulation. This is critical for the induction and maintenance of LTP, 
which requires a much longer time course in comparison with the stimulation. 
(3) Numbers of CaMKII in PSD. Because CaMKII needs to be translocated into the PSD to 
affect its target, AMPAR, and bind to NR2B-NMDAR, once a CaMKII enters into the 
PSD, its autophosphorylation is suggested to be irreversible (Mullasseril, Dosemeci et al. 
2007). The level of translocated CaMKII can be an indicator of the potential ability to 
form CaMKII-NMDAR complexes. 
(4) Numbers CaMKII-NMDAR complex in PSD at time t = 300 s. The persistent localisation 
of CaMKII in PSD is suggested to be a critical factor for LTP induction and maintenance, 
and NR2B may play a key role in the synaptic CaMKII maintenance and recruitment 
(Bayer, LeBel et al. 2006). Therefore, the level of CaMKII-NMDAR complex numbers is 
an important output that can provide insights into the induction and maintenance of 
NMDAR-LTP.  
5.2.1 NR2A/NR2B-NMDAR 
The numbers of NR2A-NMDAR and NR2B-NMDAR in PSD under healthy conditions are 
assumed to be 12 and 8, respectively, to be consistent  with the conditions in the previous 
chapters. We decrease the number of one of them from the standard value to zero to mimic 
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the increasing degree of reduction in the availability of a particular NMDAR type in the PSD. 
Reduction in the numbers of NR2A-NMDAR in PSD greatly reduces the maximum amplitude 
of Ca2+ elevation during the first 10 stimulation pulses of pairing HFS, and this effect 
diminishes as more pulses arrive (Figure 5.3 A). The decrease in the Ca2+ elevation level 
during first few stimulation pulses reduces all the other four outputs (Figure 5.3 B). The 
amplitudes of Ca2+ elevation in response to 4 TBS show similar decreases with the degree of 
reduction in the NR2A-NMDAR number (Figure 5.4 A). During both stimulation protocols, a 
50% reduction (6 NR2A-NMDAR left in the PSD) can block all downstream events (Figure 
5.3 C and Figure 5.4 C). Especially, the formation of CaMKII-NMDAR is mostly sensitive to 
NR2A-NMDAR reduction, a 25% reduction (9 NR2A-NMDAR left in the PSD) can lead to 
no production of CaMKII-NMDAR. Even 8% reductions (11 NR2A-NMDAR left) can 
reduce the level of CaMKII-NMDAR formation by 60% (pairing HFS; Figure 5.3 B and 
Figure 5.3 C) and 75% (4 TBS; Figure 5.4 B and Figure 5.4 C), respectively. 
In contrast, a reduction in NR2B-NMDAR numbers affects all outputs more lightly than the 
reduction in NR2A-NMDAR numbers. Even when reducing the NR2B-NMDAR from 8 to 1 
(88% reduction), the amplitude of Ca2+ elevation only decreases by about 35% (from 42 μM 
to 27.3 μM) (Figure 5.5 A and Figure 5.6 A). This decrease is not able to fully block most 
downstream events, except for the formation of CaMKII-NMDAR complex(Figure 5.5 C and 
Figure 5.6 C). The level of Ca4CaM formation, CaMKII autophosphorylation and 
translocation are reduced by about 65%, 78 % and 75%, respectively (Figure 5.5 B and C and 
Figure 5.6 B and C). The formation of CaMKII-NMDAR complex is largely reduced by the 
reduction in NR2B-NMDAR numbers, that reduce the NR2B-NMDAR numbers by 50% 
leads to a 70% reduction in the final level CaMKII-NMDAR complex at t =300 s. 
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(A). Ca2+ response to pairing HFS 
 
 
(B) 
 
 
(C) 
 
 
Figure 5.3. Effects of reduction in NR2A-NMDAR numbers in response to pairing HFS. 
(A) Ca2+ responses in spine head and (B) four outputs from downstream events with a 
different level of reduction in NR2A-NMDAR. (C)The relationship between the 
reduction level in NR2A-NMDAR numbers and selected typical values of the outputs. 
The results are normalised to those at the healthy condition (NR2A-NMDAR = 12; 0% 
reduction). 
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(A). Ca2+ response to 4 TBS 
 
(B) 
 
 
(C) 
 
 
Figure 5.4. Effects of reduction in NR2A-NMDAR numbers in response to 4 TBS. (A) 
Ca2+ responses in spine head and (B) four outputs from downstream events with a 
different level of reduction in NR2A-NMDAR. (C)The relationship between the 
reduction level in NR2A-NMDAR numbers and selected typical values of the outputs. 
The results are normalised to those at the healthy condition (NR2A-NMDAR = 12; 0% 
reduction).  
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(A). Ca2+ response to pairing HFS 
 
(B) 
 
(C) 
 
 
Figure 5.5. Effects of reduction in NR2B-NMDAR numbers in response to pairing HFS. 
(A) Ca2+ responses in spine head and (B) four outputs from downstream events with a 
different level of reduction in NR2B-NMDAR. (C)The relationship between the 
reduction level in NR2B-NMDAR numbers and selected typical values of the outputs. 
The results are normalised to those at the healthy condition (NR2B-NMDAR = 8; 0% 
reduction).  
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(A). Ca2+ response to 4 TBS (first three bursts) 
 
(B)
 
(C) 
 
 
 
Figure 5.6. Effects of reduction in NR2B-NMDAR numbers in response to 4 TBS. (A) 
Ca2+ responses in spine head (only first three bursts are shown here to display the 
difference clearly). (B) Four outputs from downstream events with a different level of 
reduction in NR2B-NMDAR. (C)The relationship between the reduction level in NR2B-
NMDAR numbers and selected typical values of the outputs. The results are normalised 
to those at the healthy condition (NR2B-NMDAR = 8; 0% reduction).  
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5.2.2 The ratio of NR2B:NR2A 
The ratio of NR2A- to NR2B-NMDAR (NR2A/NR2B ratio) is precisely regulated by the 
production, trafficking and degradation of NMDARs, and the different ratios are linked to the 
preferences in the induction of different types of synaptic plasticity (Yashiro and Philpot 
2008). Therefore, we investigate the effects of a disturbance on the NR2A/NR2B ratio in the 
CaMKII-NMDAR complex formation by keeping the total number of NMDARs in PSD 
constant (20 NMDARs) and varying the NR2A/NR2B ratio from 1: 19 to 19:1. 
The amplitude of [Ca2+]spine by stimulation increases with the NR2A/NR2B ratio (Figure 5.7A 
and Figure 5.8 B). When the NR2A/NR2B ratio belows 6:14, the peak [Ca2+]spine in responses 
to each stimulation pulse are the same, and are less than with the standard NR2A/NR2B ratio 
(12:8). Productions of the other four outputs are blocked when the NR2A/NR2B ratio belows 
6:14 (Figure 5.7 B and C and Figure 5.8 B and C). With the increase in the NR2A/NR2B ratio 
peak levels of all outputs, but not the production of CaMKII-NMDAR complex, rise with 
different slopes in response to a pairing HFS (Figure 5.7). The results from the 4TBS 
simulation show similar trends, but higher increases in comparison with the ones from the 
pairing HFS (Figure 5.8C). In contrast, the normalised final level of CaMKII-NMDAR after 
stimulation increases to a maximum level of 1.69 (pairing HFS) and 2.04 (pairing TBS), 
respectively, at the NR2A/NR2B ratio of 15:5, and decreases afterwards (Figure 5.9). This  
suggests the existence of an optimal NR2A/NR2B ratio in generation CaMKII-NMDAR 
complex. 
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(A). Ca2+ response to pairing HFS 
 
 
(B)
(C) 
 
 
Figure 5.7. Effects of variation in the NR2A/NR2B ratio in response to pairing HFS. (A) 
Ca2+ responses in spine head and (B) four outputs from downstream events with 
different NR2A/NR2B ratio. (C)The relationship between the NR2A/NR2B ratio and 
selected typical values of the outputs. The results are normalised to those at the healthy 
condition (NR2A-NMDAR:NR2B-NMDAR = 12:8). 
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(A). Ca2+ response to 4 TBS (first three bursts) 
 
(B)
 
(C) 
 
 
Figure 5.8. Effects of variation in the NR2A/NR2B ratio in response to 4TBS. (A) Ca2+ 
responses in spine head (only first three bursts are shown here to display the difference 
clearly). (B) Four outputs from downstream events with different NR2A/NR2B ratio. 
(C)The relationship between the NR2A/NR2B ratio and selected typical values of the 
outputs. The results are normalised to those at the healthy condition (NR2A-
NMDAR:NR2B-NMDAR = 12:8). 
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Figure 5.9. Effect of variation in the NR2A/NR2B ratio on the level of CaMKII-NMDAR 
complex production. 
 
5.3 Discussion and summary 
In this chapter, we extend our Ca2+ model presented in the previous chapter with a CaMKII 
TS model, to investigate the roles of NMDARs in Ca2+ transients in the dendritic spine head 
and the subsequent CaMKII TS in response to repeated paired pre/postsynaptic stimulation. 
We simulate the model under the conditions of the dysregulated level of NMDARs to study 
their role as Ca2+ channels (NR2A- and NR2B-NMDAR) and as a scaffold in PSD to anchor 
CaMKII. We also predict their contributions to a series of selected downstream events leading 
to CaMKII-NMDAR complex formation. The simulation results of the levels of the selected 
outputs are useful to gain insights into the different contributions of NR2A- and NR2B-
NMDAR in the induction of LTP and the ability for maintenance later on. It also helps us to 
better understand the potential outcomes of the disturbances in NMDAR observed in AD and 
to explain the possible linkages between those disturbances and the pathology of the disease. 
Simulation of the reduction in NR2A- and NR2B-NMDAR show negative effects on the 
activation, autophosphorylation and translocation of CaMKII and the formation of CaMKII-
NMDAR complexes at different degrees. This suggests that both types of NMDAR are 
necessary for LTP formation, while contributing to its induction and maintenance in different 
ways. Specifically, the role of NR2A-NMDARs is to allow sufficient Ca2+ influx to trigger 
the downstream Ca2+-CaM interaction, which determines the activation of CaMKII. NR2B-
NMDAR contributes less as a Ca2+ channel than NR2A-NMDAR and itself alone is 
insufficient to trigger the activation of CaMKII. However, it is required to function as a 
scaffold in PSD that anchors CaMKII by forming a CaMKII-NMDAR complex. This is 
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consistent with the experimental findings and hypothesis that the opening of NR2B-NMDAR 
may not be necessary for LTP induction (Kim, Dunah et al. 2005, Foster, McLaughlin et al. 
2010). Simulation with different NR2A/NR2B ratios suggests that although a high 
NR2A/NR2B ratio facilities activation, autophosphorylation and translocation of CaMKII, it 
still requires a certain level of NR2B-NMDAR to anchor CaMKII in the PSD. Overall, these 
results provide a clearer picture that NMDAR-LTP may require cooperation between the 
NR2A- and NR2B-NMDAR. 
The internalisation of synaptic NMDAR seen in AD (Snyder, Nong et al. 2005, Li, Jin et al. 
2011) could underly some of the critical alterations in the pathology of the disease. For 
instance, in AD transgenic mice, it has been observed that Aβ can alter the CaMKII 
distribution and reduce the synaptic CaMKII level, which may be the mechanism by which 
Aβ induces the loss of synaptic AMPARs (Gu, Liu et al. 2009). It is unclear how the 
distribution of CaMKII is altered by Aβ. Here, the simulation results predict that a reduction 
in synaptic NMDARs by Aβ can reduce the CaMKII-NMDAR formation in PSD by affecting 
the upstream Ca2+ response to stimulation or the scaffold function of NR2B-NMDAR. 
Consequently, this may contribute to the deficits of LTP  and loss of synapse in AD 
(Townsend, Mehta et al. 2007, Koffie, Hyman et al. 2011). 
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stimulations in comparison to the resting level. The model also predicts that the internalisation 
of synaptic NR2B-NMDAR has fewer effects on the synaptic Ca2+ response in comparison to 
the internalisation of synaptic NR2A-NMDAR, suggesting the dysregulation by synaptic 
NR2B-NMDAR internalisation observed in the AD condition may be because of disturbances 
in the other roles of NR2B-NMDAR. 
Furthermore, we use PRCC to analyse the global sensitivities of these parameters and predict 
the most vulnerable target of Aβ to disturb the postsynaptic Ca2+ response. The results suggest 
that the glutamate amount released by presynaptic stimulation is the most sensitive factor and 
an Aβ-induced increase in synaptic glutamate release may play a major role in the 
overexcitation and Ca2+ overload of postsynaptic neurons in comparison to other factors in 
our test. 
The second objective is to investigate the effects of disturbances of ER Ca2+ handling in AD 
on the NMDAR-mediated Ca2+ dynamics in the spine head (Chapter 4). We extend the Ca2+ 
model by adding the internal ER components. We use this model to investigate effects in the 
postsynaptic Ca2+ response by three reported alterations in AD: (1) ER Ca2+ overload; (2) 
upregulation of RyR; and (3) disturbances of SERCA pumps in ER. We analyse and compare 
the contributions of ER in the postsynaptic Ca2+ response between the healthy condition and 
the AD condition. The simulation predicts both an ER Ca2+overload and RyR upregulation 
will promote Ca2+ release from the ER over Ca2+ uptake and amplify the external Ca2+ signal. 
Multipulse simulations at different  frequencies show a frequency-dependant effect on the 
postsynaptic response.The model also predicts and suggests that inhibition of the SERCA 
pumps may protect the spine head from Ca2+ dysregulation by an ER Ca2+ overload. 
The third objective is to investigate the effects of Ca2+ dysregulation in one of the key 
downstream events, CaMKII-NMDAR complex formation (Chapter 5). We add a CaMKII ST 
model  (He, Kulasiri et al. 2015)  downstream of our Ca2+ model to study the different roles of 
NMDARs collectively. We simulate conditions that alter the availability of different types of 
synaptic NMDAR and in the ratio of NR2A- to NR2B-NMDAR and analyse their effects on 
the Ca2+ response and CaMKII state transition. The model predicts that a reduction in NR2A-
NMDAR predominantly decreases the postsynaptic Ca2+ elevation and subsequent CaMKII 
state transition while a reduction in NR2B-NMDAR mostly only affects the CaMKII-
NMDAR complex formation. Simulations with changes in the ratio of NR2A- to NR2B-
NMDAR suggest cooperation between the two is required for LTP induction.  
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6.2 Contributions 
The major contributions of this thesis are: 
 Development of an integration model representing an average CA1 pyramidal 
dendritic spine, with and without the presence of the ER component. 
 Advancement of our understanding of Aβ-dependent disturbances in NMDAR-
mediated Ca2+ dynamics in the dendritic spine. Predict the most vulnerable target of 
Aβ among those that affect the Ca2+ response in the synaptic spines. 
 Advancement of our understanding of the effects of ER dysfunction under the AD 
condition in response to NMDAR-mediated Ca2+ elevation in the dendritic spine. 
 Extendsion of the Ca2+ model with a state transition model of CaMKII to advance our 
understanding of the subunit-specific roles of NMDAR in the postsynaptic response 
and CaMKII state transition.  
 Prediction of the consequences of the internalisation of NMDAR with different 
subunit compositions as seen in AD in NMDAR-LTD induction and maintenance. 
Revelation that cooperation and a balance between NR2A- and NR2B-NMDAR is 
necessary for NMDAR-LTD. 
 
6.3 Policy Implication 
A number of therapy research on the AD is mainly focused on reducing the concentration of 
Aβ or inhibiting Ca2+ overload of a neuron. For example, memantine is one of the popular 
drugs that is used to block NMDARs, however, there are adverse effects that could arise in 
both the brain and the body (Areosa et al, 2005). Our research suggests that selective 
inhibition on the internalisation of synaptic NR2B-NMDARs in AD can be a useful 
therapeutic approach that may prevent the loss of synapses and memory decline. Besides, the 
extracellular glutamate concentration could be an indicator of AD and therapeutic research 
can be carried out on controlling the extracellular glutamate level to avoid the excess 
activation of  extrasynaptic NMDARs. 
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6.4 Future Directions 
We suggest several future directions that can follow the current work: 
 Release of glutamate vesicles from the presynaptic terminal induced by APs is a 
highly stochastic process and is mediated by different functional pools, Ca2+ dynamics 
in the presynaptic terminal and the frequency of APs (Nadkarni, Bartol et al. 2010, 
Alabi and Tsien 2012). It is very unlikely that each presynaptic stimulation can 
successfully induce a vesicle release under certain conditions, such as readily 
releasable pool size is very small. Therefore, a model of the vesicle release probability 
can be add to the upstream of our Ca2+ model to decide whether there is a release 
event in response to each presynaptic stimulation at various frequencies. 
 The dendritic spines are remarkably dynamic over time, and the morphology of spines 
can be altered by synaptic activity (Hering and Sheng 2001, Holtmaat, Wilbrecht et al. 
2006, Roberts, Tschida et al. 2010). In this research, we fix the geometry of the 
dendritic spine to represent an average CA1 pyramidal dendritic spine. Therefore, the 
model can be extended by taking consideration of the variation  and changes in the 
geometry of the spine, to test how it will affect the results. 
 The modelling strategies in this research are all based on deterministic approaches. 
However, the Ca2+ dynamics in the dendritic spine are actually stochastic in realistic 
biological systems, because of its small volume and the low copy numbers of the 
reactants in it. For instance, the concentration of Ca2+ near its channels may be at a 
higher level than other sites when taking Ca2+ diffusion into account (Keener 2006). 
Therefore, instead of simulating the diffusion of glutamate and Ca2+ using PDE or  
between neighbouring compartments, stochastic modelling, such as a Brownian 
motion random walk, can be applied (Grewer, Gameiro et al. 2008). Morover, the 
binding of ligands to a single receptor can be treated stochastically. 
 The dendritic shaft compartments can be extended and modified to study Ca2+ 
dysregulation in the dendrites in AD. IP3R can be included because it is an important 
factor in Ca2+ oscillation and propagation in the dendrites (Bezprozvanny 2005), and 
under AD conditions, a disturbance in IP3R has been reported (see Section 2.2.4). 
Another factor related to ER Ca2+ handling is the store-operated Ca2+ channels, which 
are also reported to be affected in AD. Therefore, these two aspects can be added to 
the ER component in the dendritic compartment in a future study. 
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 Ca2+-sensitive phosphatase 2B (PP2B) is sensitive to Ca2+ more than CaM and 
indirectly contributes to the dephosphorylation of CaMKII (Klee 1991, Colbran 2004). 
PP2B activity is found to increase in the aging brain and the presence of Aβ can 
further increase its activity (Zhao, Watson et al. 2004, O'Dwyer, Lamberton et al. 
2012). This may because of the alteration in the NMDAR-induced Ca2+ influx by Aβ, 
and, consequently, it impairs NMDAR-LTP induction (Chen, Wei et al. 2002). 
Therefore, the model of Ca2+ dynamics and CaMKII ST in Chapter 5 can be extended 
to incorporate PP2B to investigate the Aβ disturbance in NMDAR-LTP.   
6.5 Conclusions 
The Ca2+ dysregulation reported in AD can be a result of alterations of multiple factors in 
Ca2+ signalling. It is important to understand how these alterations individually and collectively 
affect the system. However, it is challenging and expensive to study these effects 
experimentally. Mathematical modelling and computational simulation provide great 
opportunities to explore the network and investigate the dysregulations by conducting 
simulation experiments with models. In this thesis, we develop an integration mathematical 
model of  a CA1 pyramidal dendritic spine and investigate the various alterations that are 
reported in AD. We analyse the Ca2+ response in the spine head at different levels for each 
alteration. We also extend our study by including an important Ca2+ downstream event, the 
CaMKII state transition, in the induction of LTP. We use the model to investigate how 
alterations in the different composition of NMDARs affect the Ca2+ responses as well as the 
autophosphorylation, and the formation of CaMKII-NMDAR and to provide important insights 
into how NMDAR-mediated LTP gets disturbed in AD. 
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Appendix A. Simulation tools  
Table A. 1. Simulation tools 
A. General purpose simulation tools 
Tool Freeware Website 
MATLAB  http://www.mathworks.com 
Mathematica  http://www.wolfram.com/mathematica 
Python √ https://www.python.org 
XPPAUT √ https://www.math.pitt.edu/~bard/xpp/xpp.html 
 
 
B. Biological specific simulation tools 
Tool 
Simulation algorithm Interface for 
model 
development 
Freeware Website 
Deterministic Stochastic 
CellDesigner √  GUI √ 
http://www.celldesig
ner.org 
COPASI √  GUI √ 
http://www.copasi.or
g 
VCell √ √ GUI √ 
http://www.nrcam.uc
hc.edu 
MCell  √ CellBlender √ http://www.mcell.org 
Smoldyn  √ CLI √ 
http://www.smoldyn.
org 
STEPS  √ Python √ 
http://steps.sourcefor
ge.net 
Chemesis √  GENESIS √ 
http://krasnow1.gmu.
edu/CENlab/software
.html 
MOOSE √ √ Python √ 
http://moose.ncbs.res
.in 
NEURON √ √* 
GUI; 
CLI 
√ 
http://www.neuron.y
ale.edu 
NeuroRD  √ xml files √ 
http://krasnow1.gmu.
edu/CENlab/software
.html 
*Channel states and total conductance can be deterministic or stochastic (Brette, Rudolph et 
al. 2007). 
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(A) 
 
 
(B) 
 
Figure A. 1. Interface captures of simulation tools. Biological simulation tools (e.g., 
CellDesigner) with user-friendly GUI allow users to draw biochemical networks of their 
model (A, left) and run models with simulation control panel (A. right). Neuronal 
simulation tools (e.g., NEURON (B)) provide several built-in builders, with which users 
can set the precise parameters of neuronal specific features for their model. (A) 
CellDesigner interface capture for a sample model (MAPK.xml). (B) NEURON interface 
capture of a sample demonstration of a hippocampal pyramidal neuron. All sample 
models in this figure are pre-assembled in these software. 
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Appendix B. Glutamate Diffusion Model 
B.1 Fick’s first law 
Adolf Fick was the first one to describe diffusion process quantitatively (Fick 1855). Fick's 
first law states that the diffusion flux is proportional to the concentration gradient and the rate 
of concentration change at a point in space is proportional to the second derivative of 
concentration with space. For example, Fick’s law in one dimension is: 
𝐽(𝑥, 𝑡) = −𝐷
𝜕𝐶(𝑥, 𝑡)
𝜕𝑥
, 
(B. 1) 
where 𝐽(𝑥, 𝑡) is the diffusion flux (the amount of a substance crossing through a unit area per 
unit time), D is the diffusion coefficient, 𝐶(𝑥, 𝑡) is the concentration of substance at position x 
at time t. The negative sign before D denotes the diffusion is from a higher concentration to a 
lower one.  
Consider the diffusion space is separated into a series of compartments. In each compartment, 
the substance is well mixed. Therefore, its concentration in compartment i is changed by the 
diffusion between neighbour compartments i-1 and i+1: 
𝑑𝐶𝑖
𝑑𝑡
=
𝐽𝑖,𝑖−1 + 𝐽𝑖,𝑖+1
𝑉𝑖
= −
𝐷
𝑉𝑖
[(
𝐴
𝛿
)
𝑖,𝑖−1
(𝐶𝑖 − 𝐶𝑖−1) − (
𝐴
𝛿
)
𝑖+1,𝑖
(𝐶𝑖+1 − 𝐶𝑖)], 
(B. 2) 
where (
𝐴
𝛿
)
𝑝,𝑞
=
𝐴𝑝𝑞 
∆𝑙𝑝𝑞
 describes the movement of Ca2+ ions from compartment 𝑝 to 𝑞, 
where 𝐴𝑝𝑞 is the cross-sectional area of the two compartments and ∆𝑙𝑝𝑞 is the distance 
between the midpoints of compartments 𝑝 and 𝑞.  
B.2 Diffusion inside the synaptic cleft 
The synaptic cleft is divided into N concentric cylindrical rings, with a thinness of ∆𝑅=20 nm. 
Therefore, the dynamics of glutamate in the i-th ring is  
𝑑[𝐺𝑙𝑢𝑖]
𝑑𝑡
= −
DGlu
𝑉𝑖
[(
𝐴
𝛿
)
𝑖,𝑖−1
([𝐺𝑙𝑢𝑖] − [𝐺𝑙𝑢𝑖−1]) – (
𝐴
𝛿
)
𝑖+1,𝑖
([𝐺𝑙𝑢𝑖+1]
− [𝐺𝑙𝑢𝑖𝑖−1])], 
(B.3) 
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where 𝑉𝑖 = ℎ𝜋[(∆𝑅𝑖]
2 − ℎ𝜋[(∆𝑅(𝑖 − 1)]2 and (
𝐴
𝛿
)
𝑝,𝑞
=
2ℎ𝜋∆𝑅𝑞
∆𝑅
. 
B.3 Diffusion in the extrasynaptic space 
Diffusion in the extrasynaptic space is modified from the model of Rusakov (2001). The 
coordinate origin is set at the centre of synaptic cleft, the space compartments runs in the 
radial direction with step ∆𝑅2 and in the tangential direction with an angular step ∆𝜃 (Figure 
D.1). Each ring-shaped (i,j)-th compartment have four interfaces with adjacent compartments. 
In the tangential direction, the interface area is 𝑆𝑇(𝑖, 𝑗) = 2𝜋𝑖∆𝑅2𝑠𝑖𝑛𝜃(𝑗)∆𝜃. In the radial 
direction, the interface are is 𝑆𝑅(𝑖, 𝑗) = 2𝜋(𝑖∆𝑅2)
2[𝑐𝑜𝑠𝜃(𝑗) − 𝑐𝑜𝑠𝜃(𝑗 − 1)]. Its compartment 
volume is V(𝑖, 𝑗) =
1
2
[ 𝑆𝑇(𝑖, 𝑗) + 𝑆𝑇(𝑖 − 1, 𝑗)]∆𝑅2. In our simulation, ∆𝑅2 = 20 nm and ∆𝜃 =
𝜋
9
. 
The dynamic of gluatamate concentraiton in compartment (i,j) is 
𝑑[𝐺𝑙𝑢𝑖,𝑗]
𝑑𝑡
= −
DGlu
∗
𝑉𝑖,𝑗
(∑𝐽𝑅(𝑖, 𝑗)𝑆𝑅 +∑𝐽𝑇(𝑖, 𝑗) 𝑆𝑇), 
(B.3) 
where DGlu
∗is the effective diffusion coefficient in the extrasynaptic space,  ∑ 𝐽𝑅(𝑖, 𝑗) and 
∑ 𝐽𝑇(𝑖, 𝑗) are the summation of fluxes through radial and tangetial interfaces, respectively. 
The diffusion fluxe between two adjacent compartment n and n+1 can be calculated  calculate 
them using the Fick’s ist law (Eq. (B.2)) and obtain: 
𝐽𝑛,𝑛+1 =
1
𝛿𝑛,𝑛+1
([𝐺𝑙𝑢
𝑛
] − [𝐺𝑙𝑢
n+1
]), 
where 𝛿𝑛,𝑛+1 is the spatial distance between compartment n and n+1.  
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Appendix C. Mathematical expressions for rate laws 
C.1 Mass Action Based Models 
The law of mass action is a fundamental law of a chemical reaction, which defines that the 
rates of a chemical reation at constant temperature are proportional to the product of the 
reactant concentrations (Guldberg and Waage 1864). A signle step reaciton follows the mass 
action kinetics is called elementary reaction. Based on the number of reactant species, there 
are unimolecular, bimolecular and termolecular reactions. For example, the following simple 
bimolecular elementary reation: 
 𝐴 + 𝐵
𝑘
→𝐶, (C. 1) 
where A and B are the reactants, C is the product and 𝑘 is the reaction rate constant or 
proportionality rate. Based on the law of mass action, the rate of this reaction, 𝑉, is 
propotional to [A][B],  and therefore,  
  𝑉 = 𝑘[𝐴][𝐵], (C. 2) 
where [A] and [B] represent the concentrations of reactant A and B, respectively. (In the 
following section, we use [x] to denote the concentration of x). The concentration changes of 
A, B and C over time can be described by a set of differential equations (ODEs): 
 
𝑑[𝐴]
𝑑𝑡
= −𝑘[𝐴][𝐵] = −𝑉, (C. 3) 
 
𝑑[𝐵]
𝑑𝑡
= −𝑘[𝐴][𝐵] = −𝑉, 𝑎𝑛𝑑 (C. 4) 
 
𝑑[𝐶]
𝑑𝑡
= 𝑘[𝐴][𝐵] = 𝑉. (C. 5) 
An elementary reaction can be reversible, such as the following reaction 
 𝐴 + 𝐵
𝑘1; 𝑘−1
↔    𝐶 (C. 6) 
can be treated as two simultaneous reactions: one forward and one backward reaction, where 
𝑘1 and 𝑘−1 denote the forward and backward reaction rate constants, respectively. According 
to the law of mass action, the forward reaction rate, 𝑉1, is  
164 
 
 
 𝑉1 = 𝑘1[𝐴][𝐵], (C. 7) 
and the backward reaction rate, 𝑉−1, is  
 𝑉−1 = 𝑘−1[𝐶]. (C. 8) 
The concentration changes of all species in this system over time can be described three 
ODEs: 
 
𝑑[𝐴]
𝑑𝑡
= −𝑘1[𝐴][𝐵] + 𝑘−1[𝐶] = −𝑉1 + 𝑉−1 (C. 9) 
 
𝑑[𝐵]
𝑑𝑡
= −𝑘1[𝐴][𝐵] + 𝑘−1[𝐶] = −𝑉1 + 𝑉−1, 𝑎𝑛𝑑 (C. 10) 
 
𝑑[𝐶]
𝑑𝑡
= 𝑘1[𝐴][𝐵] − 𝑘−1[𝐶] = 𝑉1 − 𝑉−1. (C. 11) 
Many complex reactions contain multiple steps, and each step is an elementary reaction. For 
example, the following chain reaction 
 𝐴
𝑘1
→𝐵
𝑘2
→𝐶 (C. 12) 
consist of two elementary reaction: 𝐴
𝑘1
→𝐵 and 𝐵
𝑘2
→𝐶, with reaction rate constant 𝑘1 and 𝑘2, 
respectively. In the first reaction step, the reactant A converts into an intermediate, B, and the 
reaction rate, 𝑉1, is 
 𝑉1 = 𝑘1[𝐴]. (C. 13) 
In the second reaction step, the intermediate B converts into the final product C, and the 
reaction rate, 𝑉2, is 
 𝑉2 = 𝑘2[𝐵]. (C. 14) 
Therefore, the ODEs for the concentration changes of all species in this system over time are 
 
𝑑[𝐴]
𝑑𝑡
= −𝑘1[𝐴] = −𝑉1, (C. 15) 
 
𝑑[𝐵]
𝑑𝑡
= 𝑘1[𝐴] − 𝑘2[𝐵] = 𝑉1 − 𝑉2, 𝑎𝑛𝑑 (C. 16) 
165 
 
 
 
𝑑[𝐶]
𝑑𝑡
= 𝑘2[𝐵] = 𝑉2. (C. 17) 
 
C.2 Michaelis-Menten model 
C.2.1 Equilibrium approximation 
The Michaelis-Menten model is a classic more for enzyme kinetic (Michaelis and Menten 
1913). In an enzyme-catalysed reactions:  
 𝐸 + 𝑆
𝑘1; 𝑘−1
↔    𝐸𝑆
  𝑘2  
→  𝐸 + 𝑃, (C. 18) 
a substrate, S, reversibly binds to an enzyme, E, to form a substrate-enzyme complex, ES, 
with the forwar reaction rate constant, 𝑘1, and the backward reaction rate constant, 𝑘−1. Then, 
ES irreversibly converts into the production, P,  with rate constant 𝑘2 and releases E at the 
same time. Therefore, based on the law of mass action, the concentration changes of all 
species in this system can be described by four ODEs:  
 
𝑑[𝑆]
𝑑𝑡
= −𝑘1[𝐸][𝑆] + 𝑘−1[𝐸𝑆], (C. 19) 
 
𝑑[𝐸]
𝑑𝑡
= −𝑘1[𝐸][𝑆] + (𝑘−1 + 𝑘2)[𝐸𝑆], (C. 20) 
 
𝑑[𝐸𝑆]
𝑑𝑡
= 𝑘1[𝐸][𝑆] − (𝑘−1 + 𝑘2)[𝐸𝑆], 𝑎𝑛𝑑 (C. 21) 
 
𝑑[𝑃]
𝑑𝑡
= 𝑘2[𝐸𝑆]. (C. 22) 
The total concentration of the enzyme (𝐸0) is a constant, where  
 [𝐸0] = [𝐸] + [𝐸𝑆]. (C. 23) 
The original assumption by Michaelis and Menten (1913) was that the substrate-enzyme 
complex, ES reaches its equilibrium instantly (𝑘1[𝐸][𝑆] = 𝑘−1[𝐸𝑆]). Therefore, the 
concentration of the substrate-enzyme complex is given by 
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 [𝐸𝑆] =
𝑘1
𝑘−1
[𝐸][𝑆]. (C. 24) 
 
According to the Eq. (C.23), Eq. (C.24) is modified to  
 [𝐸𝑆] =
𝑘1
𝑘−1
[𝑆]([𝐸0] − [𝐸𝑆]). (C. 25) 
Let 𝐾𝑑 =
𝑘−1
𝑘1
 represent the dissociation constant of the ES complex. Substiute 𝐾𝑑 =
𝑘−1
𝑘1
  in to 
Eq. (C.25) and rearrage it to  
 [𝐸𝑆] =
[𝑆][𝐸0]
𝐾𝑑 + [𝑆]
. (C. 26) 
Therefore, the reaction rate of the final production P (Eq. (22)), V, is given by 
 𝑉 =
𝑑[𝑃]
𝑑𝑡
= 𝑘2[𝐸𝑆] = 𝑘2
[𝑆][𝐸0]
𝐾𝑑+ [𝑆]
. (C. 27) 
Let 𝑉𝑚𝑎𝑥 = 𝑘2[𝐸0] represent the maximum reaction rate the system can reach at a saturating 
substrate concentration. Then, Eq. (C.27) becomes 
 𝑉 = 𝑉𝑚𝑎𝑥
[𝑆]
𝐾𝑑 + [𝑆]
. (C. 28) 
When [S] = 𝐾𝑑, 𝑉 =
1
2
𝑉𝑚𝑎𝑥. This equilibrium approximation is valid when the reversible 
reaction is much faster than the irreversible reaction (𝑘−1 ≫ 𝑘2), and thus, the reaction rate of 
the production P is limited by the irreversible reaction limites. 
C.2.2 Quasi-steady-state approximation 
Briggs and Haldane (1925) suggested an alternative approximation, the quasi-steady-state 
approximation, which assumes the concentration of the intermediate substrate-enzyme 
complex ES does not change during the production of P. Therefore, 
𝑑[𝐸𝑆]
𝑑𝑡
= 0 and rearrange 
the Eq. (21) to 
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 [𝐸𝑆] =
𝑘1
𝑘−1 + 𝑘2
[𝐸][𝑆]. (C. 29) 
Based on the conservation of the enzyme in Eq. (C.23), Eq. (C.29) is modified to  
 [𝐸𝑆] =
[𝑆][𝐸0]
𝐾𝑀 + [𝑆]
, (C. 30) 
where 𝐾𝑀 =
𝑘−1+𝑘2
𝑘1
 is called Michaelis-Menten constant. 
Substitue Eq. (C.30) into Eq. (C.22), the reaction rate of the final production P, V, is given by 
 𝑉 =
𝑑[𝑃]
𝑑𝑡
= 𝑘2[𝐸𝑆] = 𝑘2
[𝑆][𝐸0]
𝐾𝑀 + [𝑆]
= 𝑉𝑚𝑎𝑥
[𝑆]
𝐾𝑀 + [𝑆]
. (C. 31) 
The quasi-steady-state approximation is valid when [𝐸0] ≪ [𝑆0], where 𝑆0is the total substrate 
concentration ([𝑆0] = [𝑆] + [𝐸𝑆]). Eq. (C.31) is very similar to Eq. (C.28), with the only 
difference that the equilibrium approximation uses 𝐾𝑀 (Eq. (C.31)) whereas the equilibrium 
approximation uses 𝐾𝑚𝑎𝑥 (Eq. (C.28)). To be notice, when 𝑘−1 ≫ 𝑘2, 𝐾𝑀 ≈ 𝐾𝑚𝑎𝑥 and these 
two approximation will produce similar results. 
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C.3 Hill model 
The Hill model is a type of model that describes the cooperativity cooperative binding of 
ligands to receptors (Hill 1910). It is widely used as the mathematically formulate to quantify the 
binding between ligands and receptors by expressing the fraction of the bound receptor as a 
function of the ligand concentration (Weiss 1997). The Hill model provides a way to describe the 
dependence between chemical substances in modelling the cooperative activation or inhibition in 
complex biochemical systems.  
Consider an receport protein consists of n subunits and each subunits contains one binding 
site for a ligand. The binding of the ligands to the receptor can be seperated into n reversible 
elementary reaction steps as follows: 
 𝐿 + 𝑅 +
𝑘1; 𝑘−1
↔    𝐿𝑅, (C. 32) 
 𝐿 + 𝐿𝑅
𝑘2; 𝑘−2
↔    𝐿2𝑅, 
(C. 33) 
 …  
 𝐿 + 𝐿𝑛−1𝑅
𝑘𝑛; 𝑘−𝑛
↔    𝑑 𝐿𝑛𝑅, 
(C. 34) 
where 𝐿 is the ligand, 𝑅 is the free receptor, 𝐿𝑛𝑅 is the n-ligand bound receptor, and 𝑘𝑛 and 
𝑘−𝑛 are the forward and backward reaction for the n-th elementary reaction steps, respectively. 
Besides, the rate of ions enter through this recepoter is propotianl to the concentration of the full 
bound receport, 𝐿𝑛𝑅, with a rate constant of 𝑘𝑖𝑜𝑛. Let [x] be the concentration of x. The 
dynamics of all species in this system can be governed by a set of ODEs: 
 
𝑑[𝑅]
𝑑𝑡
= −𝑘1[𝑅][𝐿] + 𝑘−1[𝐿𝑅], (C. 35) 
 
𝑑[𝐿𝑅]
𝑑𝑡
= 𝑘1[𝑅][𝐿] − 𝑘−1[𝐿𝑅] − 𝑘2[𝐿𝑅][𝐿] + 𝑘−2[𝐿2𝑅], (C. 36) 
 
𝑑[𝐿2𝑅]
𝑑𝑡
= 𝑘2[𝐿𝑅][𝐿] − 𝑘−2[𝐿2𝑅] − 𝑘3[𝐿2𝑅][𝐿] + 𝑘−3[𝐿3𝑅], (C. 37) 
 …  
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𝑑[𝐿𝑛−1𝑅]
𝑑𝑡
= 𝑘𝑛−1[𝐿(𝑛−2)𝑅][𝐿] − 𝑘−(𝑛−1)[𝐿𝑛−1𝑅] − 𝑘𝑛[𝐿𝑛−1𝑅][𝐿]
+ 𝑘−𝑛[𝐿𝑛𝑅], 
(C. 38) 
 
𝑑[𝐿𝑛𝑅]
𝑑𝑡
= 𝑘𝑛[𝐿𝑛−1𝑅][𝐿] − 𝑘−𝑛[𝐿𝑛𝑅], 𝑎𝑛𝑑 (C. 39) 
 
𝑑[𝐿]
𝑑𝑡
= −(𝑘1[𝑅] + 𝑘2[𝐿𝑅] + 𝑘3[𝐿2𝑅] + ⋯+ 𝑘𝑛[𝐿𝑛−1𝑅])[𝐿]
+ (𝑘−1[𝐿𝑅] + 𝑘−2[𝐿2𝑅] + 𝑘−3[𝐿3𝑅] + 𝑘−𝑛[𝐿𝑛𝑅]). 
(C. 40) 
The ion flux rate through this receptor is 𝑓 = 𝑘𝑖𝑜𝑛[𝐿𝑛𝑅]. Assume there is no change in the 
concentraions of all binding states (𝐿𝑅, 𝐿2𝑅,… , 𝐿𝑛𝑅) over the timescale of 𝑓, thus, Eq. (C.36) 
to Eq. (C.39) become zeros and obtain: 
 [𝐿𝑅] =
[𝑅][𝐿]
𝐾1
, (C. 41) 
 
[𝐿2𝑅] =
[𝑅][𝐿]2
𝐾1𝐾2
, 
(C. 42) 
 …  
 
[𝐿𝑛𝑅] =
[𝑅][𝐿]𝑛
𝐾1𝐾2…𝐾𝑛
, 
(C. 43) 
where 𝐾1 =
𝑘−1
𝑘1
, 𝐾2 =
𝑘−2
𝑘2
, … and 𝐾𝑛 =
𝑘−𝑛
𝑘𝑛
.  
Let 𝑅0 be the total concentration of the receptor, [𝑅0] = [𝑅] + [𝐿𝑅] + [𝐿2𝑅] + ⋯+ [𝐿𝑛𝑅] 
besed on the law of conservation of mass. Therefore, we can calculate the fraction of receptor 
that has been full-bound by n ligands: 
[𝐿𝑛𝑅]
[𝑅0]
=
[𝐿𝑛𝑅]
[𝑅] + [𝐿𝑅] + [𝐿2𝑅] + ⋯+ [𝐿𝑛𝑅]
=
[𝑅][𝐿]𝑛
𝐾1𝐾2…𝐾𝑛
[𝑅] +
[𝑅][𝐿]
𝐾1
+
[𝑅][𝐿]2
𝐾1𝐾2
+⋯+
[𝑅][𝐿]𝑛
𝐾1𝐾2…𝐾𝑛
=
[𝐿]𝑛
𝐾1𝐾2…𝐾𝑛 + 𝐾2…𝐾𝑛[𝐿] + 𝐾3…𝐾𝑛[𝐿]2 +⋯+ [𝐿]𝑛
. 
(C. 44) 
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If we assume the first ligand binding is slow, but once one site is occupied, binding to the rest 
site is fast and the binding affinity for the remaining sites are changed by the first binding and 
ligands can bind to them simultaneously. This can be modelled as  𝑘1 → 0,  𝑘2𝑡𝑜 𝑘𝑛 → ∞ and 
𝑘1𝑘2…𝑘𝑛 is fixed. Therefore,  𝐾1 → ∞, 𝐾2…𝐾𝑛 → 0 and 𝐾1𝐾2…𝐾𝑛 is a constant. Let 𝐾𝑎
𝑛 =
𝐾1𝐾2…𝐾𝑛, which discribes the ligand concentration producting half occupation of all binding 
sites. Eq. (C.44) can be simplified to 
 
[𝐿𝑛𝑅]
[𝑅0]
=
[𝐿]𝑛
𝐾𝑎
𝑛+[𝐿]𝑛
. (C. 45) 
The Eq. (C.45) is the classic form of Hill equation, and n is called Hill coefficient. Hill 
equation can also be written as 
 
[𝐿𝑛𝑅]
[𝑅0]
=
[𝐿]𝑛
𝐾𝑑 + [𝐿]𝑛
, (C. 46) 
where 𝐾𝑑 = 𝐾𝑎
𝑛 denotes the apparent dissociation constant which can be derived from the 
law of mass action. 
Rearrange the Eq. (C.46), the concentration of 𝐿𝑛𝑅 becomes a function of the ligand 
concentration: 
 [𝐿𝑛𝑅] =
[𝑅0][𝐿]
𝑛
𝐾𝑎
𝑛+[𝐿]𝑛
. (C. 47) 
Therefore, the ion flux rate through this receptor is 𝑓 = 𝑘𝑖𝑜𝑛[𝐿𝑛𝑅]. 
 𝑓 = 𝑉𝑚𝑎𝑥
[𝐿]𝑛
𝐾𝑎
𝑛+[𝐿]𝑛
, (C. 48) 
where 𝑉𝑚𝑎𝑥 = 𝑘𝑖𝑜𝑛[𝑅0] is the maximum flux rate when all receptors are full bound by 
ligands. 
The modified hill model (Eq. (B.48)) describes a sigmoid relationship between the flux rate 𝑓 
and the ligand concentration [𝐿] (Figure C.1). The curve of 𝑓 versus [𝐿] has an “S” shape 
(sigmoid curve). The Hill coefficient n determines the steepness of the sigmoid curve. When n 
= 1, the Hill model becomes Michaelis-Menten model, which shows no cooperativity binding. 
This is valid when each ligand binding site is independent from each other and the binding affinity 
for a ligand to a binding site is not affected if  the receport is already bound by other ligands. 
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When n >1, the Hill model describes a positively cooperative binding process that once a ligand is 
bound to the receptor, the affinity for the rest ligands increases. On the contrary, when n < 1, the 
Hill model describes a negatively cooperative binding that the binding affinity decreases once a 
ligand is bound to the receptor. 
 
Figure C.1. The normalised flux rate from a Hill model. The flux rate is normalised to 
the 𝑽𝒎𝒂𝒙. The ligand concentration [𝑳𝒏] is normalised to the 𝑲𝒂. 
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C.4 Application of Michaelis-Menten model to simulation of Ca2+ extrusion 
mechanisms 
The intracellular Ca2+ ions are removed from the cytosol by membrane exchangers or pumps, 
which can be assumed as two steps: (1) intracellular Ca2+ binds to the Ca2+ pump or and (2) 
the Ca2+ pump or exchanger releases the bound Ca2+ to the extracellular space 
 𝐶𝑎𝑖
2+ + 𝑃
𝑘1; 𝑘−1
↔    𝐶𝑎𝑃
  𝑘2  
→  𝐶𝑎0
2+ + 𝑃, (C. 49) 
where 𝐶𝑎𝑖
2+ and  𝐶𝑎𝑜
2+ denotes intracellular and extracellular Ca2+, respectively. 𝑃 and 𝐶𝑎𝑃 
denotes the free and intermediate Ca2+-bound Ca2+ pumps or exchangers, respectively. The 
Ca2+ pumps in membrane of internal Ca2+ stores, such as ER or mitochondrion, can be 
represented in a similar way. The only difference is that 𝐶𝑎𝑜
2+ represents the the Ca2+ in 
internal Ca2+ store. The Ca2+ binding step is reveserble, with forward rate constant, 𝑘1, and 
backward rate constant, 𝑘−1, respectively. The release step, with release time constant 𝑘2, is 
irreverseble when assuming the 𝐶𝑎0
2+is a constant. Ca2+ normally bind to the pump with a 
high affinity, and the release process is relatively much slower than the Ca2+ binding process 
(𝑘−1 ≫ 𝑘2). Therefore, the Ca
2+ flux via the Ca2+ pump or exchanger can be described by a 
Michaelis-Menten model: 
 𝐽𝑝𝑢𝑚𝑝 = 𝑉𝑝𝑢𝑚𝑝
[𝐶𝑎2+]𝑖
𝐾𝑝𝑢𝑚𝑝 + [𝐶𝑎2+]𝑖
, (C. 50) 
where 𝐽𝑝𝑢𝑚𝑝 denotes the pump Ca
2+ flux (in units of conerntration per unit time), 𝑉𝑝𝑢𝑚𝑝 
denotes the maximum pump velocity, 𝐾𝑝𝑢𝑚𝑝 is Michaelis-Menten constant, which denotes 
the Ca2+ concentration with half 𝑉𝑝𝑢𝑚𝑝, and [𝐶𝑎
2+]𝑖 denotes the intracellualr Ca
2+ 
concentration. 𝑉𝑝𝑢𝑚𝑝 can be calculated from the maximum velocity and the total pump 
number: 
𝑉𝑝𝑢𝑚𝑝 = 𝑘2𝑃𝑠
𝐴
𝑉
, 
where 𝑃𝑠 is the surface density of the pump (in units of molecue number per unit area of 
membrane), 𝐴 is the suface area of membrane and 𝑉 is the volume of the cytosol. According 
to Eq. (C.30), 𝐾𝑝𝑢𝑚𝑝 =
𝑘−1+𝑘2
𝑘1
, in the unit of concentrations. 
In some literature, SERCA pump is simulated using a Hill model with with a Hill coefficient 
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greater than 1 (offen use 2) (Lytton, Westlin et al. 1992). The SERCA pump in the smooth ER 
membrane binds to two Ca2+ ions for each ATP molecule, and can be modelled as two 
sequentially binding steps: 
𝐶𝑎𝑖
2+ + 𝑃
𝑘1; 𝑘−1
↔    𝐶𝑎𝑃
  𝑘𝑟1  
→   𝐶𝑎𝐸𝑅
2+ + 𝑃, (C. 51) 
𝐶𝑎𝑖
2+ + 𝐶𝑎𝑃
𝑘2; 𝑘−2
↔    𝐶𝑎2𝑃
  𝑘𝑟2  
→   𝐶𝑎𝐸𝑅
2+ + 𝐶𝑎𝑃, (C. 52) 
where 𝐶𝑎𝐸𝑅
2+ denotes the Ca2+ in the ER, 𝑘1 and 𝑘2 are the forward rate constants and 𝑘−1 and 
𝑘−2 are the backward rate constants, of the each reveserble Ca
2+ binding step, respectively. 
𝑘𝑟1 and 𝑘𝑟2 are the release time constant. The total concentration of SERCA, 𝑃0, is a constant 
that  𝑃0 = [𝑃] + [𝐶𝑎2𝑃]. Assume the concentration of 𝐶𝑎𝑃 and 𝐶𝑎2𝑃 reach to the 
equilibriums instantly, then the Ca2+ flux via the SERCA pump can be described by a hill 
model: 
 𝐽𝑝𝑢𝑚𝑝 = 𝑉𝑝𝑢𝑚𝑝
[𝐶𝑎2+]𝑖
𝑛
𝐾𝑝𝑢𝑚𝑝
𝑛 + [𝐶𝑎2+]𝑖
𝑛, (C. 53) 
where the Hill coefficient n = 2 (Lytton, Westlin et al. 1992). 
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Appendix D. ODEs for Tr, CaD and CaM 
D.1 Gluatmate tranporter (Tr). 
Glutamate uptake by glial transporters can be represented as a follwing simple kinetic scheme 
(Rusakov and Kullmann 1998): 
 𝐺𝑙𝑢 + 𝑇𝑟
𝑘1𝑓; 𝑘1𝑏
↔    𝐺𝑙𝑢 − 𝑇𝑟
𝑘2
→ 𝑇𝑟,  
where 𝐺𝑙𝑢 is the glutamate, 𝑇𝑟 is the unbound surface transporter and 𝐺𝑙𝑢 − 𝑇𝑟 is the 
glutamate-transporter complex (See section 3.1.1 for the explanation). The dynamics of all 
species in the model can be described by three ODEs (Appendix C.1): 
𝑑[𝐺𝑙𝑢]
𝑑𝑡
= −𝑘1𝑓[𝐺𝑙𝑢][𝑇𝑟] + 𝑘1𝑏[𝐺𝑙𝑢 − 𝑇𝑟], (D. 1) 
𝑑[𝑇𝑟]
𝑑𝑡
= −𝑘1𝑓[𝐺𝑙𝑢][𝑇𝑟] + (𝑘1𝑏 + 𝑘2)[𝐺𝑙𝑢 − 𝑇𝑟], 𝑎𝑛𝑑 (D. 2) 
𝑑[𝐺𝑙𝑢 − 𝑇𝑟]
𝑑𝑡
= 𝑘1𝑓[𝐺𝑙𝑢][𝑇𝑟] − (𝑘1𝑏 + 𝑘2)[𝐺𝑙𝑢 − 𝑇𝑟]. (D. 3) 
According to the law of conservation of mass, [𝑇𝑟𝑡𝑜𝑡𝑎𝑙] = [𝑇𝑟] +  [𝐺𝑙𝑢 − 𝑇𝑟], [𝑇𝑟𝑡𝑜𝑡𝑎𝑙] is the 
total concentration of the transporter, therefore Eq. (D.1) to  Eq. (D.3) can be simplified to 
two ODEs: 
𝑑[𝐺𝑙𝑢]
𝑑𝑡
= −𝑘1𝑓[𝐺𝑙𝑢][𝑇𝑟] + 𝑘1𝑏([𝑇𝑟𝑡𝑜𝑡𝑎𝑙] − [𝑇𝑟]), 𝑎𝑛𝑑 (D. 4) 
𝑑[𝑇𝑟]
𝑑𝑡
= −𝑘1𝑓[𝐺𝑙𝑢][𝑇𝑟] + (𝑘1𝑏 + 𝑘2)([𝑇𝑟𝑡𝑜𝑡𝑎𝑙] − [𝑇𝑟]). (D. 5) 
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D.2 Buffers 
Dynamics of the immobile buffer and CaD are governded by a same ODE: 
where 𝑘𝑏𝑓 and 𝑘𝑏𝑏 are the forward and backward buffer rate constants, respectively, and 
[𝐵]𝑡𝑜𝑡𝑎𝑙,𝑗 is the total concentration of immobile buffer or CaD in compartment 𝑗.  
One CaM can bind four Ca2+ ions: 
𝐶𝑎2+ + 𝐶𝑎𝑀
𝑘1; 𝑘−1
↔    𝐶𝑎𝐶𝑎𝑀,  
𝐶𝑎2+ + 𝐶𝑎𝐶𝑎𝑀
𝑘2; 𝑘−2
↔    𝐶𝑎2𝐶𝑎𝑀, 
 
𝐶𝑎2+ + 𝐶𝑎2𝐶𝑎𝑀
𝑘3; 𝑘−3
↔    𝐶𝑎3𝐶𝑎𝑀, and  
 
𝐶𝑎2+ + 𝐶𝑎4𝐶𝑎𝑀
𝑘4; 𝑘−4
↔    𝐶𝑎4𝐶𝑎𝑀. 
 
The dynamics of all species in the model can be described by four ODEs (Appendix C.1): 
where [𝐶𝑎𝑀] = [𝐶𝑎𝑀]𝑡𝑜𝑡𝑎𝑙 − [𝐶𝑎𝐶𝑎𝑀] − [𝐶𝑎2𝐶𝑎𝑀] − [𝐶𝑎3𝐶𝑎𝑀] − [𝐶𝑎4𝐶𝑎𝑀] 
([𝐶𝑎𝑀]𝑡𝑜𝑡𝑎𝑙 is the total concentration of CaM). 
 
 
 
𝑑[𝐵]𝑗
𝑑𝑡
= −𝑘𝑏𝑓[𝐶𝑎
2+]𝑗[𝐵]𝑗 + 𝑘𝑏𝑏([𝐵]𝑡𝑜𝑡𝑎𝑙 − [𝐵]𝑗), 
(D. 6) 
 
𝑑[𝐶𝑎𝐶𝑎𝑀]
𝑑𝑡
= 𝑘1[𝐶𝑎
2+][𝐶𝑎𝑀] − 𝑘−1[𝐶𝑎𝐶𝑎𝑀]
− 𝑘2[𝐶𝑎
2+][𝐶𝑎𝐶𝑎𝑀] + 𝑘−2[𝐶𝑎2𝐶𝑎𝑀] 
(D. 7) 
 
𝑑[𝐶𝑎2𝐶𝑎𝑀]
𝑑𝑡
= 𝑘2[𝐶𝑎
2+][𝐶𝑎𝐶𝑎𝑀] − 𝑘−2[𝐶𝑎2𝐶𝑎𝑀]
− 𝑘3[𝐶𝑎
2+][𝐶𝑎2𝐶𝑎𝑀] + 𝑘−3[𝐶𝑎3𝐶𝑎𝑀] 
(D. 8) 
 
𝑑[𝐶𝑎3𝐶𝑎𝑀]
𝑑𝑡
= 𝑘3[𝐶𝑎
2+][𝐶𝑎2𝐶𝑎𝑀] − 𝑘−3[𝐶𝑎3𝐶𝑎𝑀]
− 𝑘4[𝐶𝑎
2+][𝐶𝑎3𝐶𝑎𝑀] + 𝑘−4[𝐶𝑎4𝐶𝑎𝑀] 
(D. 9) 
 
𝑑[𝐶𝑎4𝐶𝑎𝑀]
𝑑𝑡
= 𝑘4[𝐶𝑎
2+][𝐶𝑎3𝐶𝑎𝑀] − 𝑘−4[𝐶𝑎4𝐶𝑎𝑀] 
(D. 10) 
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Appendix E. Markov State Models of Ca2+ channels 
E.1 Markov kinetic models for a single ligand-gated ion channel 
Most voltage- and ligand-gated ion channels go through multiple conformational changes 
during gating (Tombola, Pathak et al. 2006). Markov kinetic model is widely used to capture 
the stransition dynamics of between different states and the ligand dependece of voltage- and 
ligand-gated ion channels (Destexhe, Mainen et al. 1994). The Markov kinetic model consists 
of  a seriers of discrete states, such as open, close, desensitisation and ligand-bound states, and 
discribes the transition pathways among these states with specific rate constants, dependent or 
independent of voltage and/or ligand, accordingly. The state transition in a Markov kinetic 
model is memoryless, only depends on the state the channels in, not on time or its previous 
transitions.  
The rate constants can be estimated by fiting experimental single-channel data to proposed 
Markov kinetic schemes. The experimental single-channel data by single-channel recording 
techniques describles the dwell times single channels spent in open or closed states. The 
frequency distribution of dwell-times can be discribed as a sum of exponential decay 
components by fitting the dwell-time histgrams to multiple exponential functions (Colquhoun 
and Hawkes 1982). Fit the dwell-time distributions to the Markov kinetic model to estimate 
values of each rate constant (Qin and Li 2004). 
The deterministic interpretation of the Markov kinetic scheme can be represented as a set of 
ODEs (Stevens 1978). For example, the following simple four-state model of a ligand-gated 
channel is: 
 𝐶 + 𝐿
𝑘1; 𝑘−1
↔    𝐿𝐶1
𝑘2; 𝑘−2
↔    𝐶𝐿2
𝑘3; 𝑘−3
↔    𝑂, (E. 2) 
where 𝐶, 𝐿𝐶1, and 𝐿𝐶2 represtent close state and two ligand-bound close state, 𝐿 denotes the 
ligand and  𝑂 denotes the open state. 𝑘1 and 𝑘−1 are the forward and backward rate constants 
for the ligand binding step, respectively. 𝑘2 and 𝑘−2 are rate constants for the state transition 
between 𝐿𝐶1, and 𝐿𝐶2. 𝑘3 and 𝑘−3 are the rate constants of opening and the open state 
inactivation back to 𝐿𝐶2, respectively.  
Let [x] represents the fraction of a single channe in x state. The dynamics can be described by 
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a set of ODEs as following: 
 
𝑑[𝐿]
𝑑𝑡
= −𝑘1[𝐶][𝐿] + 𝑘−1[𝐿𝐶1], (E. 3) 
 
𝑑[𝐶]
𝑑𝑡
= −𝑘1[𝐶][𝐿] + 𝑘−1[𝐿𝐶1], (E. 4) 
 
𝑑[𝐿𝐶1]
𝑑𝑡
= 𝑘1[𝐶][𝐿] − 𝑘−1[𝐿𝐶1] − 𝑘2[𝐿𝐶1] + 𝑘−2[𝐿𝐶2], (E. 5) 
 
𝑑[𝐿𝐶2]
𝑑𝑡
= 𝑘2[𝐿𝐶1] − 𝑘−2[𝐿𝐶2] − 𝑘3[𝐿𝐶2] + 𝑘−3[𝑂],and (E. 6) 
 
𝑑[𝑂]
𝑑𝑡
= 𝑘3[𝐿𝐶2] − 𝑘−3[𝑂]. (E. 7) 
Because of [𝐶] + [𝐿𝐶1] + [𝐿𝐶2] + [𝑂] = 1, the fraction of channel in state C is:   
 [𝐶] = 1 − [𝐿𝐶1] − [𝐿𝐶2] − [𝑂]. (E. 8) 
Therefore, Eq. (E.3) can be removed and Eq. (E.4) becomes: 
 
𝑑[𝐿𝐶1]
𝑑𝑡
= 𝑘1[𝐿](1 − [𝐿𝐶1] − [𝐿𝐶2] − [𝑂]) − 𝑘−1[𝐿𝐶1] − 𝑘2[𝐿𝐶1]
+ 𝑘−2[𝐿𝐶2] 
(E. 9) 
When the total concentration of the ligand is much greater than the number of channels, [𝐿] 
can be approximated to be unaffected by the binding step. Therefore, the dynamics of the 
four-state Markov model in Eq. (E.1) are governed by three ODEs: Eq. (E.5) , Eq. (E.6), and 
Eq. (E.8) 
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E.2 Eight-state NMDAR model 
The Markov kinetic scheme of NMDAR in Figure 3.4A contains eight states (Erreger, Dravid 
et al. 2005). Let [X] denotes the fraction of a single NMDAR in state X, and, thus, [𝑅𝑁] +
[𝑅𝑁𝐺] + [𝑅𝑁𝐺2] + [𝑅𝑁𝐺2𝐹] + [𝑅𝑁𝐺2𝑆] + [𝐷1] + [𝐷2] + [𝑂𝑁] = 1. We assume the 
glutamate concentration is not affected by the binding processes. The parameters of the 
reaction rates are summarised in Table 3.2. The dynamics of this Markov model are governed 
by seven ODEs: 
𝑑[𝑅𝑁𝐺]
𝑑𝑡
= 2𝑘𝑜𝑛[𝑅𝑁][𝐺] − 𝑘𝑜𝑓𝑓[𝑅𝑁𝐺] − 𝑘𝑜𝑛[𝑅𝑁𝐺][𝐺] + 2𝑘𝑜𝑓𝑓[𝑅𝑁𝐺2], 
(E. 10) 
𝑑[𝑅𝑁𝐺2]
𝑑𝑡
= 𝑘𝑜𝑛[𝑅𝑁𝐺][𝐺] − 2𝑘𝑜𝑓𝑓[𝑅𝑁𝐺2] − 𝑘𝑑1+[𝑅𝑁𝐺2] + 𝑘𝑑1−[𝐷1]
− 𝑘𝑑2+[𝑅𝑁𝐺2] + 𝑘𝑑2−[𝐷2] − 𝑘𝑓+[𝑅𝑁𝐺2] + 𝑘𝑓−[𝑅𝑁𝐺2𝐹]
− 𝑘𝑠+[𝑅𝑁𝐺2] + 𝑘𝑠−[𝑅𝑁𝐺2𝑆], 
(E. 11) 
𝑑[𝑅𝑁𝐺2𝐹]
𝑑𝑡
= 𝑘𝑓+[𝑅𝑁𝐺2] − 𝑘𝑓−[𝑅𝑁𝐺2𝐹] − 𝑘𝑠+[𝑅𝑁𝐺2𝐹] + 𝑘𝑠−[𝑂𝑁], 
(E. 12) 
𝑑[𝑅𝑁𝐺2𝑆]
𝑑𝑡
= 𝑘𝑠+[𝑅𝑁𝐺2] − 𝑘𝑠−[𝑅𝑁𝐺2𝑆] − 𝑘𝑓+[𝑅𝑁𝐺2𝑆] + 𝑘𝑓−[𝑂𝑁], 
(E. 13) 
𝑑[𝐷1]
𝑑𝑡
= 𝑘𝑑1+[𝑅𝑁𝐺2] − 𝑘𝑑1−[𝐷1], 
(E. 14) 
𝑑[𝐷2]
𝑑𝑡
= 𝑘𝑑2+[𝑅𝑁𝐺2] − 𝑘𝑑2−[𝐷2], 𝑎𝑛𝑑 
(E. 15) 
𝑑[𝑂𝑁]
𝑑𝑡
= 𝑘𝑠+[𝑅𝑁𝐺2𝐹] − 𝑘𝑠−[𝑂𝑁] + 𝑘𝑓+[𝑅𝑁𝐺2𝑆] − 𝑘𝑓−[𝑂𝑁], 
(E. 16) 
where [𝑅𝑁] = 1 − [𝑅𝑁𝐺] − [𝑅𝑁𝐺2] − [𝑅𝑁𝐺2𝐹] − [𝑅𝑁𝐺2𝑆] − [𝐷1] − [𝐷2] − [𝑂𝑁]. The 
fraction of a single NMDAR in the open state at time t is 𝑃𝑜𝑁𝑀𝐷𝐴𝑅(𝑡) = [𝑂𝑁](𝑡).  
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E.3 Seven-state AMPAR model 
The Markov kinetic scheme of AMPAR in Figure 3.4B contains seven states (Jonas, Major et 
al. 1993). Let [X] denotes the fraction of a single AMPAR in state X, and, thus, [𝑅𝐴] +
[𝑅𝐴𝐺1] + [𝑅𝐴𝐺2] + [𝐷1] + [𝐷2] + [𝐷𝑂𝐴] + [𝑂𝐴] = 1. We assume the glutamate concentration 
is not affected by the binding processes. The parameters of the reaction rates are summarised 
in Table 3.2. The dynamics of this Markov model are governed by six ODEs: 
𝑑[𝑅𝐴𝐺1]
𝑑𝑡
= 𝑘11[𝑅𝐴][𝐺] − 𝑘10[𝑅𝐴𝐺1] − 𝑘21[𝑅𝐴𝐺1][𝐺] + 𝑘20[𝑅𝐴𝐺2]
− 𝛼1[𝑅𝐴𝐺1] + 𝛽1[𝐷1], 
(E. 17) 
𝑑[𝑅𝐴𝐺2]
𝑑𝑡
= 𝑘21[𝑅𝐴𝐺1][𝐺] − 𝑘20[𝑅𝐴𝐺2] − 𝛼[𝑅𝐴𝐺2] + 𝛽[𝑂𝐴] − 𝛼2[𝑅𝐴𝐺2]
+ 𝛽2[𝐷2], 
(E. 18) 
𝑑[𝐷1]
𝑑𝑡
= 𝛼1[𝑅𝐴𝐺1] − 𝛽1[𝐷1] − 𝑘31[𝐷1][𝐺] + 𝑘30[𝐷2], 
(E. 19) 
𝑑[𝐷2]
𝑑𝑡
= 𝑘31[𝐷1][𝐺] − 𝑘30[𝐷2] + 𝛼2[𝑅𝐴𝐺2] − 𝛽2[𝐷2] − 𝛼4[𝐷2] + 𝛽4[𝐷𝑂𝐴], 
(E. 20) 
𝑑[𝐷𝑂𝐴]
𝑑𝑡
= 𝛼4[𝐷2] − 𝛽4[𝐷𝑂𝐴] + 𝛼3[𝑂𝐴] − 𝛽3[𝐷𝑂𝐴], 𝑎𝑛𝑑 
(E. 21) 
𝑑[𝑂𝐴]
𝑑𝑡
= 𝛼[𝑅𝐴𝐺2] − 𝛽[𝑂𝐴] − 𝛼3[𝑂𝐴] + 𝛽3[𝐷𝑂𝐴], 
(E. 22) 
where [𝑅𝐴] = 1 − [𝑅𝐴𝐺1] − [𝑅𝐴𝐺2] − [𝐷1] − [𝐷2] − [𝐷𝑂𝐴] − [𝑂𝐴].The fraction of a single 
AMPAR in the open state at time t is 𝑃𝑜𝐴𝑀𝑃𝐴𝑅(𝑡) = [𝑂𝐴](𝑡). 
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Appendix F. MCMC and PRCC 
F.1 MCMC for parameter estimation 
Markov chain Monte Carlo (MCMC) is a general sampling strategy. It is always used in solving 
problems with high-dimensional spaces, such as parameter estimation in a multi-dimensional 
system (Andrieu, De Freitas et al. 2003). In this research, we estimate the values of parameters 
using an MCMC Matlab toolboxes downloaded from http://helios.fmi.fi/~lainema/mcmc/. 
A Markov chain is a discrete random process that consists of a finite number of states. The 
probability of being at a state only depends on the previous states. Suppose a Markov chain is a 
sequence of random variables (𝑋0, 𝑋1, … , 𝑋𝑁) at t = 0, 1, …, n, respectively, with a state space of  
𝑋 = {𝑥1, 𝑥2, … , 𝑥𝑠}. Therefore, the probability of transifer from one state 𝑋𝑛 at time n to next state 
𝑋𝑛+1 at time n+1 is  
𝑝(𝑋𝑛+1 = 𝑥𝑗|𝑋𝑛 = 𝑥𝑖𝑛 , 𝑋𝑛−1 = 𝑥𝑖𝑛−1 , … , 𝑋0 = 𝑥𝑖0) =  𝑝(𝑋𝑛+1 = 𝑥𝑗|𝑋𝑛 = 𝑥𝑖𝑛), (𝑛 ∈ 𝑁, 𝑖𝑛, 𝑗 ∈ 𝑠), 
where 𝑝(𝑥𝑗|𝑥𝑖) denotes the probability of moving from state i to j at current time step. A 
transition matrix, 𝑇, describes the transition probabilities across the state space is 
𝑇 =
(
 
 
 
 
𝑝(𝑥1|𝑥1)   𝑝(𝑥1|𝑥2) …   𝑝(𝑥1|𝑥𝑗) …    𝑝(𝑥1|𝑥𝑠) 
𝑝(𝑥2|𝑥1)   𝑝(𝑥2|𝑥2) …   𝑝(𝑥2|𝑥𝑗) …     𝑝(𝑥2|𝑥𝑠)
…
𝑝(𝑥𝑖|𝑥1)   𝑝(𝑥𝑖|𝑥2) …   𝑝(𝑥𝑖|𝑥𝑗) …     𝑝(𝑥𝑖|𝑥𝑠)
…
𝑝(𝑥𝑠|𝑥1)   𝑝(𝑥𝑠|𝑥2) …   𝑝(𝑥𝑠|𝑥𝑗) …     𝑝(𝑥𝑠|𝑥𝑠))
 
 
 
 
. 
The total of the transition probabilities from a state 𝑥𝑖 to the rest states in 𝑋 is 1, therefore, 
∑𝑝(𝑥𝑗|𝑥𝑖)
𝑠
𝑖=1
= 1. 
For example, a simple Markov chain consists a state space of three discrete states(𝑋 =
{𝑥1, 𝑥2, 𝑥3}) and its transition matrix is  
𝑇 = (
0.5   0   0.5
0   0.4   0.6
0.1   0  0.9
). 
The probability distribution over states at time n  is 𝑃𝑛 at time, and   
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𝑃𝑛+1 = 𝑃𝑛𝑇 = (𝑃𝑛−1𝑇)𝑇 = ⋯ = 𝑃0𝑇
𝑛, 
where 𝑃0 is the initial distribution. When n is large enough, that 
𝑙𝑖𝑚
𝑛→∞
(𝑇)𝑛 = (
0.1667   0   0.8333
0.1667   0   0.8333
0.1667   0   0.8333
). 
Therefore, the chain converges to an invariant or stationary distribution, (0.1667   0   0.8333), 
regardless the initial distribution 𝑃0.  
When an aperiodic Markov chain starts from any state and all the rest states of the state space are 
reachable within finite steps, the chain will converge to an invariant or stationary distribution 
(Andrieu, De Freitas et al. 2003). The MCMC is developed based on this convergence property of 
the Markov chain. The invariant or stationary distribution must have the following detailed 
balance: 
𝑃(𝑥𝑖)𝑇𝑖𝑗 = 𝑃(𝑥𝑗)𝑇𝑗𝑖  , (𝑖, 𝑗 = 1, … , 𝑠), 
where 𝑇𝑖𝑗 = 𝑝(𝑥𝑖|𝑥𝑗). Summing both sides of the above equation over 𝑥𝑗, thus 
𝑃(𝑥𝑖) =∑𝑝(𝑥𝑗)𝑇𝑗𝑖 . 
When we use MCMC to estimate parameter values, if we let the constructed Markov chain 
converging to the optimal distribution of parameters, then the optimal distribution of parameters 
can be directly generated from the converged chain.  
The Metropolis-Hastings algorithm is one of the most general MCMC methods (Metropolis, 
Rosenbluth et al. 1953, Hastings 1970). For a given aperiodic and irreducible Markov chain, MC1 
with a discrete parameters space 𝑋 = {𝑥1, 𝑥2, … , 𝑥𝑠}. Its transition matrix Q is  
𝑄 = 𝑞(𝑋𝑛+1 = 𝑥𝑗|𝑋𝑛 = 𝑥𝑖) = 𝑄𝑖𝑗 , (𝑖, 𝑗 = 1, … , 𝑠). 
Suppose the optimal distribution of parameters is 𝑃(𝑋), and MC1 does not converge to P(X): 
𝑃(𝑥𝑖)𝑄𝑖𝑗 ≠ 𝑃(𝑥𝑗)𝑄𝑗𝑖  , (𝑖, 𝑗 = 1, … , 𝑠). 
If MC1 can be transformed by a function A into MC2 and MC2 satisfies the detailed balance 
condition and converges to  𝑃(𝑋): 
𝑃(𝑥𝑖)𝑄𝑖𝑗𝐴(𝑥𝑖, 𝑥𝑗) = 𝑃(𝑥𝑗)𝑄𝑗𝑖𝐴(𝑥𝑗 , 𝑥𝑖) , (𝑖, 𝑗 = 1, … , 𝑠). 
182 
 
 
Therefore, the simplest for of A satisfies 𝐴(𝑥𝑖 , 𝑥𝑗) =  𝑃(𝑥𝑗)𝑄𝑗𝑖 and 𝐴(𝑥𝑗, 𝑥𝑖)= 𝑃(𝑥𝑖)𝑄𝑖𝑗. The 
function A is called the acceptance probability and it describes the probability of accepting the 
transition happens in MC1 also occurs in MC2.  
Then the transition matrix of MC2 is 
𝑄′ = 𝑞′(𝑋𝑛+1 = 𝑥𝑗|𝑋𝑛 = 𝑥𝑖) = 𝑄
′
𝑖𝑗 = 𝑄𝑖𝑗𝑄𝑗𝑖  𝑃(𝑥𝑗), (𝑖, 𝑗 = 1,… , 𝑠). 
If A is very small, it may take a long time for MC2 to explore the whole parameter space to 
converge to 𝑃(𝑋). In that case, multiply A with a factor k where 
𝑘𝐴(𝑥𝑖 , 𝑥𝑗) ≤ 1, 𝑘𝐴(𝑥𝑗, 𝑥𝑖) ≤ 𝑎𝑛𝑑 𝑘 ≥ 1. 
Then we obtain a Markov chain MC3 which can converge to 𝑃(𝑋) faster than MC2: 
𝑃(𝑥𝑖)𝑄𝑖𝑗𝑘𝐴(𝑥𝑖, 𝑥𝑗) = 𝑃(𝑥𝑗)𝑄𝑗𝑖𝑘𝐴(𝑥𝑗 , 𝑥𝑖) , (𝑖, 𝑗 = 1, … , 𝑠). 
When 𝑘𝐴(𝑥𝑖 , 𝑥𝑗) = 1 or 𝑘𝐴(𝑥𝑗 , 𝑥𝑖) = 1, the convergence of MC3 reaches to the maximum speed, 
and therefore, the maximum of 𝑘𝐴(𝑥𝑖 , 𝑥𝑗) is min [1,
𝐴(𝑥𝑖,𝑥𝑗)
𝐴(𝑥𝑗,𝑥𝑖)
] .   
With a given initial state 𝑥0 (𝑥0 ∈ 𝑋), at iteration t (t = 1, 2, …, T), the Metropolis-Hastings 
algorithm follows the following steps: 
(1) Draw y from 𝑋 and generate a random number, u, from uniform distribution, U(0,1); 
(2) If 𝑢 < min [1,
𝐴(𝑥𝑖,𝑥𝑗)
𝐴(𝑥𝑗,𝑥𝑖)
], 𝑥𝑡 = 𝑦; 
Otherwise, 𝑥𝑡 = 𝑥𝑡−1. 
 
F.2 PRCC for global parameter sensitivity 
The partial ranking correlation coefficient (PRCC) is one of popular global sensitivity analysis 
methods, which quantifies the sensitivity of the model output with respect to the variation of 
selected parameters. PRCC works well for nonlinear but monotonic relationships between outputs 
and inputs, therefore, it is important to check the monotonicity of the model parameters against 
the outputs (Marino, Hogue et al. 2008). 
There is a number of sampling algorithms, such as Latin hypercube sampling (LHS) (McKay, 
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Beckman et al. 2000), which provides the model with a large number of parameter sets, varying 
within given ranges. For a given model, the correlation coefficient (CC) between a particular 
parameter, 𝑥𝑗(𝑗 = 1,2, …𝑛) and output, 𝑦, is calculated:  
𝑟𝑥𝑗𝑦 =
∑ (𝑥𝑖𝑗 − ?̅?)(𝑦𝑖 − ?̅?)
𝑁
𝑖=1
√∑ (𝑥𝑖𝑗 − ?̅?)2
𝑁
𝑖=1 ∑ (𝑦𝑖 − ?̅?)
2𝑁
𝑖=1
,  
where N is the total number of sets of parameters. 𝑥𝑖𝑗, ?̅? and ?̅? are the values of the i-th sample of 
𝑥𝑗, the mean of samples 𝑥𝑗 and the mean of outputs, repectively. The absolute value of 𝑟𝑥𝑗𝑦 which 
is close to 1 indicates a strong correlation whereas |𝑟𝑥𝑗𝑦| which is close to 0 indicates a poor 
correlation. The sign of 𝑟𝑥𝑗𝑦 means negative correlation (-) or positive correlation (+). A p-value 
shows the significance level of its correspongding 𝑟𝑥𝑗𝑦. Normally when p-value <0.05, it rejects 
the null hypothesis that 𝑥𝑗 and 𝑦 is uncorrelated. 
We generate sample parameter set simultaneously according to certain percentage around their 
reference values. Therefore, CC results may be affected by the variation of parameters and the 
reference values. The partial correlation coefficient (PCC) removes the linear effects on output y 
of all parameters other than 𝑥𝑗 and then quantifies the relation between 𝑥𝑗 and y. The PCC 
between 𝑥𝑗 and y is the CC between (𝑥𝑗 − ?̂?𝑗) and (𝑦 − ?̂?), where ?̂?𝑗 and ?̂? are calculated by 
following regression model: 
?̂?𝑗 = 𝑒1 + ∑ 𝛼𝑖𝑥𝑖
𝑛
𝑖=1,𝑖≠𝑗
, 𝑎𝑛𝑑 
?̂? = 𝑒2 + ∑ 𝛽𝑖𝑥𝑖
𝑛
𝑖=1,𝑖≠𝑗
, 
where 𝑒1and 𝑒2 are error terms, 𝛼𝑖 and 𝛽𝑖 are the regression coefficients for 𝑥𝑖 and 𝑦, repectively.  
In the PRCC analysis, the parameter 𝑥𝑗 and output y are first rank-transformed before calculating 
?̂?𝑗 and ?̂? according the linear regression models. The rank-transformed data is ranks (integers) 
which are transferred from real values. Therefore, PRCC can eliminate the effect by the variation 
of parameters as well as by the magnitude of the referece values on CC. The PRCC analysis in 
this research is using Matlab functions downloaded from 
http://malthus.micro.med.umich.edu/lab/usadata/. 
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Appendix G. Stimulation protocols 
G.1 Presynaptic stimulation 
When the presynaptic action potential (AP) reaches the presynaptic terminal it triggers the 
release of glutamate vesicles to the synaptic cleft. The glutamate receptors in the membrane of 
the postsynaptic spine are activated by the glutamate, resulting the EPSP. This presynaptic 
stimulation is simulated as the release events of glutamate vesicles, which is closely regulated 
by the stimulation patterns applied. There are four types of presynaptic stimulation patterns 
used in this research: (1) single stimulation (or 1 s of  stimulation at 1 Hz; 1 pulse); (2) 1 s of 
low frequency stimulation (LFS) at 10 Hz (10 pulses); (3) 1 s of high frequency stimulation 
(HFS) at 100 Hz (100 pulses); and (4) theta burst stimulation (TBS) (Figure G.1). We use (1) 
to (3) in chapter 3 and 4, and (3) and (4) in Chapter 5. 
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(A) single stimulation 
 
(B) LFS 
 
(C) HFS 
 
(D) TBS
 
Figure G.1. Stimulation patterns. (1) A single pulse stimulation (or 1 s of  stimulation at 
1 Hz; 1 pulse); (2) 1 s of low frequency stimulation (LFS) at 10 Hz (10 pulses); (3) 1 s of 
high frequency stimulation (HFS) at 100 Hz (100 pulses); and (4) theta burst stimulation 
(TBS). One TBS train consists of 10 stimulus bursts at 5 Hz and each burst consists of four 
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pulses at 100 Hz. The TBS trains are delivered at 0.1 Hz (10 s separation between trains) 
(Lee, Barbarosie et al. 2000). 
G.2 Postsynaptic stimulation 
The action potential (AP) of a neuron travels along the axon and it has been found that AP can 
propagate back to the dendrites of the pyramidal neurons. This phenomenon is called 
backpropagation of action potentials (bAP). bAP can create a strong depolarisation on the 
dendritic membrane, with a brief duration. It activates VDCC to induce ions flux across the 
membrane (Sabatini, Oertner et al. 2002). We simulate the bAP by injecting a potential into 
the spine head and dendrite shaft to generate the bAP amplitudes of bAPs 66.4 and 66.7 mV, 
respectively (Palmer and Stuart 2009). 
The decay of bAP is simulated by a simple function as 
𝑉𝑏𝐴𝑃 = 𝐴(𝑘𝑓 𝜃(𝑡 − 𝑡𝑖)𝑒
−(𝑡−𝑡𝑖)
𝜏𝑓 + 𝑘𝑠 𝜃(𝑡 − 𝑡𝑖)𝑒
−(𝑡−𝑡𝑖)
𝜏𝑠 ) 
 
where 𝐴 is the bAP amlitude, 𝑘𝑓 = 75% and 𝑘𝑠 = 25% are the proportions of fast and slow 
decay, respectively. 𝜏𝑓= 3ms and 𝜏𝑠 = 25 ms are the time constants for fast and slow decay, 
respectively. 𝜃(𝑡 − 𝑡𝑖) is a Heaviside function in which 𝜃(𝑠𝑡 − 𝑡𝑖) = {
0,   𝑖𝑓 𝑡 < 𝑡𝑖,
1,   𝑖𝑓 𝑡 ≥ 𝑡𝑖.
 𝑡 is the 
current time and 𝑡𝑖 is the time at when bAP occurs (𝑡𝑖 = 0 in this case). Parameter values are 
taken from (De Schutter and Bower 1994). 
 
G.3 Pairing stimulation 
Both EPSP and bAP themselves are not enough to induce significant depolarisation in the 
postsynaptic membrane. In the experiments, stimulation at both the presynaptic and 
postsynaptic neurons are used to create pairing of the bAP and the EPSP, which causes a large 
depolarisation and Ca2+ influx through the NMDARs (Caporale and Dan 2008) (Figure G.2). 
The interval between the pairing stimulation is a critical factor as it controls the significance 
of postsynaptic depolarisation (Shouval, Bear et al. 2002). The application of pairing 
stimulation is shown in Chapter 5. 
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c  
Figure G.2. Pairing stimualtion. A pairing stimulation contains a presynaptic 
stimualtion at time t1 and a postsynaptic stimualtion at t2. The time interval between the 
pairing stimulation is t2 – t1 = Δt. 
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Appendix H. Complete CaMKII ST model and Parameters  
H.1 Reation rates 
There are 7 (R1~R7) and 12 reaction rates (R8~R19) of the reactions governing the subunit 
state transitions and holoenzyme state transitions of CaMKII, respectively. All reation rates 
are given in a unit of # s-1. 
H.1.1 Subunit state transitions CaMKII  
Ca2+ attaches to CaM to form CaCaM, 
.    (H.1) 
Ca2+ attaches to CaCaM to form Ca2CaM,  
.   (H.2) 
Ca2+ attaches to Ca2CaM to form Ca3CaM, 
.   (H.3) 
Ca2+ attaches to Ca3CaM to form Ca2+/CaM complex, 
.   (H.4) 
Ca2+/CaM complex binds to iCaMKII to form CaMKIICaM.  
.  (H.5) 
Autophosphorylation of CaMKIICaM to form CaMKII* (Chiba, Schneider et al. 2008), 
,    (H.6) 
where P = . 
Dephosphorylation of CaMKII* into CaMKIICaM by PP1 (Chiba, Schneider et al. 2008), 
2
1 6 6f bR k Ca CaM k CaCaM
  
2
2 7 7 2f bR k Ca CaCaM k Ca CaM
  
2
3 8 2 8 3f bR k Ca Ca CaM k Ca CaM
  
2
4 9 3 9 4f bR k Ca Ca CaM k Ca CaM
  
5 1 4 1f bR k Ca CaM iCaMKII k CaMKIICaM  
1
6
1
cat
m
K CaMKIICaM P ATP
R
K ATP
 


2
1
total
iCaMKII
CaMKII
  
 
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.     (H.7) 
 
H.1.2 Holoenzyme state transitions of CaMKII 
Translocation of CaMKII into PSD 
,   (H.8) 
where  and  are the fraction of CaMKIICaM to the total number of unbound subunits 
and the fraction of CaMKII* to the total number of unbound subunits, respectively. (  is 
the fraction of iCaMKII to the total number of unbound subunits). 
,
 , 
, and 
 
 
Binding between CaMKII and NMDAR to form CaMKII-NMDAR complex 
,    (H.9) 
,   (H.10) 
where  and  are the modifier for average formation rate of CaMKIIS with respect to 91 
possible conformations of CaMKII and the modifier for average formation rate of CaMKII*S 
with respect to 91 possible conformations of CaMKII, 
*
2
7 *
2
1cat
m
K CaMKII PP
R
K CaMKII



2 3 4
8 2 2
3 2 3 4 3
m
f b
m m
K
R k EoPSD k EiPSD
K K
 
 
  
2 3
1
 1 * *Total
iCaMKII
CaMKII CaMKIIS CaMKII S CaMKII T
 
  
 2 * *Total
CaMKIICaM
CaMKII CaMKIIS CaMKII S CaMKII T
 
  
 
*
3 * *
Total
CaMKII
CaMKII CaMKIIS CaMKII S CaMKII T
 
  
1 2 3 1   
9 3 1 3f baR k EiPSD NMDAR k CaMKIIS   
*
10 3 2 3f bbR k EiPSD NMDAR k CaMKII S   
1 2
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, 
, 
where n is the number of CaM-pBS and m is the number of T286-pBS, is the probability 
of S site mediated binding between CaMKII and NMDAR and .
  
 Transfers of the S site binding to the T site  
,       (H.11) 
,       (H.12) 
 Autophosphorylating CaMKIIS to CaMKII*S  
.      (H.13) 
 CaMKII Turnover 
,       (H.14) 
,       (H.15) 
,        (H.16) 
,        (H.17) 
, and       (H.18) 
.       (H.19) 
 
 
   
12 12
12
1 2 3 1
1 0
12 ! 112!
!(12 )! !(12 )! 1 1 1 1
n
n m m n b
n m b b
n P n
n n m n m m P n P

 
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 
     
      
 
 
   
12 12
12
2 3 2 1
1 0
12 ! 112!
!(12 )! !(12 )! 1 1 1 1
m
m n m n b
m n b b
m P m
m m n n m n P m P

 
 
 
     
      
 
bP
*
b
Total
CaMKIIS CaMKII S
P
NMDAR


11 4R k CaMKIIS
*
12 4R k CaMKII S
1
13
1
cat
m
K CaMKIIS P ATP
R
K ATP
 


14 5R k CaMKIICaM
*
15 5R k CaMKII
16 5R k EiPSD
17 5R k CaMKIIS
*
18 5R k CaMKII S
*
19 5R k CaMKII T
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H.2 ODEs 
The time-dependent changes of the states of CaMKII are goven by 10 ODEs based on above 
19 reation rates:  
Ca2+/CaM complex formation: 
,        (H.20) 
,       (H.21) 
, and      (H.22) 
.       (H.23) 
Changes in IS of CaMKII: 
, and    (H.24) 
.       (H.25) 
CaMKII-NMDAR formation – Changes in HS of CaMKII: 
,      (H.26) 
,     (H.27) 
, and    (H.28) 
.      (H.29) 
1 2
dCaCaM
R R
dt
 
2
2 3
dCa CaM
R R
dt
 
3
3 4
dCa CaM
R R
dt
 
4
4 5
dCa CaM
R R
dt
 
5 6 7 14
dCaMKIICaM
R R R R
dt
   
*
6 7 15
dCaMKII
R R R
dt
  
8 9 10 16
dEiPSD
R R R R
dt
   
9 11 13 17
dCaMKIIS
R R R R
dt
   
*
10 12 13 18
dCaMKII S
R R R R
dt
   
*
11 12 19
dCaMKII T
R R R
dt
  
192 
 
 
 
Constraints due to the conserved molecular numbers: 
,   
,
, and   
.     
 
 
H.3 Variables 
Table H.1. Definition of the states/variables associated with inner state transition of 
CaMKII subunit of CaMKII 
States (#)  Definition 
Ca2+ Intracellular Ca2+ ion 
CaCaM one Ca2+ ion binds to CaM 
Ca2CaM two Ca2+ ions bind to CaM 
Ca3CaM three Ca2+ ions binds to CaM 
Ca4CaM Ca2+/CaM complex 
iCaMKII Inhibited CaMKII subunit 
CaMKIICaM CaM bound CaMKII subunit 
CaMKII* Autophosphorylated CaMKII subunit 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* * *
TotaliCaMKII CaMKII CaMKIICaM CaMKII CaMKIIS CaMKII S CaMKII T     
 2 3 4Total TotalCaM CaM CaCaM Ca CaM Ca CaM Ca CaM CaMKII iCaMKII      
* *
TotalNMDAR NMDAR CaMKIIS CaMKII S CaMKII T   
 12Total TotalEoPSD CaMKII EiPSD NMDAR NMDAR   
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H.4 Parameters and constants 
Table H.1 Parameters and constants: their biological meaning, values and sources where the values are obtained. 
Parameter Biological Meaning Value Source 
k1f Binding rate of Ca4CaM and iCaMKII 0.035 #-1 s-1 (Chiba, Schneider et al. 2008) 
k1b Dissociation rate of CaMKIICaM into Ca4CaM and iCaMKII 0.14 s-1 
k2f Translocation rate of EoPSD into PSD 0.0088 s-1 
(He, Kulasiri et al. 2015) 
k2b Dissociation rate of EiPSD out of PSD 0.247 s-1 
k3f Binding rate of elementary CaMKII to NMDAR at the S site 0.008 #-1s-1 
k3ba Dissociation rate of CaMKIIS into EiPSD and NMDAR 0.38 s-1 
k3bb Dissociation rate of CaMKII*S into EiPSD and NMDAR 0.024 s-1 
k4 Transfer rate of NMDAR binding from S site to T site 0.01 s-1 
k5 Turnover rate of CaMKII 1/108000 s-1 (Ehlers 2003) 
k6f Binding rate of Ca2+ and CaM to form CaCaM 0.0415 #-1 s-1 
(Chiba, Schneider et al. 2008) 
k6b Dissociation rate of  CaCaM into Ca2+ and CaM 50 s-1 
k7f Binding rate of Ca2+ and CaCaM to form Ca2CaM 1.45 #-1s-1 
k7b Dissociation rate of  Ca2CaM into Ca2+ and CaCaM 50 s-1 
k8f Binding rate of Ca2+ and CaCaM to form Ca3CaM 0.2 #-1 s-1 
k8b Dissociation rate of  Ca3CaM into Ca2+ and Ca2CaM 1250 s-1 
k9f Binding rate of Ca2+ and CaCaM to form Ca4CaM 4.15 #-1 s-1 
k9b Dissociation rate of  Ca4CaM into Ca2+ and Ca3CaM 1250 s-1 
Kcat1 Autophosphorylation rate of CaMKIICaM into CaMKII* 0.9 s-1 
Kcat2 Dephosphorylation rate of CaMKII* by PP1 1.72 s-1 
Km1 Michaelis constant of  the autophosphorylation 1150 #-1 
Km2 Michaelis constant of  the dephosphorylation by PP1 660 #-1 
Km3 Fraction of active CaMKII subunits at half maximal translocation rate 0.39 (He, Kulasiri et al. 2015) 
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Km4 
Fraction of autophosphorylated CaMKII subunits at  half maximal 
dissociation rate 
0.019 
Constant Biological Meaning Value (#) Source 
CaMKIITotal Total number of CaMKII subunits 1200 (Ribrault, Sekimoto et al. 2011) 
CaMTotal Total number of CaM molecule consistent with the Ca2+ model 
NMDARTotal Total number of NMDAR (or NR2B) 
ATP Total number of ATP 240000 (Coultrap and Bayer 2012) 
PP1 Total number of PP1 145 (He, Kulasiri et al. 2015) 
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